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Background: The dietary self-management of chronic kidney disease (CKD) is complex. 
People with CKD are advised to follow dietary recommendations that restrict individual 
nutrients, however these interventions have been described by people as confusing and an 
intense burden to follow. Emerging evidence suggests that improving the overall dietary 
pattern may attenuate cardiovascular risk, morbidity and mortality in people with CKD. 
Changing dietary patterns is a complex intervention, which may be facilitated utilising 
telehealth. Telehealth interventions may overcome patient-centred barriers to face-to-face 
programs and provide a feasible, ubiquitous and accessible solution. However, a telehealth-
delivered dietary pattern intervention has not been tested in the CKD population.  
Aim: The aim of this thesis was to develop and test the feasibility and acceptability of a 
patient-centred telehealth program for the dietary management of CKD. 
Methods: Several different methods were utilised to address the aim of this thesis. In the first 
study, a narrative review of the literature is described, exploring potential dietary 
interventions in CKD that go beyond the common single nutrient restrictions. Two systematic 
reviews and meta-analyses were then conducted. The first systematic review explores the 
association between healthy dietary patterns and all-cause mortality or progression to end-
stage kidney disease, by aggregating all existing CKD cohort studies and performing a meta-
analysis. The second systematic review investigates the effectiveness of telehealth-delivered 
dietary interventions in chronic disease evaluated in randomised controlled trials. The fourth 
study is a qualitative investigation utilising focus groups to explore the experiences of people 
with CKD with dietary recommendations and the potential to use telehealth for dietary self-
management. These projects were used to inform the development of a telehealth-delivered 
dietary intervention for people with CKD (titled ENTICE-CKD). The ENTICE-CKD study 
was a six-month pilot randomised controlled trial to explore the feasibility, acceptability, 
safety, and potential effectiveness of improving dietary quality and clinical parameters 
utilising a telehealth-delivered dietary program in people with stage 3-4 CKD. The 
intervention group received fortnightly phone calls for three months and weekly tailored text 
messages for six months to assist with the implementation of a diet consistent with the 
Australian Dietary Guidelines. The control group received usual care for three months 
followed by a non-tailored education-only text message intervention for three months. 
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Results: The narrative review highlighted the potential for a healthy dietary pattern to 
improve renal outcomes. This dietary approach may be attractive for several reasons, 
including the potential to be more comprehendible to people with CKD. 
The systematic review of healthy dietary patterns identified six existing CKD cohort studies 
(n=15,285 participants). A meta-analysis found a healthy dietary pattern was associated with 
reduced risk of all-cause mortality (relative risk 0.73, 95% confidence interval [CI] 0.63 to 
0.83), but no consistent association with end-stage kidney disease was found. There was no 
standardised dietary pattern, however, diets were generally higher in fruit and vegetables, fish, 
legumes, cereals, whole grains, and fibre and lower in red meat, salt, and refined sugars 
compared to reference diets. 
The systematic review of telehealth-delivered dietary interventions identified a total of 25 
studies (n=7,384 participants) eligible for inclusion, with study duration ranging from eight 
weeks to eight years. Telehealth interventions were effective in chronic disease dietary 
management, specifically for improving diet quality (Standardised Mean Difference [SMD] 
0.22, 95%CI 0.09 to 0.34]), fruit and vegetable intake (Mean Difference [MD] 1.04 
servings/day, 95%CI 0.46 to 1.62), and dietary sodium intake (SMD -0.39, 95%CI -0.58 to, -
0.20). Half (52%; n=13) of the included studies were conducted utilising the telephone, and 
16% (n=4) using mobile phone text messaging. Other forms of telehealth were less commonly 
utilised for chronic disease dietary management. No randomised controlled trials conducted in 
CKD populations were identified. 
The qualitative study comprised five focus groups involving 21 people with CKD (and 3 
carers; n=24 participants). Key findings were that people with CKD experience an array of 
barriers and facilitators to achieving their dietary recommendations, and these were reported 
across five primary themes: 1) Exasperating stagnancy (where people feel patronised by 
redundant advice, confused and unprepared for dietary change, feel there is an inevitability of 
failure, and many barriers to accessing dietetic services); 2) Supporting and sustaining change 
(where people prefer receiving regular feedback, getting incremental and comprehendible 
dietary modification, practical guidance on food, receive services with flexibility in 
monitoring schedule, and valuing peer advice); 3) Fostering ownership (seeking kidney diet 
information, enacting behaviour change, making reminders, and tracking progress against 
targets); 4) Motivators and positive learning instruction (relying on reassurance, positive 
reinforcement, wanting clinicians to focus on allowable foods, and involving their family); 5) 
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Threats and ambiguities of risk (where people view sugar as the culprit in their diet, 
experience ubiquity of salt, difficulty with illegible food labelling, wanting to avoid processed 
foods, and questioning credibility of sources where appropriate). Participants were open to 
using telehealth to support their dietary recommendations, with each of the five themes 
having important sub-themes related to using telehealth for dietary self-management. 
The collective results of the narrative review, two systematic reviews, as well as the 
qualitative study were used to inform the development of a telehealth-delivered dietary 
intervention specific for people with CKD. The telephone and mobile phone were identified 
as the best delivery methods, as participants in the qualitative study were most comfortable 
using these telehealth modalities. The delivery schedule was decided to be fortnightly with 
weekly text messages to ensure contact and feedback was regular, and the diet advice was not 
restriction focused, but was comprehensive and delivered in steps across each phone call.  
Eighty participants were recruited for the ENTICE-CKD pilot trial. The intervention was 
shown to be feasible and acceptable by participants. The trial had good retention with 93% 
and 98% remaining in the intervention and control groups for the six-month study duration, 
respectively. The intervention was successfully delivered to protocol, and 96% of all planned 
intervention calls were completed. All (100%) participants in the intervention group viewed 
the tailored text messages as acceptable in supporting their dietary change, compared to 27 
participants (69%) in the non-tailored education-only text messages (control) group. At three 
months, participants in the intervention group improved the proportion of calories from the 
core (non-discretionary) food groups (5.2%, 95% CI 0.6 to 9.9) that they consumed, increased 
vegetable intake (1.4 serves, 95% CI 0.6 to 2.1] per day), increased dietary fibre intake (5.5 
grams, 95% CI 2.7 to 8.2] per day), and reduced body weight (-1.7kg, 95% CI -3.1 to -0.3]) 
compared to the control group. At six months, only the proportion of calories from core (non-
discretionary) foods consumed by participants remained significant (4.3%, 95% CI 0.3 to 
8.2]) compared to the control group. No adverse events related to the intervention were 
reported throughout the study.  
Conclusion: The research conducted as part of this thesis shows that a telehealth-delivered 
intervention to improve diet quality may be feasible, acceptable, safe and effective for stage 
3-4 CKD dietary self-management. This research addresses important gaps in the literature, 
can be used to inform public policy about the use of telehealth in chronic disease 
management. A large-scale randomised controlled trial to determine the effectiveness of the 
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ENTICE-CKD program on patient-centred quality of life, and renal and cardiovascular 
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 - Introduction 
Chronic kidney disease (CKD) currently affects 1 in 10 people worldwide (Bello et al., 2017). 
The burden of CKD individuals experience is complex, as people usually have multiple 
comorbidities (particularly cardiovascular disease [CVD] and diabetes) (Ong, Jassal, Porter, 
Logan, & Miller, 2013). These comorbidities are resource intensive across multiple levels of 
the healthcare system (Sevick et al., 2007). Therefore, CKD follows a substantial impact on 
people’s lives, particularly the considerable time required to invest in the self-management of 
their diet, lifestyle, medications, and attending multiple specialist appointments (Bonner et al., 
2014).  
Dietary self-management has long been considered a modifiable risk factor for the 
progression of CKD. Dietary advice is often multifaceted, complex and requires 
individualised support (Mozaffarian, 2016; Smyth et al., 2014). However, clinicians are 
challenged in practice to provide the individualised support with the frequency and 
consistency required to sustain long-term dietary changes.  
Current best-practice guidelines from the Kidney Disease: Improving Global Outcomes 
(KDIGO) Work Group (Eknoyan et al., 2013), the American Dietetic Association (American 
Dietetic Association, 2010) and the Australian New Zealand Renal Guidelines Taskforce (Ash 
et al., 2006) focus on the modification of singular nutrients (e.g. potassium, phosphate and 
sodium), which have an conflicting evidence-base for impacting on renal and cardiovascular 
health.  
The Caring for Australians with Renal Impairment (CARI) practice guidelines now 
recommend applying the Australian Dietary Guidelines to reduce risks and complications 
associated with CKD (Chan & Johnson, 2013). This reflects a paradigm shift in renal 
nutrition, towards improving overall diet quality through targeting the overall dietary pattern, 
and away from single nutrient interventions. However, there is paucity of clinical trials to 
demonstrate the effectiveness of diet quality interventions in CKD. Furthermore, there is no 
indication as to the level of individualised support and education required to sustain a healthy 
dietary pattern over the long-term to see the improvements in outcomes demonstrated in these 
studies (Ricardo et al., 2015; Ricardo et al., 2013).  
Following single nutrient recommendations is considered complex and often results in a wide 
range of conflicting dietary recommendations for other associated commodity risk factors 
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(Smyth et al., 2014). People with CKD commonly express feeling overwhelmed with dietary 
information and an intense burden when implementing dietary advice (Palmer et al., 2014). 
People with CKD express a preference for regular coaching and monitoring to help them 
understand dietary recommendations and become confident in their ability to self-monitor and 
manage such changes (Palmer et al., 2014).  
With the growing prevalence of CKD, the demand on health services and resources are 
likewise increasing (Campbell & Murray, 2013). Specialised renal dietitians are lacking in 
number and patients may experience inconsistencies between treating clinicians. Therefore, 
regular coaching is not feasible under the current models of healthcare. It is now timely to 
look to alternative methods of healthcare delivery within current healthcare resources, which 
facilitate patient-centred care and reduce the barriers that patients face to achieve effective 
dietary self-management.  
Telehealth is an umbrella term that encompasses a whole range of health practice activities, 
specifically delivered from a distance. Utilising telehealth modalities to provide dietary 
coaching, particularly through phone-based and text message platforms, provide an alternate 
framework for frequent and structured contact that is needed to support the complex dietary 
change required in CKD. The steep trajectory in the use of technology over the last 10 years is 
well acknowledged (Wootton, 2012). It has been estimated that over 90% of Australians 
currently have access to some form of telecommunication service (e.g. telephone, mobile, 
and/or internet), highlighting the potential for such devices to be used to deliver and support 
dietary education in a widely accessible manner (ACCAN - Australian Communication 
Consumer Action Network, 2014). Telehealth interventions offer a potential solution to 
overcome the typical logistical challenges in accessing traditional healthcare services and may 
assist overcoming patient-centred barriers to implementing dietary recommendations, as they 
provide people with flexibility and have a high rate of patient acceptability (World Health 
Organization, 2010). Telehealth interventions may therefore facilitate dietary change through 
increasing the reach of service, the amount of contact with clinicians and deliver dietary 
education in an easy to understand format.  
There are important questions which remain unanswered in literature available to date (see 
section 2.7.1 Identification of key gaps in the literature). The associations of healthy dietary 
patterns to clinical outcomes in CKD have not been systematically summarised. Alternative 
methods of dietary intervention delivery have not been explored in CKD. While evidence to 
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support the improvement in diet quality in other chronic diseases exists, the wider evidence-
base for the effectiveness of telehealth-delivered interventions for complex dietary advice 
(e.g. changing overall dietary patterns) has not been systematically synthesised to date. 
Another gap in the current literature is the absence of telehealth-delivered dietary 
interventions in CKD. Before a telehealth program could be designed and piloted in CKD, 
adequate patient-engagement is needed to inform such intervention development. Finally, the 
development and pilot of a telehealth program to improve diet quality in CKD has not been 
conducted to date, and therefore there is no current knowledge as to the feasibility, 
acceptability, safety, and possible effectiveness of such an intervention.  
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1.1 Overarching thesis aim  
The overall aim of this thesis is to develop and test the feasibility and acceptability of a 
patient-centred telehealth program for the dietary self-management of CKD.  
1.2 Research questions  
This thesis will seek to investigate the following unanswered questions to address the thesis 
aim: 
1. Is a healthy dietary pattern associated with improved survival and reduced risk of end-
stage kidney disease in established kidney disease populations?  
2. What telehealth programs have been conducted in chronic disease populations; what 
content has been utilised; and what is their overall effectiveness on facilitating dietary 
change? 
3. What are the greatest challenges people with CKD experience in relation to achieving 
their dietary recommendations?  
4. What do people with CKD perceive as facilitators and barriers to using telehealth to 
support their dietary self-management? 
5. Is telehealth coaching to improve diet quality feasible and acceptable to patients with 
stage 3-4 CKD? 
6. Is a telehealth intervention safe and effective at improving diet quality in people with 
stage 3-4 CKD? 
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1.3 Conceptual framework  
To address the aim of this thesis, the steps of the m-Health framework were followed for 
developing and evaluating telehealth interventions (Whittaker, Merry, Dorey, & Maddison, 
2012), which details the steps in the development of an m-Health intervention as:  
1. Conceptualization;  
2. Formative research;  
3. Pretesting;  
4. Randomised controlled trial; and  
5. Qualitative research (interviews).  
These steps have the purpose of bringing together experts in the relevant fields, informing the 
development of the intervention, determining its acceptability, engaging with patient on the 
content and timing and the data collection process, testing  effects in comparison to a control 
group, and improving the intervention and implementation methods. This framework has been 
adapted to describe the process in developing a telehealth program in this thesis. This 
framework is outlined in Table 1-1. 
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Table 1-1: Framework for the development of a telehealth program in CKD. 
Development 
phase 














• Advisory group 
(supervisory team) 
meetings/discussions 
• Literature review  
• Scoped narrative 
review  
• Systematic review 
a. Dietary 
approaches 
b. Delivery method 
• Experts in the field of nutrition in 
CKD, chronic disease, and the use of 
telehealth methods in clinical 
research 
• Explore current patient-centred issues 
with renal nutrition practice in the 
literature 
• Establish potential associations of 
dietary patterns to CKD clinical end-
points  
• Critically appraise the evidence for 
telehealth methods in chronic disease 
• Establish the effectiveness of 
telehealth for complex dietary change 















• Focus groups 
 
• Cross-sectional survey 
(not a primary 
publication of this 
thesis; available in 
Appendix C) 
• Establish the prevalence of 
technology use in CKD patients 
• Determine what types of technology 
do patients use, or feel comfortable 
using, and what barriers they might 
experience to using 
• Explore patients’ perspectives on 
technology  
• Explore patients’ opinions on using 













 • ‘Beta-testing’ the 
developed telehealth 
program 
• Quality testing  
• Attain feedback from consumer 
groups and participants involved in 
the formative stage 
• Attain feedback from expert 




























• Determine the telehealth program’s 
feasibility, acceptability, safety and 
effectiveness in improving diet 

























 • Follow up interviews 





• Determine the telehealth program’s 






1.4 Thesis arrangement  
Following this introductory chapter, a thorough literature review was performed (Chapter 2) 
which highlights the key gaps in the literature required to address this thesis’ aim. The 
subsequent 8 distinct, yet interrelated chapters address each of the research questions detailed 
on page 4, and are arranged into 4 sections, as detailed below.   
Section 1: Dietary approaches in CKD 
• Chapter 3: Beyond sodium, phosphate and potassium: potential dietary interventions in 
kidney disease 
• Chapter 4: Healthy dietary patterns and risk of mortality and ESRD in CKD: a meta-
analysis of cohort studies 
Section 2: Telehealth delivery methods for dietary approaches in CKD 
• Chapter 5: Telehealth methods to deliver dietary interventions in adults with chronic 
disease: a systematic review and meta-analysis 
• Chapter 6: Patient experiences of dietary management in chronic kidney disease: a focus 
group study 
Section 3: Pilot randomised controlled trial 
• Chapter 7: The evaluation of individualized telehealth intensive coaching to promote 
healthy eating and lifestyle in chronic kidney disease (ENTICE-CKD): a mixed methods 
process evaluation. 
• Chapter 8: A dietary coaching program to improve dietary quality and clinical outcomes 
in CKD: Results from a pilot randomized controlled trial 
Section 4: Overall discussion, future directions and conclusion  
• Chapter 9: Discussion and future directions  
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 - Literature review 
2.1 What is Chronic Kidney Disease? 
Chronic kidney disease (CKD) is a progressive, degenerative and functional decline in the 
kidney, that has been evident for at least three months (Eknoyan et al., 2013). Chronic kidney 
disease is defined by a reduced glomerular filtration rate (GFR) of less than 60ml/min/1.73m2 
or abnormal concentrations of albuminuria, or both (Eknoyan et al., 2013). The Kidney 
Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines (2012) detail two 
main methods for diagnosing and evaluating CKD; the first is grading the estimated 
glomerular filtration rate (GFR), measured by blood test and CKD-EPI estimating equation 
(based on race, sex, and serum creatinine level) (Levey et al., 2009). The second criteria is the 
albumin excretion rate measured in the urine, and may not necessarily be present with 
impaired kidney function (Eknoyan et al., 2013). Table 2-1 lists the stages of impaired kidney 
function and guiding criteria for diagnosing CKD.  
Table 2-1: Stages of CKD defined according to GFR and albuminuria categories (Eknoyan et 






G I >90 Normal or high  
G II 60–89 Mildly decreased Monitor 
G3 IIIa 45–59 
Mildly to moderately 
decreased 
Monitor – consider 
AER 
G IIIb 30–44 
Moderately to severely 
decreased 
Referral – consider 
AER 
G IV 15–29 Severely decreased Referral 






A I <30 Normal/mildly increased  
A II 30-300 Moderately increased 
Referral – consider 
eGFR 
A III >300 Severely increased Referral 
Abbreviations: GFR – glomerular filtration rate, AER – albumin excretion rate, ml – millilitre, min – 
minute 
The burden of CKD is multifactorial. Firstly, the prevalence of CKD is growing, currently 
estimated at 10-11 percent of the adult population worldwide (Bello et al., 2017). It is 
estimated that less than a third of those with CKD are currently aware they have it (Bello et 
al., 2017). Secondly, the rising prevalence of CKD is also important due to the increased risk 
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of death. Over 10 percent of Australian deaths are attributable to CKD (Australian Institute of 
Health and Welfare, Cat. no. AUS 178). Cardiovascular disease (CVD) contributes to over 
half of the major causes of death in established CKD populations. (Stenvinkel et al., 2008; 
Tedla, Brar, Browne, & Brown, 2011). Thirdly, the current costs for treatment of people with 
end-stage kidney disease (ESKD) exceeds one billion Australian dollars (AUD) per year, 
which is greater than 15% of the Australian Government’s total expenditure on health 
(Australian Institute of Health and Welfare, Cat. no. AUS 178). By 2020, the expected costs 
to the Australian Government to treat, dialyse or transplant people with ESKD is estimated at 
12 billion AUD (Cass et al., 2006).  
2.1.1 Cardiovascular disease in CKD: a complex relationship 
Chronic kidney disease is often a progressive condition, where complications become more 
difficult to manage as an individual progress through the stages outlined in Table 2-1. If CKD 
progression cannot be slowed, then renal replacement therapy (dialysis or renal 
transplantation) will be required to sustain life. The benefit of delaying CKD progression and 
limiting CKD-related complications is to reduce the high mortality rates outlined above. 
However, the reality is that an individual who displays even early stages of CKD is more 
likely to die of CVD related causes than ESKD (Blood Pressure Lowering Treatment 
Trialists’ Collaboration, 2013; Stenvinkel et al., 2008). Furthermore, CVD risk increases as 
early as stage 2 CKD, and exponentially increases as kidney function further declines 
(Vanholder et al., 2005). Undeniably, there is a strong relationship between the kidney and 
cardiovascular function, and its complexity is only exacerbated as either system further 
declines. Thus, the mainstay and target for CKD treatment has been to slow the progression of 
the disease. 
There is great complexity to the development of CVD in CKD, involving a magnitude of 
multifactorial traditional and non-traditional risk factors (Stenvinkel et al., 2008), and it 
depends on the underlying cause of CKD, especially hypertension (McMahon, Campbell, 
Bauer, & Mudge, 2015) and diabetes (Tan, Jaung, Gamble, & Cundy, 2014). Evidence 
supports traditional CVD risk factors to be similarly present in CKD populations and may 
account for the higher CKD death rate by CVD causes, including hypertension, obesity, 
smoking, older age, left ventricular hypertrophy (LVH), and dyslipidaemia (Stenvinkel et al., 
2008). These factors are central to combating the elevated CVD risks in CKD. However, non-
traditional risk factors are emerging as influential to the incidence of CVD in CKD patients 
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(Muntner, 2004; Stenvinkel et al., 2008). These include a reduced GFR and albuminuria (van 
der Velde et al., 2011), anaemia (Hörl, 2013), increased inflammatory markers, oxidative 
stress, protein-energy malnutrition (Stenvinkel et al., 2008), vitamin D deficiency, and 
elevated serum uric acid (Glassock, Pecoits-Filho, & Barberato, 2009).   
2.2 Hypertension, CVD and CKD: Why is blood pressure control important? 
The burden of hypertension is considered both a cause and consequence of CKD, and good 
management is a central strategy to combat the excessive CVD risk in CKD.  
Hypertension affects over one-third of Australian adults (National Heart Foundation of 
Australia, 2008) and in the United States (US) (Garimella & Uhlig, 2013), yet prevalence is 
substantially higher in CKD (Tedla et al., 2011). Specifically, even in early stage 2-3 CKD, 
hypertension is prevalent in over half of patients (Tedla et al., 2011). Hypertension may also 
develop and worsen as kidney function deteriorates, with prevalence reported at 70-85% in 
stages 4-5 CKD (Cai, Zheng, Sun, & Chen, 2013; Garimella & Uhlig, 2013; Jessani, Bux, & 
Jafar, 2014; Sarafidis, 2008).  
An important body of evidence for the role of hypertension in driving higher CVD prevalence 
in CKD comes from a prospective collaborative meta-analysis of 150,000 trial participants 
with and without CKD (Blood Pressure Lowering Treatment Trialists’ Collaboration, 2013). 
Over 15,000 cardiovascular events were recorded, suggesting that a reduction of 5mmHg 
systolic blood pressure (SBP) reduced the risk of major cardiovascular events by 17% in 
participants with GFR ≤60 mL/min/1.73m2. This provides vital and compelling evidence for 
the cardiovascular benefits of reducing blood pressure (BP) in people with stages 2-3 CKD. 
However, this analysis was limited by the low percentage of participants with stage 4-5 CKD, 
who comprised less than four percent of the total CKD sample.  
A strong predictor of sudden death from CVD in CKD is left ventricular hypertrophy 
(Glassock et al., 2009; Paoletti et al., 2004; Silberberg, Barre, Prichard, & Sniderman, 1989). 
This is defined as a physiological adaption to a long-term increase in cardiac workload (from 
pressure or volume overload), with a prevalence of 75-80% in CKD stages 4 and 5 (Paoletti, 
Bellino, Cassottana, Rolla, & Cannella, 2005). Hypertension is regarded as a major 
contributor in the pathogenesis of left ventricular hypertrophy, however other important 
markers such as endothelial dysfunction have been proposed as a likely mediator (Poulikakos 
et al., 2014). Increased left ventricular mass index has been associated with acceleration of 
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progression to ESKD in a CKD stage 3 to 4 sample absent of diabetes or severe ischaemic 
heart disease (Paoletti et al., 2011). 
Thus, with a complex relationship between CKD and CVD, controlling BP is an essential 
modifiable risk factor in attenuating the risk for CVD in CKD (Elliott, McCaughan, & 
Fogarty, 2014), and is a focal medical treatment target by general practitioners and treating 
nephrologists.  
2.2.1 Blood pressure targets for the medical management of CKD 
Elevated BP follows a strong link and risk for CVD. As such, BP targets have long been 
debated in nephrology to control the elevated CVD risk. Table 2-2 shows that the optimal BP 
targets for people with CKD remains a topic of on-going debate (Kovesdy et al., 2014). 




CKD criterion BP target 
 
Level of Evidence 




≤140/90mmHg Level 1B evidence 
With albuminuria 
>30mg/day 
≤130/80mmHg Level 2D evidence – 
same recommendation 
for albuminuria 
>3000mg/day - level 2C 
evidence 
JNC – VIII (James et 
al., 2014) 
CKD >18 years 
of age 
≤140/90mmHg Expert opinion Grade E 
evidence 
 
European Society of 
Cardiology (Mancia 
et al., 2013) 
 
CKD > stage 3 ≤140/90mmHg  
Level 2B evidence CKD 3 with overt 
proteinuria  




Ninomiya, Huxley, & 
Perkovic, 2010)  
CKD > stage 3 ≤140/90mmHg Level 2D evidence 
 
Level 2B evidence 
CKD 3 with 
macroalbuminuria  
  ≤130mmHg  
Abbreviations: KDIGO – Kidney disease improving global objectives, CARI – Caring for Australians 
with Renal Impairment, JNC-VIII - Eighth Joint National Committee, CKD – Chronic Kidney 
Disease. 
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Because of the limited number of randomised controlled trials (RCT), the core 
recommendations in these guidelines (Table 2-2) are based on modest evidence limited to post 
hoc analysis following the conclusion of the randomised trial period (Appel et al., 2010; Klahr 
et al., 1994; Ruggenenti et al., 2005; Sarnak, Greene, & Wang, 2005; Wright et al., 2002).  
A recent landmark trial, the Systolic Blood Pressure Intervention Trial  (SPRINT) study 
(SPRINT Research Group, 2015) showed that intensive BP treatment to <120mmHg systole 
was not more effective than standard treatment to treat SBP <140mmHg in any of the renal 
outcomes in the established CKD sub-population. However, among those without established 
CKD at baseline, intensive BP treatment led to a higher incidence of CKD, calculated as a 
>30% reduction in GFR to <60ml/min/1.73m2. Although the primary analysis, including non-
CKD participants showed a clear, significant improvement in all-cause survival (HR 0.78 
[0.67–0.90]) and CVD death (HR 0.57 [0.38–0.85]), it appears that adequate BP control to 
standard guidelines is sufficient to reduce negative renal and CVD related complications in 
the established CKD population. 
Treatment to achieve BP targets involves a multitude of antihypertensive medications (Unni 
et al., 2014). First-line medications are angiotensin-converting enzyme (ACE) inhibitors or 
angiotensin receptor blockers (ARBs) (~80% patients) (Unni et al., 2014). Second line are 
considered diuretics and beta-adrenergic antagonists (Beta-blockers), which are not effective 
alone at reducing BP (Unni et al., 2014), yet have been shown in a recent meta-analysis to 
reduce all-cause mortality (Badve et al., 2011). However, a combination of the above 
pharmacological agents is used in practice, with less than seventy percent of people with CKD 
achieving adequate BP control (Razavian et al., 2011; Unni et al., 2014).  
As BP control is known to be sub-optimal, other strategies are necessary to assist in the 
pharmacological management of hypertension in CKD. A strong evidence base supports the 
renal protective effects of modified dietary sodium in reducing BP (thus controlling 
hypertension) (Aburto et al., 2013; He, Li, & MacGregor, 2013; McMahon et al., 2015) and 
improving the pharmacological effect of first line antihypertensive medications (ACE and 
ARB inhibitors) (Vegter et al., 2012). 
2.3 Dietary sodium modification: a key management strategy in CKD 
For many years the harmful effects of excessive dietary sodium intake have been argued, 
predominantly for its effect on BP. From epidemiological evidence, one of the first landmark 
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studies was the International Study on Salt and Blood Pressure (INTERSALT) study. This 
study found that lowering sodium intake by 100mmol/day reduced SBP by 3-6mmHg and 
prevented any age-related rise in SBP (Elliott et al., 1996). In a meta-analysis of all dietary 
sodium RCTs in the general population (non-CKD studies), BP has been decreased by 
5.06/2.7mmHg (SBP/DBP) in individuals with hypertension, and -2.03/-1.2mmHg in 
individuals defined as normotensive (He et al., 2013). Thus, most public health programs now 
recommend reducing dietary sodium intake regardless of BP status as a preventative measure 
to the pathogenesis of hypertension.   
These findings were used in the development of Australian National Health and Medical 
Research Council (NHMRC) public health guidelines, which recommend an upper limit of 
2300mg sodium (6g salt) per day, and an adequate intake set much lower at 460-920mg 
sodium (1-2.5g salt) per day (Nutrient Reference values for Australia and New Zealand, 
2005). This is in alignment with international guidelines such as the Institute of Medicine 
(Yaktine, Oria, & Strom, 2013) and the World Health Organisation (WHO) (World Health 
Organization, 2012). Such guideline recommendations have very poor uptake in the general 
population though, with estimated intake exceeding 8-12g a day in some westernised societies 
(He & MacGregor, 2010).  
Good quality evidence from RCTs supports the effectiveness of reduced sodium intake in 
improving a range of outcomes for people with CKD. Aside from increases in BP, 
cardiovascular morbidity and mortality, high dietary sodium intake is associated with 
increased proteinuria and accelerated decline in kidney function (Smyth et al., 2014). Dietary 
management and control of sodium intake is arguably one of the most fundamental treatment 
strategies for CKD.  
The Ramipril Efficacy in Nephropathy (REIN I & II) trials, were RCTs conducted in 1992 
and 1999, consisting of 177 patients with proteinuric CKD (REIN I), and 335 patients (REIN 
II) who were randomised to either control group or to treatment group receiving the ACE 
inhibitor (Ramipril). Both trials recruited adult participants with CKD and confirmed 
proteinuria (urinary protein excretion ≥1 g/24 hours for at least three months without urinary 
tract infection or overt heart failure) (Ruggenenti et al., 1999; Ruggenenti et al., 2005). In a 
post-hoc analysis conducted by Vegter and colleagues (Vegter et al., 2012), the 500 non-
diabetic CKD participants of REIN I & II were categorised according to their average urinary 
sodium/creatinine excretion: n=111 consuming a low sodium diet (<100mmol/day), n=336 
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consuming a medium sodium diet (100-200mmol/day), and n=53 consuming a high sodium 
diet (>200mmol/day) (Vegter et al., 2012).  At an average of four year follow up, a higher 
sodium diet was associated with a 3.3-fold (95%CI 1.7 to 6.4) increased risk of progressing to 
ESKD compared to a lower sodium diet (p<0.001). This risk remained significant when 
comparing to the medium sodium diet group (2.4-fold increased risk; 95% CI 1.4 to 4.1; 
p=0.002) (Vegter et al., 2012). Proteinuria reduced by 31% (p<0.001), and 20% (p=0.036) 
versus baseline in the low sodium and high sodium diet, respectively. In subsequent follow 
up, proteinuria had returned to baseline values in the high sodium group, whereas proteinuria 
reduction was sustained in the low sodium group for the entire follow up period. The use of 
BP lowering medications was not significantly different among the different levels of sodium 
intake at baseline. However, on subsequent follow-up there were fewer patients taking 
diuretic medication in the lower sodium intake group than in the medium and high sodium 
intake (reduction of 5.5% compared to an increase of 3.8%) (Vegter et al., 2012). Overall, this 
post-hoc analysis demonstrated a risk of progression to ESKD increases linearly with 
increasing dietary sodium intake; whereby for each 100mmol/day increase in urinary 
sodium/creatinine excretion a 1.61-fold (95%CI 1.15 to 2.24) greatest risk for ESKD was 
observed (Vegter et al., 2012). 
Subsequent clinical trials such as the original RENAAL (Brenner et al., 2000) and IDNT 
(Rodby et al., 2000) support these findings. A post hoc analysis in 1,117 diabetic patients 
from these trials evaluated the role of dietary sodium intake (as determined by 24-h urine 
sodium excretion) in conjunction with angiotensin-receptor blockers in preventing CKD and 
CVD end points.(McMullan et al., 2014) The results showed that patients with the lowest 
sodium-to-creatinine ratio had the highest reductions in 24-h urinary albumin-to-creatinine 
ratio and SBP.  However, changes were not significant in those with the highest baseline 
sodium-to-creatinine ratio (McMullan et al., 2014). 
2.3.1 The effect of dietary sodium on blood pressure and cardiovascular disease risk 
Controlling BP through dietary sodium modification is only important if it translates to a 
reduction in CVD outcomes. There is uncertainty regarding the relationship between sodium 
and CVD from the level 1 evidence to date (Taylor, Ashton, Moxham, Hooper, & Ebrahim, 
2011). Unfortunately, meta-analyses specifically including RCTs with cardiovascular 
outcomes (including non-CKD populations) have not been able to determine a risk of CVD, 
due to the lack of long term clinical trials (Aburto et al., 2013; Adler et al., 2014). 
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Furthermore, findings from systematic reviews of observational cohort studies (NHMRC 
level 3 evidence) exploring the association of sodium intake with CVD outcomes are divided 
and flawed with methodological issues (Cobb et al., 2014). Meta-analyses that have examined 
the relationship between dietary sodium and CVD/all-cause mortality are tabulated in Table 
2-3. 
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- Meta-analysis of observation trials with outcomes on 
ACM.  
- Healthy and diseased persons, irrespective of race, sex, 
and age were included.  
- Analysed by ‘Low sodium’ (mean daily sodium intake 
<115 mmol), ‘Usual sodium’ (mean daily sodium intake 
of 115–215 mmol), and ‘High sodium’ (mean daily 
sodium intake >215 mmol).  
- ‘Usual sodium’ further analysed by ‘Low usual sodium’ 
(115–165 mmol) and ‘High usual sodium’ (166–215 
mmol). 
- High verse low sodium, and usual verse low Na+ 
indicated inverse relationships – however, majority (19 
trials) included high risk subjects in sample). 
- 15 studies had only one measure of sodium intake. 
Abbreviations: CI: 95% confidence interval, RR: relative risk, HR: hazard ratio, g: gram, f/u: follow up, ACM: All-cause mortality, CVD: cardiovascular 
disease, HT: hypertension, NT: normotension, NP: not published, RCTs: randomised controlled trials.  
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Despite strong linear trends for the control of BP and associated CVD outcomes in the 
observational literature, inverse or J-curve relationships have been documented, which signify 
higher all-cause mortality at both the highest and lowest intakes of sodium. In recent years, 
the scientific merit of this J-shapes curve has been scrutinised for its methodological issues 
and lacking high level evidence (Cobb et al., 2014; Whelton & Appel, 2014). For example, in 
recent analyses reporting a J-curve relationship (Stolarz-Skrzypek & Staessen, 2015), the 
authors have included studies with only one measure of sodium intake over many years of 
follow up; either urinary excretion (24hr/spot/overnight samples) or dietary 
(recall/questionnaire) (Cobb et al., 2014; Merino et al., 2015). This is a critical limitation to 
these study designs, and many have questioned whether a true association between all-cause 
mortality and dietary sodium intake can be interpreted from a single measure of sodium 
intake. In addition, there are limitations in urinary sodium collections and diurnal variation in 
daily intake, and dietary recall methods which notoriously underestimate dietary sodium` 
intake (Beevers, 2002; Whelton et al., 2012). Furthermore, it seems that these relationships 
may only relate to people at high risk of CVD (Alderman, Madhavan, Cohen, Sealey, & 
Laragh, 1995; O'donnell et al., 2011; Stolarz-Skrzypek & Staessen, 2015) and are likely 
subject to reverse-causality, whereby high risk (e.g. heart failure) patients are told to reduce 
their sodium intake to avoid mortality (thus subsequent mortality would be unrelated to their 
sodium intake but in-fact their underlying condition) (Merino et al., 2015; Whelton & Appel, 
2014). Another possibility is that certain populations may have a reduced sodium intake in the 
context of malnutrition (i.e. a reduced sodium intake as a consequence of not eating), which 
would further confound the conclusions that could be drawn. 
In contrast to these findings, a recent large scale meta-analysis reported on the results of 107 
RCTs (all durations, levels of sodium intake and measure of compliance) (Mozaffarian et al., 
2014) showing that for each reduction of 2.3 g of sodium per day, a reduction of 3.8 mmHg 
(95% CI 3.08 to 4.55) in BP may result. This study postulated that 1.65 million annual deaths 
from CVD (95% CI 1.10 million to 2.22 million) were attributed to a sodium intake above 
100mmol/day. The statistical estimations used by these investigators do have limitations as 
they rely on linear relationships between sodium and BP. Furthermore, the sodium 
estimations were based on single morning urine collections, adding further confusion to the 
literature. 
Thus, all observational evidence must be taken in context of their study designs and 
associated methodological limitations. Given a lack of high level evidence, the evidence for a 
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J-curve relationship is controversial at best. Furthermore, prior to the year 2016, not one study 
had been conducted in a CKD population. In a re-analysis of the Chronic Renal Insufficiency 
Cohort (CRIC) study, Mills et al explored the association between 24-hour urinary sodium 
excretion and clinical CVD events among 3,757 patients with established CKD (Mills et al., 
2016). Over a median follow-up of 6.8 years the highest intake of sodium (>4548mg/24 
hours) compared to the lowest (<2894mg/24 hours) was associated to a significantly higher 
rate of composite CVD outcomes (HR 1.36, 95%CI 1.09 to 1.70) with no evidence of a J-
curve. This study is notably limited as it cannot infer causality, however some strengths which 
surpasses the observational literature in the general population. First, compliance to 24 hour 
urine collections was high (>80%) and multiple collections were used across the study period, 
reducing the bias in single 24 hour collections (Powe & Bibbins-Domingo, 2016).  Second, 
the relationship held robust regardless of changes in BP, indicating the mediating factor likely 
goes beyond that of BP control, and can include arterial stiffness and volume (fluid status) 
control. This was evident in the strong association to heart failure events for high verses low 
sodium intake (HR 1.34, 95%CI 1.03 to 1.74). 
Despite caution advised against excessive restriction, RCT evidence suggests dietary sodium 
modification is an important management strategy in CKD. A recent Cochrane review and 
meta-analysis indicated clear benefits of sodium restriction on BP and BP-independent effects 
in short-term studies in CKD studies, showing clinically meaningful SBP reductions ranging 
from 2-12mHg SBP and 1-8mmHg diastolic blood pressure (DBP) in trials one week to six 
months in duration (McMahon et al., 2015). Meta-analysis showed dietary sodium reduction 
(MD -105.9, 95%CI -119.2 to -92.5mmol/day) resulted in significant reduction in SBP (MD -
8.76, 95%CI -11.35 to -3.80 mm Hg). A summary of RCTs which have tested high against 
low sodium intake in CKD populations is shown below in Table 2-4.   
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As shown in Table 2-4, less than half of the studies have durations greater than four weeks, 
and therefore interpretation is limited due to the inclusion of studies with small sample sizes 
(median n=32; range 14-56), short duration of follow-up (median six weeks; range one week 
to six months), and lack of dietary sodium interventions which reflect real-life practice (i.e. a 
dominance of sodium supplementation studies). In a 2015 Cochrane review, which included 
eight studies (two in ESKD and six reported in CKD in Table 2-4), a key limitation was that 
not one included trails had CVD outcome data or all-cause mortality. This is likely 
attributable to the small sample sizes and absence of long-term duration trials with the longest 
trial duration in CKD patients only six months. Unfortunately, no trials reporting this data 
have been conducted to date, which in-part may be due to the difficulty and expense in 
conducting RCTs with hard clinical endpoints. Without such evidence, the confusion in the 
literature will continue and proof-of concept studies will not be translated into clinical 
practise. Accordingly, large-scale RCTs are needed that incorporate multiple measures of 
dietary sodium intake and compliance, and are of sufficient duration to allow accurate and 
reliable reporting of CVD events (Aburto et al., 2013; Burnier & Wuerzner, 2014; Hooper et 
al., 2002; Taylor et al., 2011).  
As seen in Table 2-4, there is good evidence from RCTs that sodium reduction can effectively 
reduce BP and proteinuria. The LowSalt study (McMahon et al., 2013) is the most robust 
CKD sodium trial to date, demonstrating NHMRC level 2 evidence for substantial reduction 
in BP, pulse pressure and proteinuria following a low sodium diet. However, the high sodium 
intake was achieved through sodium supplementation (i.e. sodium tablets), and the study 
duration was only two weeks which reduces its clinical application (McMahon et al., 2013). 
The longest study duration to date is a trial conducted in a sample of 48 Bangladeshi 
immigrants in the United Kingdom (de Brito-Ashurst et al., 2013). Participants were 
randomised to cooking classes or to a control group for six months. A dietitian assessed the 
patients and provided low sodium education (in addition to standard care) to the intervention 
group. In the cooking classes, participants’ traditional recipes were cooked and then modified 
to be 50 percent less salt. Fortnightly telephone calls were utilised to support the health 
message delivered by the intervention team and dietitian. After six months, urinary sodium 
excretion decreased by approximately 122mmol/day and approximately 13mmol/day in the 
intervention and control group, respectively (de Brito-Ashurst et al., 2013). This change in 
sodium excretion corresponded to a mean SBP reduction of 7mmHg and 1mmHg increase in 
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the intervention and control group, respectively. DBP reduced by 5mmHg and 2mmHg in the 
intervention and control groups, respectively (de Brito-Ashurst et al., 2013).  
This trial demonstrated that culturally targeted and tailored interventions with regular contact 
by telephone are effective at reducing dietary sodium intake and ultimately reducing BP. 
Despite there only being two educational interactions with the research team, increasing the 
frequency of interaction with a healthcare professional to facilitate behaviour change and 
provide long term monitoring and support to patients was successful in transferring the 
responsibility of care to the individual and improving their self-efficacy (de Brito-Ashurst et 
al., 2013). This trial is an example of a study which reflects a real-world intervention, which 
could be translated into practice.  
The most recent low sodium diet trial in CKD comes from a Dutch group (Meuleman et al., 
2017), who conducted a three month open-label randomized controlled trial involving 138 
adults with CKD, hypertension, and high urinary sodium excretion (≥120 mmol/day; 
reflecting higher habitual intake of salt compared to national guidelines). Participants either 
received fortnightly advice to improve their self-monitoring of sodium (<100mmol/day) and 
BP control, or usual care according to national best-practice guidelines. The dietary 
intervention was reflective of dietary education provided in clinical practice. After three 
months, participants in the self-management intervention led significant decreases in 24-hour 
urinary sodium excretion and BP, as well as in the secondary outcomes of proteinuria and 
body weight. This was matched with improved levels of self-efficacy and intervention 
acceptance. However, at six months (three months post intervention) the sodium results were 
no longer significant. Even though self-efficacy and BP remained significantly lower than the 
control group at 6 months, the immediate intervention decay highlights the need for behaviour 
change interventions which can provide long term monitoring and feedback for complex 
dietary changes. 
In summary, the current evidence-base for dietary sodium restriction in CKD is supported 
primarily through proof-of-concept studies. Longer term studies have methodological flaws 
and show conflicting results for their associations with long term CKD outcomes. It seems 
that dietary interventions that are translatable and pragmatic in clinical practice do show 
efficacy, however they are more complex, requiring higher levels of support and frequency of 
contact to achieve the desired dietary change.  
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2.4 Complexity of diet change 
Dietary interventions are exceptionally challenging to practically implement in practice, 
particularly for those with a chronic disease. Dietary recommendations can be influenced 
according to the stage of someone’s disease, their current treatment, and the best practise 
guidelines. Furthermore, food selection is heavily influenced by considerable physiological, 
social and emotional determinants (Brownell & Cohen, 1995; Vanstone et al., 2013). To 
sustain dietary behaviour change, regular contact with health professionals and long-term 
follow-up is essential (Renders et al., 2001). The complexity to dietary change is further 
exacerbated in interventions such as reducing dietary sodium intake, because the magnitude of 
dietary monitoring changes required can severely impact on the success and compliance of the 
program (Smyth et al., 2014). In CKD and dialysis patients specifically, the suite of lifestyle 
and medical management strategies are incredibly intensive (Bonner et al., 2014) and dietary 
changes are complex and not solely focused on a singular dietary component (Smyth et al., 
2014).  
A recent qualitative synthesis summarised the experiences of CKD and dialysis patients when 
implementing diet and fluid recommendations (Palmer et al., 2014). It included 46 studies and 
showed that kidney patients experience conflict in dietary advice and feel an intense burden 
when trying to adopt these into their everyday life. People with kidney disease described 
feeling ‘overwhelmed by information’ and that too much (complex) information is given in 
‘one-off education sessions’. To overcome these challenges, patients expressed preference for 
a collaborative approach to learning in partnership with dietitians and their families. 
Additionally, patients desired regular coaching and monitoring to help them understand 
dietary information and become confident in their ability to self-monitor and manage these 
changes (Palmer et al., 2014). This type of approach is known to improve their dietary 
adherence (Bonner et al., 2014), and such strategies are central to successful change in dietary 
behaviour. 
2.4.1 Addressing the complexity: a move toward dietary patterns   
Adding to this complexity, dietary recommendations for those with a diet-related chronic 
disease usually reflect singular nutrients, and not whole foods. The 2013 Australian Dietary 
Guidelines were published, reflecting an emphasis on whole foods, rather than specific 
nutrients. This was because previous fascination and focus on individual nutrients was known 
to cause dietary confusion and to impede the maintenance of behaviour change (Australian 
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Institute of Health and Welfare, Cat. no. AUS 178; National Health and Medical Research 
Council, 2013).  
Interventions aimed at changing whole dietary patterns are well documented throughout the 
literature.  Since 1983 a range of patterns have been trialled (Howard et al., 2006; Hutchison 
et al., 1983; Takahashi, Sasaki, Okubo, Hayashi, & Tsugane, 2006), with the most recent 
substantial body of literature relating to Mediterranean-type and the Dietary Approaches to 
Stop Hypertension (DASH) dietary patterns (Athyros et al., 2011; Esposito et al., 2004; 
Estruch et al., 2013; Singh et al., 2002; Wardle et al., 2000). These studies typically include 
intensive education periods with participants, usually provided by regular individual and/or 
group sessions. Most of the landmark dietary pattern studies thus utilise controlled feeding 
study designs (Appel et al., 1997; Appel et al., 2005; Blumenthal et al., 2010; Sacks et al., 
2001; Writing Group of the PREMIER Collaborative Research Group, 2003), which do not 
reflect true behaviour change interventions. For these reasons, these studies are considered 
proof-of-concept and are not translatable into practice.  
Controlled feeding studies, despite translational limitations, provide high quality (and highly 
controlled) evidence for the effect of dietary patterns in controlling BP. Originating some 30 
years ago, a series of studies were conducted in vegetarians (who were observed to have 
lower BP than animal protein consumers) (Sacks & Kass, 1988). In these studies, changing 
specific micro and/or macro nutrients did not alter BP, leaving the authors to conclude it 
likely that BP is affected by a series of nutrients from within the dietary pattern. These 
findings led to originated subsequent food-based dietary pattern research, such as the DASH 
trial which demonstrated the efficacy of the DASH dietary pattern for the control of BP. 
The DASH-sodium study was the first clinical trial to explore a concept of dietary patterns 
over targeted nutrients with an emphasis on dietary sodium (Appel et al., 1997; Sacks et al., 
1995; Sacks et al., 2001). The DASH sodium showed a combined effect of a DASH pattern 
and low sodium diet to reduce SBP by 11.5mmHg in hypertensive subjects and 7.1mmHg in 
pre-hypertensive subjects. Following the results of these original DASH pattern trials, 
subsequent trials have utilised this dietary pattern for the control of BP and other clinical 
outcomes. These trials have been reviewed, providing level I evidence on the effects of the 
DASH pattern on BP (Saneei, Salehi-Abargouei, Esmaillzadeh, & Azadbakht, 2014). In a 
meta-analysis of all available 17 studies, involving 2561 participants, the overall effect size of 
DASH pattern reduced SBP by 6.7 mmHg (95%CI -8.3 to -5.2) and DBP by -3.5 mmHg 
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(95%CI -4.3 to - 2.8). Intervention strategies included the provision of DASH pattern dietary 
advice in 12 RCTs, whilst the remaining five RCTs were controlled feeding conditions 
(full/partial food provision). The other major variation in the interventions was energy 
restriction, with eight studies encompassing energy restriction and eight others not (one study 
used both in a three-arm trial). Studies with concurrent energy restriction reduced SBP more 
substantially (MD-8.13, 95% CI -10.75 to-5.31];p<0.001) than studies that did not (MD-5.57, 
95% CI -7.43 to -3.7;p<0.001).  
The recommended nutrient intakes advised for people with CKD are mostly in-line with 
Australian Dietary Guideline recommendations, with relatively minor modifications for non-
dairy alternatives lower in calcium and low potassium fruit/vegetables if required. While the 
DASH and Mediterranean patterns are higher protein (as a percent of total calories 
consumed), they contain higher plant-based protein ratios which may be kidney-sparing and 
cardio-renal protective (Kidney Disease Outcomes Quality Initiative (K/DOQI), 2004). The 
bioavailability of phosphorous and calcium from plant-based sources is typically poor which 
strengthens the kidney-sparing potential these diets may possess (Moe et al., 2011). The 
nutrient differences in the common dietary patterns is summarised in Table 2-5. 
Table 2-5: Average nutrient content of the DASH, Mediterranean and ADG diets 









10-19 18 15 10-35 10 15-
18 
Fat (%EEI) 20-30 27 <30 20-35 <30 <30 






11 >20 >20 
Polyunsaturated fat 
(%EEI) 
5 7 NR >10 >10 
Carbohydrates (%EEI) 
45-70 58 <60 45-65 50-60 50-
55 
Fibre (g/day) 
37 30 >25 20-30 20-30 20-
30 
Sodium (mg/day) 
3616 2886 <2400 <2300 <2400 <240
0 
Potassium (mg/day) 





Phosphorous (mg/day) 2226 1481  700 800-1000  
Calcium (mg/day) 1409 1220  1000-1200 700  
Abbreviations: ADG: Australian Dietary Guidelines, MED: Mediterranean, EEI: Estimated Energy 
Intake; g: gram; mg: milligram; NR: No recommendation. ^ Reference: (Almeida, Parisi, & Delgado, 
2017; Serra-Majem et al., 2009), # reference: (Karanja et al., 1999), Ұ reference: (Lichtenstein et al., 
28 
2006), + reference: (National Health and Medical Research Council, 2013), *As recommended by the 
K/DOQI guidelines. ¥ >30% energy from Mono- and poly-unsaturated fatty acids combined. 
As shown in Table 2-5, there are differences in the nutrient content of these common dietary 
patterns, which might not always be appropriate for the CKD patient. Commentary articles 
have outlined that the DASH pattern has important concepts that are potentially valuable for 
the management of CKD (Thoms, 2004) and dialysis patients with some slight modifications 
(Lindley, 2009). The DASH eating pattern is endorsed by the National Heart Foundation and 
is recommended for management of hypertension and prehypertension (Huang, Duggan, & 
Harman, 2008). The Kidney Health Australia CARI and the 2004 KDOQI guidelines deem 
the DASH pattern in early CKD a suitable method to increase fruit and vegetable intake and 
improve kidney outcomes (Chan & Johnson, 2013; K/DOQI working group, 2004), however 
note the typically high intake of protein (1.4g/kg/day) and advise caution in the absence of 
clinical trials (Chan & Johnson, 2013). The 2007 KDOQI guidelines on nutrition in diabetes 
and CKD allude to a ‘DASH-type’ diet which concludes protein intake as likely safe, given an 
altered red meat-to-plant-based protein ratio as potentially ‘kidney sparing’ (National Kidney 
Foundation, 2007). It is not known whether the type of protein or the macro/micronutrient 
profile of this dietary pattern is the influential contributor to this effect, however. Overall, the 
weight of available evidence and guideline recommendations suggests that the DASH pattern 
and other similar dietary patterns may be modifiable to be suitable and beneficial to CKD 
patients.  
With an absence of clinical trials for a DASH pattern in CKD, a recent five week single arm 
(non-randomised) trial on the feasibility of using the DASH pattern (maintaining protein 
intake 1g/kg/day, 1500g sodium/day) was conducted to assess safety in people with stage 3 
CKD patients and co-morbid hypertension (Wells, Hannah, & Jones, 2015). After a one-week 
run-in period, participants had regular blood tests for safety monitoring of blood 
biochemistry. The primary outcome measures were blood and urinary electrolytes with 
secondary outcomes being changes in clinic BP, other nutrients, and overall acceptability of 
the DASH pattern. The DASH pattern intervention proved to be safe in all participants, with 
one participant withdrawal during run-in due to a serum potassium of >5.5mmol/L, unrelated 
to the intervention. Mean dietary sodium was reduced from 2785mg to 1583mg per day (P< 
0.001). Importantly, serum potassium and dietary potassium and protein intake did not 
significantly change throughout the five-week study period. However, a trend in urinary 
potassium bordered on significance after increasing from 77mmol/L to 85mmol/L (p=0.051) 
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suggesting that participants were able to effectively regulate the slight increase in dietary 
potassium intake. A small single arm study (Tyson et al., 2016) has also supported the safety 
of a two week DASH pattern on BP and serum biochemistry in CKD. No incident 
hyperkalaemia was observed, and there were no significant changes to ambulatory or clinic 
BP after 2 weeks (Tyson et al., 2016). The results of this trial, as with the previous safety trial, 
contest arguments against a DASH-like pattern in CKD. However, without a control group, 
the reduction in urinary sodium and BP achieved should be interpreted with caution. Other 
important limitations to this study include the lack of a diet quality outcome and no measures 
to monitor the effect on sustaining behaviour change. However, the findings support the acute 
safety of a DASH pattern in CKD and support the notion that increasing fruits and vegetables 
may be achievable with minimal risk to incident hyperkalaemia. 
Similarly, the evidence for the Mediterranean diet suggests it is likely a safe intervention for 
CKD populations. Unlike the DASH pattern, however, there is no one standardised 
Mediterranean diet. Rather, the widely used term Mediterranean diet reflects a variety of 
eating habits traditionally practiced by populations in countries bordering the Mediterranean 
Sea, with considerable variability by location. The Mediterranean diets is rich in healthy food 
groups, such as fruits, vegetables, legumes, fibre and lower in red- and processed meats. In 
addition, this dietary pattern is inherently lower in sodium and saturated fat, and higher in 
potassium, unsaturated fats, and polyphenols (Davis, Bryan, Hodgson, & Murphy, 2015). The 
Mediterranean diet has well established associations with reduced CVD incidence and 
mortality in the non-CKD population (Estruch et al., 2013; Rees et al., 2013; Sofi, Cesari, 
Abbate, Gensini, & Casini, 2008; Trichopoulou, Bamia, & Trichopoulos, 2009). Long term 
outcomes have not been tested in CKD clinical trials, however one cohort study estimated that 
dietary improvements by two-points on the Mediterranean diet score translated to a reduced 
risk of all-cause mortality (HR 0.77, 95% CI 0.63 to 0.93) (Huang et al., 2013). One known 
trial has demonstrated the Mediterranean diet’s effectiveness in reducing systemic 
inflammation and microalbuminuria (De Lorenzo et al., 2010), which further supports that a 
healthy dietary pattern may translate to better clinical outcomes in the CKD population.  
Healthy dietary patterns promote higher plant-based food intake, and less refined and 
processed food. Fundamentally, healthy dietary patterns may contribute to improved clinical 
outcomes in CKD due to being higher in fruit and vegetables (with vitamins and antioxidants) 
(Wai, Kelly, Johnson, & Campbell, 2016a), fish and omega-3 fatty acids (Chrysohoou et al., 
2013), legumes, wholegrain cereals and nuts (Gutiérrez et al., 2014; White, 2017), and at the 
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same time promoting a lower consumption of sodium (McMahon et al., 2015), red and 
processed meat (Lew et al., 2016), saturated fats (Lin et al., 2010), and common phosphate 
additives that are highly prevalent in the Australian food supply (McCutcheon, Campbell, 
Ferguson, Day, & Rossi, 2015). Adopting a healthy dietary pattern in CKD is consistent with 
the dietary advice given in healthy eating guidelines to the general population (McGuire, 
2016; National Health and Medical Research Council, 2013). While the DASH and 
Mediterranean diets do have evidence for effectiveness in reducing CVD risk in non-CKD 
populations (Saneei et al., 2014; Schwingshackl & Hoffmann, 2014), this evidence is limited 
in CKD (Tyson, Nwankwo, Lin, & Svetkey, 2012). It is possible that aligning CKD diet 
guidelines with that of the Australian Dietary Guidelines better represent a pragmatic strategy 
to improve diet quality, increase plant-animal protein ratio, minimise sodium intake, and 
ultimately improve short- and long-term clinical outcomes. However, the Australian Dietary 
Guidelines, as a dietary pattern, remains an untested intervention strategy in the CKD 
population. It is also largely unknown what amount of individual support would be required 
for people with CKD to adopt this dietary pattern, and whether the current healthcare system 
has the resources to meet these demands. 
In summary, dietary patterns reflect a whole pattern of eating and have widely accepted 
evidence for reducing BP and cardiovascular health. Evidence of potential effectiveness likely 
relates to the synergistic effects of all the foods and nutrients as part of the dietary pattern. As 
dietary patterns are a whole food-based intervention and characteristically higher in fruit, 
vegetables and wholegrains, caution has been advised in the CKD population due to potential 
electrolyte derangement. It is important to note that there have been no randomised controlled 
trials conducted to either support or refute these claims and so potential harms from higher 
fruit and vegetable intake in CKD populations remains unclear. Preliminary data shows there 
are no adverse effects from following a DASH pattern in CKD. Promoting fruit, vegetable 
and wholegrain intake in-line with the Australian Dietary Guidelines represent a healthy 
dietary pattern which is in-line with current renal practice guidelines. Although this 
intervention may be promising to test in the CKD population, it is unclear how clinicians can 
best support people with CKD adopt and adhere to these complex dietary changes in a safe 
manner.  
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2.5 Healthcare challenges to improving dietary behaviour change 
Regular contact with health professionals and repeated follow-up is required to sustain long-
term dietary behaviour change (Renders et al., 2001). Dietary change is but one component of 
the suite of lifestyle and medical management therapies in CKD, which as described 
previously are incredibly intensive and difficult to implement (Bonner et al., 2014). 
The growing prevalence of CKD in Australia (Campbell & Murray, 2013) and globally (Baek 
et al., 2012), paired with the persistent rise in diet-related chronic disease, has led to 
increasing demand on health services and resources (Wilcox, 2014). One of the consequences, 
across major renal services in Australia, has been that specialised renal dietitians are not 
always available to care for people with CKD, and there can be inconsistencies in treating 
practitioners when following up with patients in practice (Campbell & Murray, 2013). At the 
same time, people with CKD have expressed a preference for regular coaching and 
monitoring of dietary change (Palmer et al., 2014). However, this is not considered 
universally feasible in the current models of healthcare. 
Dietary education programs are traditionally delivered face-to-face and are limited in their 
translation to practice due to common logistical constraints. Existing hospital and community-
based services available within or outside major metropolitan areas are only attended by a 
minority of patients, and a large number of patients not willing or unable to travel to face-to-
face clinics (Dale et al., 2014; Whelan et al., 2016). Evidence-based recommendations for 
optimising adherence to dietary recommendations includes the provision of on-going 
monitoring, coaching and frequent feedback (Desroches et al., 2013).  
Dietary interventions which have lower adherence have typically incorporated ‘intensive‘, and 
‘maintenance’ periods of contact to facilitate greater uptake in non-CKD populations 
(Applegate et al., 1992; Beard, Gray, Cooke, & Barge, 1982; Hypertension Prevention Trial 
Research Group, 1990; Trials of Hypertension Prevention Collaborative Research Group, 
1997; Whelton et al., 1998; Whelton et al., 1997; Writing Group of the PREMIER 
Collaborative Research Group, 2003). Strategies trialled in the literature include weekly-to-
fortnightly group and/or individual sessions with a dietitian, who works with participants to 
individualise advice to reduce dietary sodium intake and increase adherence to a healthy 
dietary pattern. These behavioural interventions have typically only shown small reductions in 
urinary sodium excretion, with compliance declining considerably with reduced contact 
during maintenance stages and at follow-up (Burke et al., 2005; Hinderliter et al., 2014; 
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Hypertension Prevention Trial Research Group, 1990; Writing Group of the PREMIER 
Collaborative Research Group, 2003). The results of these behaviour change interventions 
suggest that the establishment of long-term behaviour change requires strategies that maintain 
regular follow-up prevent intervention decay. However, such strategies are not practical at a 
scale within the current health system. Thus, alternate methods of healthcare delivery may be 
appropriate, to complement and/or replace traditional dietary intervention delivery. 
2.6 Telehealth strategies to address these barriers and improve dietary change 
Technology to deliver healthcare interventions is a potential solution to overcome the 
challenges of face-to-face delivered care (World Health Organization, 2010). Around the 
world technology is the fastest growing avenue for delivering health interventions. 
Telecommunications technology use has rapidly grown in recent years and more than three-
quarters of the world’s population having access to a mobile phone (Shin, 2014). Smart phone 
and home internet use is currently over 75% in the Australian population (Australian 
Communications and Media Authority, 2013; Mackay, 2012), which highlights the 
widespread potential technology has to provide healthcare services. However, the overall 
effectiveness of technology-based interventions has been debated for over 20 years (Wootton, 
2012), and there is little information available about the proportion of the CKD population 
that use various technologies.  
2.6.1 What is telehealth? 
Telehealth is an umbrella term that encompasses a whole range of technology-assisted health 
practice activities, specifically delivered from a distance. There have been numerous studies 
conducted utilising various telehealth strategies, targeted at various patient populations and 
delivered by various healthcare professionals (Wootton, 2012). The overall effectiveness of 
telehealth to date has not been conclusive or consistent (Wootton, 2012), despite more than 22 
systematic reviews of chronic disease management via telehealth (Wootton, 2012). The 
number of telehealth reviews has been so great that meta-reviews (reviews of systematic 
reviews) have also been conducted and published (Ekeland, Bowes, & Flottorp, 2010; 
Salisbury et al., 2015; Wootton, 2012). In a meta-review of 80 systematic reviews on 
telehealth, with no restriction of disease state or health status, of 20 (25%) reviews were 
identified which concluded telehealth is ‘effective’, 19 (24%) as ‘promising’, and 22 (28%) 
with ‘limited and inconsistent’ findings (Ekeland et al., 2010). Effective telehealth 
interventions ranged from home tele-monitoring of heart failure patients, to cognitive 
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behaviour therapy delivered by psychologists. Promising telehealth interventions were mostly 
targeted towards behaviour or education, with more research needed before reliable 
conclusions could be drawn. In contrast, the limited and inconclusive telehealth interventions 
were mostly in emerging technologies (e.g. virtual reality) and self-monitoring data in heart 
failure. This meta-review highlighted that inconclusive evidence does not equate to in-
effective, rather that more research is needed before conclusions can be drawn (Ekeland et al., 
2010). 
Despite the number of telehealth interventions conducted in chronic disease, the effectiveness 
for these interventions to influence behaviour change is largely unknown. A recent review 
constructed a conceptual model for telehealth programs addressing the ineffectiveness of 
various telehealth interventions among people with a chronic disease (Salisbury et al., 2015). 
The review concluded that self-monitoring, regular review, and the use of evidenced-based 
behaviour change programs (e.g. dietary or physical activity) are required to improve chronic 
disease self-management. A conceptual model for telehealth programs in chronic disease 
focused on a number of relevant predisposing, enabling, and reinforcing factors that affect 
patient uptake of a telehealth program has been proposed (see Table 2-6). This work 
illustrates that patient confidence in the proposed technology, ease of access and simplicity of 
use, with regular review and encouragement is paramount to the success of the program and 
study retention.   
Table 2-6: Precede-proceed model of factors proposed to influence telehealth use by patients. 





▸ Attraction of having support for health problems on demand, having more 
time, and getting greater support 
▸ Patients having a clear understanding of why they have been offered 
telehealth treatment 
▸ Confidence in ability to use the technology 
▸ Being reassured about privacy and confidentiality 
Enabling 
▸ Good access to fast reliable internet connection 
▸ Technology which is simple, inexpensive, and not complicated to use 
 
Reinforcing 
▸ Benefits of having regular review 
▸ Importance of self-monitoring which promotes continued engagement 
▸ Encouraging patient activation and involvement rather than passive 
reminders 
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Behavioural interventions have also been synthesised in telehealth meta-reviews with varying 
results. In a recent meta-review of 53 systematic reviews, 232 telehealth-delivered 
interventions to support five selected chronic disease self-management were evaluated 
(Hanlon et al., 2017). Overall, the included studies were all complex interventions with 
multiple components, and therefore no single self-management component was found to be 
consistently effective. The most commonly utilised tool for behaviour change in the telehealth 
interventions was ‘monitoring and feedback’, and this was associated with improved clinical 
outcomes in diabetes and heart failure. Telehealth was also beneficial for improving ‘remote 
clinical review’ and providing ‘education and information’ in diabetes, cancer and heart 
failure. However, findings for asthma and COPD were mostly neutral or inconsistent across 
these components (Hanlon et al., 2017). 
Telehealth strategies may provide a feasible way to facilitate dietary behaviour change, and 
offers a potential solution to overcome many patient-centred-barriers to accessing face-to-face 
clinics (Goode, Reeves, & Eakin, 2012). Telehealth interventions can provide people with a 
chronic disease greater flexibility in receiving health services (White, Krousel-Wood, & 
Mather, 2001), increase the reach of service, the amount of contact a health professional can 
have with a patient, and have a high rate of acceptability by patients (Bennett, Broome, 
Schwab-Pilley, & Gilmore, 2011; Deitz, Cook, Hersch, & Leaf, 2014; Nundy et al., 2013; 
Southard, Southard, & Nuckolls, 2003; Yehle, Chen, Plake, Yi, & Mobley, 2012). The 
benefits that telehealth offers to patients are often contrasted against conventional programs 
(Nolan, Liu, & Payne, 2014), as summarised in Table 2-7. These novel approaches can be 
forecast to reduce overall participant burden (thus enhancing intervention compliance), which 
hypothetically could facilitate dietary behaviour change. As one example, a person with a 
chronic disease who may have limited time to attend face-to-face education, may find a 
telehealth program can provide access to tailored education material without requiring a 
physical appointment (Dale et al., 2014; Lutz et al., 2014), thus allowing that person to access 
relevant information from the comfort of their own home, at a time of their own choosing 
(Southard et al., 2003). Mobile and other telecommunication technologies offer the 
opportunity to deliver a patient-centred program in a way that both causes minimal disruption 
to people’s lives and improves appointment attendance - commonly observed to be poor in 
both hospital and community-based health programs (Dale et al., 2014). 
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Table 2-7: Summary of outcomes and benefits of telehealth in comparison to conventional 
face-to-face programs; adapted from (Nolan et al., 2014).  




Patient education ✓  ✓  
Self-monitoring ✓  ✓  
Provision of feedback ✓  ✓  
Regular, scheduled                        ✓  
Evidenced-based  ✓  ✓  
Access to on-going health professional communication  ✓  
Education based on setting and resources  ✓  





Decrease non-attendance and wasted clinic resources  ✓  
No waiting time (waiting room)   ✓  
Overcome parking and logistical challenges  ✓  
Physician onsite availability  ✓   
2.6.2 The effectiveness of telehealth interventions: evidence from systematic reviews  
There has been no systematic evaluation of the effects of telehealth for improving complex 
dietary change in chronic disease. However, several systematic reviews have been conducted 
in various health conditions and populations, all with varying methodologies and outcomes 
(including dietary outcomes).  
In developed countries, text messaging interventions show promise for improving adherence 
to clinics and better medication adherence in chronic disease (Beratarrechea et al., 2014). Two 
reviews have demonstrated that the self-care activities for diabetes control (measured by 
HbA1c) can be achieved through telehealth (Cassimatis & Kavanagh, 2012), and dietary 
change may be possible through the provision of internet-based education (Cotter, Durant, 
Agne, & Cherrington, 2014). However, the evidence is not strong and both reviews did not 
specifically summarise the dietary outcomes, so interpretation of dietary effectiveness is 
difficult (Cassimatis & Kavanagh, 2012; Cotter et al., 2014). Two Cochrane reviews report on 
behavioural outcomes in diabetes (Pal et al., 2013) and in chronic disease (Murray, Burns, 
See, Lai, & Nazareth, 2005). In a computer-based intervention review to assess effectiveness 
for the management of diabetes, HbA1c and dietary outcomes showed improvement 
favouring the intervention for estimated daily fat intake (MD -3.44, 95% CI -7.93 to 1.05) and 
weekly calorie intake (SMD -0.23, 95% CI -0.46 to 0.01) (Pal et al., 2013). In the other 
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review, web-based computer programs in chronic disease showed an increase in knowledge 
and self-efficacy was found, and a pooled odds ratio of 1.66 (95% CI 0.71 to 3.87) for all 
behavioural outcomes (Murray et al., 2005).  
The effectiveness of mobile health m-Health interventions has been extensively synthesised. 
In a recent publication, a compelling narrative review of current m-Health interventions for 
improving CVD outcomes was conducted (Burke et al., 2015). A total of 69 m-Health studies 
were reviewed for their effect on CVD risk behaviours, which included 10 RCTs targeting 
weight loss, 14 on increasing physical activity, 14 aiming to improve smoking cessation, 15 
on blood glucose management, 13 on hypertension management, and three targeting lipid 
management. M-Health facilitated significant weight loss (-0.5 to -6.5kg), as shown by seven 
of ten studies reviewed, however an emphasis on text message interventions and high rates of 
attrition (up to 50%) were acknowledged as limitations in the generalisability and translation 
of this work. In the 15 diabetes studies, HbA1c was the most common outcome measure, as 
the gold standard measure of glycaemic control with similar outcomes as reported in the 
previous paragraph. This review found that text message studies had poor retention whereas 
email interventions generally had high retention in studies on hypertension. Change in SBP 
ranged from -4.4 to -23.7mmHg (Burke et al., 2015). Important recommendations on study 
design were made given the poor methodological rigor of the reviewed studies. For example, 
the majority of studies on physical activity and BP control failed to perform intent to treat 
analyses, which can potentially introduce bias into the results of these studies. Furthermore, 
the majority of studies (except for weight loss studies) were short term, thus limiting any 
conclusions on sustained behaviour change.  
Of the evidence available to date, there is clear potential that telehealth technologies can 
facilitate lifestyle modification, even in the context of their limitations. The current body of 
telehealth literature is summarised in Table 2-8, showing general support for the use of 
various telehealth methods in chronic disease. However, these reviews have not analysed 
dietary change individually (thus not all dietary results are summarised and/or reported), focus 
on singular telehealth interventions (e.g. telephone only), focus solely on single disease-states 
and/or they include short-term interventions, which are insufficient to assess sustainable 
dietary change. In-fact at least two of these drawbacks is present in all telehealth reviews, 
outlined in Table 2-8. 
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Table 2-8: Systematic Reviews of relevant lifestyle interventions considering the effect on changing dietary intake  






Jamsek, Car, & Atun, 
2012) 
• General population 
(primary and/or 






1. HbA1c: (MD -0.15, 95% CI -0.77 to 0.47). 
2. Blood pressure: SBP (MD 1.10, 95% CI -4.37 to 6.57); 
DBP (MD 1.84, 95% CI -2.14 to 5.82). 
3. Capacity to self-manage: 5/6 studies showed 
improvements. 
4. Health service utilisation: 2/3 studies: (RR 0.32, 95%CI 





Urganci, Atun, & 
Car, 2012) 
• General population  




1. Higher satisfaction in the 1 study involving pregnant 
women.  
2. 1 study relating to smoking cessation past 6 months (RR 
2.20, 95% CI 1.79 to 2.70). 
3. 1 study relating to vitamin C adherence: (RR 1.41, 95% 
CI 1.14 to 1.74). 
4. None of the studies reported the secondary outcomes of 






• General population 




1. All measurable outcomes of care for patients treated 
remotely via telemedicine compared with those treated 













1. Significant weight and WC reduction in the high quality 
studies.  Low quality studies: Weight reductions ranging 
0.8-1.4kg for weight and 2.0 – 2.9 cm for waist 
circumference. 
2. High quality studies showed no effect on BP, 3 low 
quality studies showed a decline in BP. 
3. Decline in BGL (1 high quality study), mixed results in 
poor quality studies. 
4. 6 high quality lipid studies – 3 showed reductions in the 
intervention group. 3 studies that were low quality all 
showed reductions.  
5. Diet – 9 high quality studies. 5 found no improvement. 
3 low quality follow-up studies showed improvements 
in fruit and vegetable intake. 
6. PAL – 9 high quality studies only 1 showed significant 
improvement. 2 low quality studies showed increase in 
PAL. 
7. Smoking cessation: 3 follow up studies showed 
improvements in smoking cessation.  
No dietary 
outcomes 
(Kodama et al., 2012) • Overweight/obese  
(only three exclusive 




1. Weight loss: (MD -0.68 kg, 95% CI -1.29 to -0.08). No dietary 
outcomes 
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(Bacigalupo et al., 
2013) 
• Overweight/obese 
(only 2 obesity 
studies included) 






1. Weight loss observed in 6 of 7 included studies.  
2. 5 studies had clinically significant weight loss 





study had a 
low risk of 
bias.  




1. Weight management: Seven of the 10 RCTs, reported 
significantly more weight loss in the intervention group 
than in the control or comparison group, ranging from -
0.5 to -6.5kg, with pooled effects being -2.56 kg (95% 
CI -3.46 to-1.65).  
2. Physical activity: 9/14 studies report significant 
improvements on PAL. 
3. HbA1c: Pooled effect −0.5 (95% CI −0.3 to −0.7). 
4. Blood pressure: Change in SBP ranged from -4.4 to -
23.7mmHg, with an systematic review of internet and 
email studies with at least 8 weeks follow-up finding a 












report it as 
an outcome.  
Abbreviations: HbA1c: Glycated haemoglobin, PAL: Physical Activity Level, CI: Confidence Interval, Kg: Kilograms, BMI: Body Mass Index, WC: waist 
circumference, SBP:  Systolic Blood Pressure, DBP:  Diastolic Blood Pressure, MD: Mean Difference, RR: Risk ratio, RCT: randomised controlled trial, NP – 
not published. BGL, blood glucose level. * Intervention description: Mobile, use of text-messaging using a mobile phone; Internet: online education using 
secure portals and/or email; M-health: multiple forms of mobile technology (including text-messaging, Apps and tablets). 
40 
Perhaps the most relevant systematic review related to dietary change in chronic disease is a 
Cochrane review (Desroches et al., 2013) that assessed the effectiveness of various methods 
for enhancing adherence to dietary interventions. This review  suggested that  improvements 
to dietary adherence can be facilitated by the use of some technology such as telephone 
interventions and video contact, but also included face-to-face approaches (Desroches et al., 
2013). Although an extensive review, this work was not designed to assess the effectiveness 
of dietary education in chronic disease, due to the inclusions definition of ‘reference standard 
of care’. Study groups had to be receiving the same dietary advice as the intervention arm, 
with the comparator being an alternate delivery method for the same dietary advice. 
Consequently, studies that conducted interventions educating patients about diet that was not 
provided to a control group (e.g. standard care dietary advice from a dietitian or treating 
physician), was excluded. From a telehealth potential perspective, this review did not evaluate 
the effects of telehealth exclusively, and no meta-analysis was conducted due to the high 
heterogeneity of the studies clinically and statistically. Therefore, the dietary intake and 
clinical effectiveness of telehealth-delivered dietary interventions in chronic disease 
management is currently unknown in comparison to standard care. 
2.6.3 Telehealth interventions in kidney disease 
There are limited trials that have evaluated the effectiveness of telehealth interventions in 
kidney disease populations. Following a systematic search for all telehealth interventions in 
chronic disease using a structured search strategy and selection of studies (described in 
Appendix B), only three trials were found to have been conducted in kidney disease 
(Cummings, Becker, Kirscht, & Levin, 1981; Williams, Manias, Walker, & Gorelik, 2012; 
Wong, Chow, & Chan, 2010) (two in ESKD and one in CKD) that met the inclusion criteria 
in Appendix B.   
In a RCT of people with CKD and co-morbid diabetes, the effects of an intervention utilising 
digital video disk (DVD) education package with fortnightly telephone coaching specifically 
for medication adherence and self-monitored BP was evaluated. Outcomes were compared to 
those receiving usual care (Williams et al., 2012). The telephone coaching group effectively 
lowered the primary outcome SBP by 6.9mmHg compared to -3mmHg in the control, 
however no significant difference was observed in medication adherence within or between 
the study groups. This study did not provide dietary coaching, although >50% self-reported at 
baseline that they managed their diet “well’, however, no results were reported at follow-up.   
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In another RCT, the effect of a telephone-based, nurse-led program was evaluated in patients 
receiving continuous ambulatory peritoneal dialysis (CAPD) (Wong et al., 2010). In this 
study, intervention participants were telephoned every week over a period of six weeks by 
nurse case managers, who provided feedback on patient-goals set in an initial assessment, and 
then continued to monitor progress and provide health advice (Wong et al., 2010). 
Participants in the control group received usual care only. Diet and fluid adherence was 
assessed using the dialysis diet and fluid non-adherence questionnaire (Vlaminck, Maes, 
Jacobs, Reyntjens, & Evers, 2001) and both groups had improvements in the frequency of 
days that their diet was adherent to recommended guidelines. However, no significant 
between group difference was noted. There was a significant between group difference in the 
degree of dietary adherence (F = 4.19 (p=0.04)). No significant difference between groups 
was noted for biochemistry and symptom control, however all readings were within 
acceptable range. Due to the short 6-week follow up, it appears the marginal changes in 
dietary outcomes were not great enough to alter biochemistry markers. Despite the authors 
discussing the results as adding to the evidence for CKD, this study was in-fact exclusive to 
ESKD patients only.  
The only other trial published is the oldest kidney-specific telehealth-delivered dietary 
intervention conducted to date. In this non-randomised pre/post-test controlled trial, the 
effects of various dietary interventions for adherence to potassium and fluid requirements in 
haemodialysis patients were compared (Cummings et al., 1981). Four study groups received a 
behavioural contract (patient and nurse), a behavioural contract (patient and nurse and a 
family or friend), a control group, and a group who received weekly telephone follow-up for 
six weeks by a dialysis nurse, respectively. Attrition in the telephone group was 18% 
compared to 8%, 5% and 4% in the other groups. Baseline serum potassium and fluid was not 
reported across any study group, impacting the interpretation of the efficacy of the 
intervention. However, compared to the other behaviour change contract interventions, 
telephone contact resulted in the only significant reduction in serum potassium from baseline 
to follow up when compared to the control arm (F= 10.51, P < 0.05). Interestingly, ‘general 
health beliefs’ of haemodialysis patients did not predict their compliance, and the authors 
hypothesised that there must be other features of the telephone-based follow-up that 
influenced patients' dietary and fluid compliance. Serum potassium is insufficient to infer 
dietary compliance and thus this study is limited in its generalisability to dietary practice. 
However, the results are meaningful in its comparison of dietary interventions which may 
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improve dietary adherence and is promising for informing telehealth interventions in kidney 
patient targeted programs.  
With regard to telehealth-delivered dietary interventions that specifically measure changes in 
dietary behaviour, there is a paucity of telehealth interventions in people with CKD (GFR 
<60ml/min/1.73m2). In addition to the three dietary telephone-based counselling interventions 
discussed above (in ESKD), the CKD literature has demonstrated improvements in CKD 
rated quality of life (Blakeman et al., 2014; Campbell, Ash, & Bauer, 2008; Li et al., 2014), 
and a pilot mobile phone text messaging intervention in ESKD was rated as 9.8 out of 10 for 
usefulness in medication and appointment reminders (Cueto-Manzano et al., 2015). These 
studies however, are based on small sample sizes (Blakeman et al., 2014; Cueto-Manzano et 
al., 2015), and did not contain a dietary intervention. Therefore, more robust interventions are 
required to both understand the feasibility, acceptability and overall effectiveness of 
telehealth-delivered dietary interventions in CKD.  
2.7 Summary of the evidence 
The long-term management of CKD requires people to adopt complex dietary 
recommendations. Such interventions are best facilitated via regular coaching to support 
sustained behaviour change. Dietary changes have historically targeted single nutrients rather 
than food-based dietary patterns, and such dietary pattern studies have not been well tested in 
CKD populations. Telehealth interventions can overcome patient-centred barriers to accessing 
face-to-face programs and provide feasible delivery methods, as they are ubiquitous and 
accessible regardless of geographic location. This may facilitate long-term contact with a 
healthcare professional. Utilising telehealth methods to deliver dietary interventions may be a 
viable option for the healthcare system in order to deal with the rising prevalence of chronic 
disease, and consequently increasing demand on healthcare resources. This opportunity is 
reflected in the increasing trajectory of trials over the last five years utilising telehealth 
methods for the delivery of lifestyle interventions. Although promising, the effectiveness of 
telehealth interventions is not conclusive. Whether telehealth could overcome the previously 
reported patient-centred barriers to adhering to diet recommendations remains unclear. 
2.7.1 Identification of key gaps in the literature  
1. There is a need for systematically reviewed evidence of dietary patterns and associations 
with clinical outcomes in established CKD populations. 
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While dietary patterns have low level evidence for associations with improved CKD 
outcomes, particularly albuminuria, mortality and CVD, this evidence has not been 
systematically evaluated to date. Furthermore, the potential mechanisms by which these 
dietary approaches might lead to these improved outcomes in established CKD populations 
has not been thoroughly summarised in the scientific literature.  
This gap in the literature is addressed in thesis research question 1.  
2. There is a need for systematically reviewed evidence of the effectiveness of telehealth 
methods to achieve complex dietary change in chronic disease. 
The current body of literature generally supports the use of various telehealth methods in 
chronic disease. However, these reviews have translational limitations which need addressing. 
Specifically, they have not analysed dietary change as an independent outcome (thus not all 
diet results are summarised and/or reported in systematic reviews to date); they have focused 
on singular telehealth interventions (e.g. telephone only); commonly focus on only single 
disease states; or included short-term interventions, which are insufficient to assess 
sustainable dietary changes. At least two of these restrictions are present in all previous 
published telehealth reviews. A gap in current knowledge is that the effect of telehealth-
delivered dietary interventions for achieving complex dietary change in chronic disease 
is unknown. 
This gap in the literature is addressed in thesis research question 2.  
3. CKD patients’ opinions are underrepresented and more patient-engagement is needed for 
informing possible dietary interventions in the future.  
People with kidney disease (dialysis and CKD) express preference for regular and repeated 
follow up to help them adhere to their dietary recommendations. However, a gap in current 
knowledge is the delivery mode and method preferred by people with CKD in the 
context of the healthcare limitations (Section 1.5). Furthermore, the experiences and 
perspectives of people with CKD have about using technology as possible solutions to 
access on-going, repeated coaching have not been studied.  
This gap in the literature is addressed in thesis research question 3 and 4.  
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4. The Australian Dietary Guidelines as a dietary pattern has not been trialled for its 
effectiveness on improving diet quality in people with stage 3-4 CKD.  
If a dietary telehealth intervention program is to be rolled out in CKD, which has yet to be 
disseminated in scientific literature, it is important to consider the complexity to dietary 
change, in which dietary requirements historically revolve around singular nutrients. Specific 
nutrient reducing strategies which ignore this complexity have long been plagued by poor 
compliance. Dietary patterns are not well tested in the CKD population, although the 
Australian Dietary Guidelines represent a healthy dietary pattern, which appears to be in-line 
with the many single nutrient recommendations/advice given to CKD patients, and now 
feature in the Australian evidence-based practice guidelines. This dietary approach has not 
been tested in CKD, and the effect of telehealth to deliver dietary education is unknown. 
Therefore, a gap in current knowledge is the feasibility and acceptability of a telehealth-
delivered intervention to facilitate adherence to the Australian Dietary Guidelines in 
stage 3-4 CKD. Furthermore, the clinical safety and effectiveness of a telehealth 
intervention aimed at improving overall diet quality (in-line with the Australian Dietary 
Guidelines) has yet to be determined in CKD to date.  
This gap in the literature is addressed in thesis research questions 5 and 6.  
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 - Beyond Sodium, Phosphate and Potassium: Potential Dietary 
Interventions in Kidney Disease 
3.1 Preface 
While the framework depicted in Table 1-1 details the steps in developing a telehealth 
program in CKD, the development of dietary approaches for telehealth interventions is not 
covered by this framework. This chapter provides a comprehensive overview of potential 
dietary interventions in people with kidney disease. Without first understanding what dietary 
approaches could work (in terms of adherence and clinical outcomes) in people with CKD, 
any subsequently developed telehealth program may fail or fall victim to the same patient-
centred barriers that affect current dietary recommendations and interventions. This chapter 
explains the concept of dietary patterns, specifically a plant-based dietary pattern and how this 
type of dietary intervention may overcome many of the dietary adherence issues highlighted 
in Chapter 2. Finally, this chapter will address the potential mechanisms by which 
components of a plant-based dietary pattern works together to influence clinical outcomes, 
and highlights proposed approach to test these hypotheses in people with CKD.  
This chapter contains the accepted version of an Editorial published in the peer-reviewed 
journal Seminars in Dialysis. The paper formatting has been modified in accordance with a 
consistent thesis style. However, the grammar, headings, and references (in-text and 
bibliography) are unaltered in accordance with the journal publishing guidelines. 
Citation: Kelly JT, Rossi M, Johnson DW, Campbell KL. Beyond sodium, phosphate and 
potassium: Potential dietary interventions in kidney disease. Seminars in Dialysis. 2017; 
30(3), 197-202. 
3.1.1 Related work to this Chapter completed by the candidate  
One other manuscript relating to this chapter has also been published by the candidate, in the 
form of another invited Editorial (Appendix E). While this Editorial is not a primary 
publication within this thesis, the candidate took the lead author role and uses this article to 
further articulate on the key concept presented in Chapter 2. Specifically, the paper reports on 
the concepts and mechanisms underpinning protein quality (animal and plant-based protein 
types) - this relates to thesis research question 1.  
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• Kelly, JT, Carrero-Roig, JJ. Protein Quality and CKD progression: protection may be in 
the pattern. Journal of Renal Nutrition. 2017; 27(4), 221-224.  
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3.2 Abstract  
People with kidney disease are advised to restrict individual nutrients, such as sodium, 
potassium and phosphate, in line with current best practice guidelines. However, there is 
limited evidence to support the efficacy of single nutrient strategies, and compliance remains 
a challenge for clinicians to overcome. Many factors contribute to poor compliance with 
dietary prescriptions, including conflicting priorities for single nutrient restriction, the arduous 
self-monitoring required, and the health-related knock-on effects resulting from targeting 
these nutrients in isolation. This paper reviews the evidence-base for the overall pattern of 
eating as a potential tool to deliver a diet intervention in which all the nutrients and foods 
work cumulatively and synergistically to improve clinical outcomes. These interventions may 
assist in kidney disease management and overcome these innate challenges that single nutrient 
interventions possess. Healthy dietary patterns are typically plant-based and lower in sodium 
and animal proteins. These patterns may have numerous mechanistic benefits for 
cardiovascular health in kidney disease, most notably through the increase in fruit, vegetables, 
and plant-based protein, as well as improved gut health through the increase in dietary fiber. 
The evidence to date on optimal dietary patterns points towards use of a predominantly plant-
based diet, and suggests its adoption may improve clinical outcomes in dialysis patients. 
However, clinical trials are needed to determine whether these diet interventions are feasible, 
safe and effective in this patient population. 
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3.3 Background  
Diet has long been considered a modifiable risk factor for chronic kidney disease (CKD), and 
a key management strategy in end-stage kidney disease (ESKD). International guidelines for 
managing kidney disease have traditionally focused on the modification of the macro- and 
micro-nutrients such as protein, energy, sodium, potassium, phosphorous, and types of 
macronutrients, including fatty acids and sugars.1, 2 This approach of individual nutrient 
modification can result in complex nutrition messages. Translating these into clear food-based 
recommendations is challenging. It comes as little surprise that food and fluid advice have 
been reported as ambiguous and frustrating by patients,3 inherently restrictive4 and have been 
shown to adversely impact overall diet quality.5  
The aim of dietary management in patients with early stage CKD is to delay progression and 
reduce cardiovascular risk. Conversely, in dialysis patients, the focus is to mitigate protein-
energy wasting and electrolyte disturbances (i.e. low potassium, low phosphorous, high 
calorie).6 In contrast, a traditional cardio-protective diet targeting higher fiber, and lower 
saturated fat may be considered to be in direct conflict with low electrolyte and high calorie 
advice in CKD management.7 Adopting an alternative whole-of-diet approach, which shifts 
focus onto foods, such as wholegrains, fruits, and vegetables, shows considerable promise 
with respect to pragmatically and effectively achieving the universal goals of retarding CKD 
progression and attenuating cardiovascular risk, whilst still avoiding serious electrolyte 
derangements.4, 8 
This paper will consider historical evidence for individual nutrient-based restrictions, appraise 
and contrast new evidence and controversies, and discuss emerging, whole-of-diet strategies 
for the management of kidney disease and its complications.  
3.3.1 Challenges with traditional individual nutrient approaches to nutrition 
management 
Current international guidelines recommend patients receive individualised dietary 
interventions by a qualified dietitian focusing on individual nutrients, including salt, 
phosphate, potassium, protein and calories.2, 9-12 These traditional single-nutrient focus 
recommendations present four key issues:  
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3.3.1.1 Poor evidence base underpinning individual nutrient strategies 
Most studies examining individual nutrient modification strategies have been limited in 
methodologic quality. Studies in nutritional nephrology are plagued by small sample sizes, 
short follow-up and use of non-validated surrogate outcome measures,2, 13-17 such that the 
effects of these approaches on patient-level outcomes, including ESKD and mortality, remain 
uncertain. For example, dietary salt reduction is considered a key dietary strategy in kidney 
disease, with strong evidence supporting a role for augmenting the pharmacological effects of 
antihypertensive medications and reducing blood pressure and albuminuria. However, the 
effects of long-term salt restriction on CKD progression and cardiovascular outcomes remain 
uncertain.17-22 Similarly, dietary phosphate restriction has been advocated by many guidelines 
to ameliorate renal and cardiovascular risk. However, the evidence that change to dietary 
phosphorus intake can impact outcomes beyond serum measures is notably absent.23, 24 
Dietary potassium restriction for the prevention and management of hyperkalaemia is further 
advocated, particularly in more advanced forms of CKD. However, to date there have been no 
randomised-controlled trials evaluating the impact of potassium restriction on clinical events. 
In contrast, increased dietary potassium consumption is advocated in the general population in 
concert with dietary sodium restriction to reduce cardiovascular risk.25 There is observational 
evidence of the benefits of this in CKD models on CV risk factors,26 which provides further 
uncertainty. 
Modified protein diets continue to be at the forefront of nutritional management for people 
with kidney disease. Low protein diets are favoured in CKD for ameliorating uraemia, kidney 
stone formation, gout, hyperphosphatemia, and gut-derived uremic toxins.27 However, protein 
restriction trials report inconsistent findings and at best, provide a modest benefit for 
progression to ESKD28 or mortality.29 Meta-analysis shows protein reductions of 0.2g/kg/day 
delay CKD progression by only 0.5mL/min/year in both randomised and non-randomised 
trials.30 In addition, compliance with low protein diets is poor,5, 31 and can risk protein-energy 
wasting.30, 32 It should therefore come as no surprise that there is a paucity of evidence 
supporting the assertion that low protein diets reduce the risk of progression to ESKD28 or 
mortality.29 As in CKD, most  of the evidence in dialysis is based on observational studies, 
and in many instances the target protein intakes are rarely achieved.33 This continues to 
challenge guidelines committees tasked with designing evidence-based protein 
recommendations.  
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3.3.1.2 Complex nutritional interventions impair dietary adherence 
Individual nutrient modification can lead to complex nutritional messages, which people with 
kidney disease report to be confusing and constraining.3-5, 34 Patients with CKD report dietary 
interventions to be burdensome35 leading to overall poor adherence to dietary restrictions.5, 36 
A number of characteristics are known to influence a patient’s ability to follow dietary 
recommendations, including a patient’s  knowledge, self-efficacy, motivation, and uremic-
related factors.37 Poor dietary adherence in CKD and dialysis populations may therefore place 
patients at risk of clinical complications, such as malnutrition, fluid overload and CVD. 5, 36, 38  
3.3.1.3 Conflict between competing priorities of individual nutrient strategies 
When adopting an individual nutrient approach, translating these recommendations to food-
based advice can create conflicting priorities. A key example is between dietary protein and 
phosphorous. In dialysis, a high protein intake with optimal phosphate management is 
associated with the best survival.39 However, advice to increase protein intake to prevent 
protein-energy wasting may in fact introduce an increase in phosphorous intake due to the 
high phosphorous content in protein sources. As a result, this approach can compete with an 
increased risk of hyperphosphatemia.39 
3.3.1.4 Health-related knock-on effects from restricting single nutrients  
As mentioned above, the restriction of single nutrients is a challenging and complex task for 
people with kidney disease. In addition, the practical application of these individual nutrient 
restrictions can compromise the overall quality of the diet and be detrimental to one’s health. 
For example, a dialysis patient may be instructed to restrict their potassium intake from fruits, 
vegetables and whole grains. The ‘knock-on’ consequences impact both nutrition and overall 
health. Avoiding these foods reduces the exposure to dietary fiber, limiting its therapeutic role 
in preventing constipation and as a pre-biotic in maintaining a healthy gut microbiome.40  
Therefore, attempts to quantify and limit nutrient intake is a challenge for clinicians and 
problematic given the poor quality supporting evidence.2, 9-11 It also presents an intense 
burden for people with kidney disease to implement day-to-day, and presents conflicting 
priorities which risk knock-on health consequences.  
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3.3.2 A move to dietary patterns: A potential paradigm shift in kidney disease 
The change in dietary management of chronic diseases from a single nutrient focus, towards 
the overall patterns of eating may address some of these concerns. Dietary patterns consider 
the cumulative effect and synergy between the combinations of foods and nutrients, which are 
more applicable to chronic disease management.41, 42 Healthy dietary patterns with evidence 
for mitigating CVD risk include the Dietary Approaches to Stop Hypertension (DASH) diet,43 
the Mediterranean diet,44 vegetarian diets,45, 46 and other patterns of eating consistent with 
dietary guidelines.47, 48 Observational studies suggest these mentioned dietary patterns may be 
superior to single nutrient interventions,49 particularly due to the cumulative effects of 
multiple nutrients consumed through diets rich in fruit and vegetables,50 fish and omega-3 
fatty acids,51 legumes, wholegrain cereals and nuts,52 and lower in sodium,19 red meat,53 
saturated fats,54 and common phosphate additives.55  
There is a paucity of evidence for the effectiveness of changing dietary patterns in the 
established CKD population. However, emerging data support the belief that dietary patterns 
that follow the Healthy Eating Index, DASH, and the Mediterranean diet are associated with 
reduced renal-related mortality and slower progression to ESKD.49, 56, 57 Preliminary data also 
suggest that adherence to the DASH diet may reduce the risk of ESKD incidence in people 
with established CKD,58 and a small single arm trial demonstrated the DASH diet as safe in a 
CKD sample.59 Other studies demonstrate that the DASH dietary pattern is associated with 
preserved residual kidney function and reduced overall incidence of CKD in community-
dwelling individuals.56, 60, 61  
Similarly, the Mediterranean diet has long-standing associations with reduced CVD incidence 
and mortality in the non-CKD population.62-65 Within the CKD population specifically, it 
appears that the Mediterranean diet may be particularly effective in reducing systemic 
inflammation and microalbuminuria.66 While no randomised controlled trials have been 
conducted in established CKD or dialysis populations to examine the effects of these diets on 
long-term patient-level outcomes, a recent meta-analysis of longitudinal studies demonstrated 
a healthy eating pattern was consistently associated with a 27% reduced risk of mortality in 
populations with established kidney disease.8 
3.3.2.1 How can whole-of-diet approaches improve health outcomes?  
The opportunity to educate people with kidney disease to achieve a healthy dietary pattern 
presents itself with many benefits in comparison to isolated nutrient interventions. The 
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translation of nutrient-based recommendations is exceptionally challenging for patients to 
quantify without ongoing guidance and feedback on daily consumption of these nutrients.34 In 
contrast, behavioural counselling to achieve a desired pattern of eating can lead to better 
compliance due to offering flexibility, choices to suit individual preferences, and a 
manageable change to a multitude of nutrients within the whole diet concurrently.34 
Adopting a healthy dietary pattern has many mechanisms of benefit for cardiovascular health 
in CKD, most notably through the increase in fruit, vegetables and a predominance of plant-
based protein.  
3.3.2.2 Fruit and vegetables and cardiovascular health in kidney disease 
Fruit and vegetables generate bicarbonate naturally as they release potassium-salts and 
decrease the renal acid load. In-fact, a diet higher in fruit and vegetable has been shown to 
more effectively manage metabolic acidosis compared to standard bicarbonate prescriptions.67 
In contrast, sulphur containing animal proteins are naturally acid-producing and can 
exacerbate acidosis.58 Plant-based diets also limit the bioavailability of dietary phosphorus 
thereby decreasing absorption (due to the presence of phytate in vegetable forms of 
phosphorous),68 particularly in comparison to higher animal protein diets.45 Plant-based diets 
are also characteristically higher in fruit, vegetables and whole grains, which increase the 
exposure to dietary fiber, which in turn is linked to reduced inflammation and improved 
survival.69  
3.3.2.3 Plant-based dietary patterns have different animal-plant protein ratios  
Lowering the red meat-to-plant-based protein ratio  has been described as likely ‘kidney 
sparing’ in CKD.53, 70 Balanced portions from both red meat, fish and plant-based sources 
have been demonstrated in a cohort of 1355 haemodialysis patients to be associated with an 
appreciably lower risk of cardiovascular hospitalization death due to any cause compared with 
an unbalanced diet.71 However, despite the theoretical benefits of a plant-based diet, studies 
regarding the safety and efficacy of increased fruit and vegetable intake over the long term are 
lacking in both CKD and dialysis populations. This evidence gap needs addressing before 
such diets can become routinely recommended in the kidney disease population. 
3.3.2.4 Safety profile of a plant-based dietary pattern in the kidney disease population 
Safety concerns regarding plant-based diets relate to the high fruit and vegetable intake. 
However, fruit and vegetable intake is typically low across the CKD spectrum and 
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unnecessary restriction may risk many vitamin and mineral insufficiencies.5 While fruit and 
vegetable intake conveys higher dietary potassium, it has been recently argued this does not 
necessarily translate into hyperkalaemia.72 It was also recently demonstrated that adults with 
stage 4 CKD can safely increase their servings of fruit and vegetables to correct metabolic 
acidosis and reduce blood pressure without an appreciably increased incidence of 
hyperkalaemia.73, 74 In addition, a higher fiber intake from a higher fruit and vegetable diet 
can prevent constipation in dialysis populations and facilitate faecal excretion of excess 
potassium,  which can be up to 3.5 times greater than that of the general population.74 This 
ability of intestinal potassium excretion to compensate for a reduction in renal potassium 
handling has called into question the priority for dietary restriction in hyperkalemic states.72 
Nonetheless, efficacy trials are needed to confirm the safety of plant-based diets.  
3.3.2.5 Dietary patterns and manipulation of the gut microbiome 
The bacterial community in the gut (termed the microbiota) contributes to digestion through 
fermentation and putrefaction,75 and is able to be manipulated by plant-based dietary patterns 
which emphasize whole grain carbohydrates, higher intakes of fibrous fruits, vegetables, 
legumes and nuts.75, 76 Gut dysbiosis is commonly observed in kidney disease populations and 
is a major contributor to the build-up of uraemic toxins. Indoxyl sulphate (IS) and p-cresyl 
sulphate (PCS) are two uremic toxins produced by the gut microbiome, which originate from 
protein metabolism in the gut and are associated with an increased risk of cardiovascular 
disease.77  
It has been established that the concentration of these uremic toxins is increased by a high 
protein-to-fiber ratio in the diet.78 Higher protein diets promote proteolytic (putrefaction) 
bacteria over saccharolytic (fermentation) bacteria, which in turn contributes to dysbiosis and 
a higher risk of cardiovascular disease.79 Protein metabolism in the gut leads to the breakdown 
of tyrosine, phenylalanine, and tryptophan which are precursor products for PCS and IS 
conversion.79 In contrast, the fermentation of fiber (non-digestible carbohydrate) releases 
short-chain fatty acids that favour healthy microbial activity to control dysbiosis.80 
Populations consuming a predominantly plant-based diet have greater microbiome abundance 
and biodiversity compared with populations consuming a diet subject to processing and 
inadequate fiber.81 A high fiber vegetarian diet has also been shown to reduce the production 
of IS and PCS compared to a high meat diet in a healthy population,46 which might translate 
to a reduced risk of CVD and mortality.  
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In the kidney disease population specifically, recent trials have demonstrated the roles of  pre-
biotics,82  pro-biotics,83 and their combination as synbiotics84 to modulate the composition of 
the intestinal microbiota, thereby controlling the production of IS and PCS, and ultimately 
potentially mitigating CVD risk and mortality.85 Improving the microbial diversity through 
synbiotics in kidney disease populations highlights an important role of the gut in mediating 
CVD risk, but also reaffirms the role of the overall quality of the diet. Specifically, a plant-
based dietary pattern which contain natural pre-biotics86 and is lower in red meat proteins 
represents an important strategy for reducing uremic toxin production naturally.46 This dietary 
pattern is more likely to support the production of saccharolytic bacteria, generate short-chain 
fatty acids and improve cardiovascular risk and gastrointestinal health overall, beyond that of 
the single nutrient strategies targeting prebiotics, fiber, carbohydrates or protein in isolation.78, 
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3.3.3 Is a new paradigm shift in renal nutrition management on the horizon?  
People with kidney disease are advised to restrict individual nutrients, in line with current best 
practice guidelines. However, patients face several challenges from conflicting priorities 
which often result in poor compliance. Recent evidence supports a shift in nutritional focus to 
a healthy dietary pattern which is predominantly plant-based to promote control over a range 
of clinical risk factors and end-points in kidney disease. This is likely an approach which 
could facilitate compliance with dietary change in kidney disease. In addition, the non-
invasive manipulation of the gut microbiota through a plant-based diet which is high in 
natural prebiotics has promising clinical potential. 
It is now timely to determine whether a predominantly plant-based diet is feasible, safe and 
effective in the management of CKD and dialysis. To test the important question of whether 
the adoption of healthy eating patterns could improve patient-level outcomes in the kidney 
disease population, high quality controlled clinical trials are needed. However, until a plant-
based dietary pattern has been deemed both safe and effective, and tested using a pragmatic 
implementation strategy, these theories of what exactly constitutes a ‘healthy’ diet will 
continue to be hypothetical.  
We do, however, know how frequently we currently fall short when focussing on individual 
nutrients, particularly sodium, potassium, phosphate and protein. Dietary management of 
dialysis patients may require a new approach emphasizing healthy eating patterns and a more 
broad based view of what constitutes success. 
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 - Healthy Dietary Patterns and Risk of Mortality and ESRD in 
CKD: A Meta-Analysis of Cohort Studies 
4.1 Preface 
Chapter 3 highlights the possibility of a healthy dietary pattern and associations to improved 
clinical outcomes in CKD. Chapter 3 also addresses potential mechanisms by which a healthy 
dietary pattern may influence clinical outcomes and generates a hypothesis which may be a 
more pragmatic, understandable, and possibly more effective dietary approach than single 
nutrient restrictions. 
With a lack of randomised controlled trial evidence of a dietary pattern and long-term CKD 
endpoints, cohort studies form the body of evidence with informs practice. However, cohort 
studies which have evaluated the association of health dietary patterns and CKD outcomes has 
not been systematically synthesised to date.  
Chapter 4 reports on a systematic review which evaluated cohort studies for the associations 
of healthy dietary patterns with mortality and ESKD in established kidney disease 
populations. The purpose of this chapter is to address thesis research question 1 and determine 
whether dietary patterns may have a place in the dietary management of CKD.  
This chapter contains the accepted version of an original manuscript published in the peer-
reviewed journal, the Clinical Journal of the American Society of Nephrology. The paper 
formatting has been modified in accordance with a consistent thesis style. However, the 
grammar, headings, and references (in-text and bibliography) are unaltered in accordance with 
the journal publishing guidelines. 
Citation: Kelly JT, Palmer SC, Wai SN, Ruospo M, Carrero JJ, Campbell KL, Strippoli GF. 
Healthy dietary patterns and risk of mortality and ESRD in CKD: A meta-analysis of cohort 
studies. Clinical Journal of the American Society of Nephrology. 2016; 12(2), 272-279. 
4.1.1 Related work to this Chapter completed by the candidate  
One other manuscript relating to this chapter has also been published by the candidate, in the 
form of an original research article (Appendix F). While this paper is not a primary 
publication within this thesis, the candidate supervised the student researcher who led this 
project and used the findings to augment the findings of Chapter 4 in an Australian setting. As 
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this study is published outside the search date used in the review reported in Chapter 4, this 
work contributes important concepts and findings directly related to the research question this 
chapter addresses. Specifically, the associations of higher consumptions of fruit, vegetables 
and different dietary habits and hard clinical end-points in CKD stages 3-4. 
• Wai SN, Kelly JT, Johnson DW, Campbell KL. Dietary patterns and clinical outcomes in 




4.2 Abstract  
4.2.1 Background and objectives 
Patients with chronic kidney disease are advised to follow dietary recommendations that 
restrict individual nutrients. Emerging evidence indicates overall eating patterns may better 
predict clinical outcomes, however evidence for dietary patterns in kidney disease has not 
been previously synthesized.  
4.2.2 Design, setting, participants and measurements 
This systematic review aimed to evaluate the association between dietary patterns and 
mortality or end-stage kidney disease among adults with chronic kidney disease. Medline, 
Embase, and reference lists were systematically searched to 24 November 2015 by two 
independent review authors. Eligible studies were longitudinal cohort studies reporting the 
association of dietary patterns with mortality, cardiovascular events, or end-stage kidney 
disease.  
4.2.3 Results 
A total of seven studies involving 15,285 participants were included. Healthy dietary patterns 
were generally higher in fruit and vegetables, fish, legumes, cereals, whole grains, and fiber 
and lower in red meat, salt, and refined sugars. In six studies, healthy dietary patterns were 
consistently associated with lower mortality (3983 events; adjusted relative risk 0.73, 95% 
confidence interval 0.63 to 0.83; risk difference 46 fewer (29 to 63 fewer) events per 1000 
people over five years). There was no statistically significant association between healthy 
dietary patterns and risk of end-stage kidney disease (1027 events; 1.04, 0.68 to 1.40).  
4.2.4 Conclusions 
Thus, healthy dietary patterns are associated with lower mortality in people with kidney 
disease. Interventions to support adherence to increased fruit and vegetable, fish, legume, 
whole grains, and fiber intake and reduced red meat, sodium, and refined sugars could be 




Chronic kidney disease affects about 10% to 13% of adults1 and represents a public health 
challenge due to the substantially increased risks of death and cardiovascular disease among 
affected people.2 3 Patients who have chronic kidney disease are advised to follow dietary 
recommendations that restrict individual nutrients such as phosphorus, salt, potassium, and 
protein to prevent short- and long-term clinical complications.4 Historically, dietary advice 
has been based on individual nutrients or food groups instead of whole eating patterns, 
although considered complex, challenging to adhere to, and an intense burden for some 
patients.5 In addition, there is limited evidence that restricting or supplementing specific 
nutrients or single food groups effectively prevents clinical complications including kidney 
failure or death.6-9 Fluid and dietary restrictions remain frequently identified as priority areas 
of research by patients with kidney disease and healthcare providers.10 
Recent evidence has linked dietary patterns rich in fruit and vegetables, fish, legumes, cereals, 
and nuts with reduced cardiovascular events and death in healthy adults and those at high risk 
of cardiovascular disease.11-14 In parallel, there is an emerging trend toward the study of 
whole dietary patterns rather than single nutrient or food group restrictions among people with 
kidney disease.15-17 However, existing cohort studies of dietary patterns in people with kidney 
disease have small sample sizes, while existing randomized trials are insufficiently powered 
to establish the role of whole dietary patterns on mortality and kidney failure limiting the 
impact of single studies to inform clinical practice and policy.18 19 Existing dietary guidelines 
lack robust evidence for effects on patient-centered outcomes.20 
The aim of this study was to conduct a meta-analysis of the evidentiary basis for the 
association of dietary patterns with mortality and cardiovascular endpoints to establish the 
potential role of dietary patterns among people with chronic kidney disease. 
4.4 Material and methods 
Our primary aim was to assess the association of healthy dietary patterns on the risk of 
mortality and end-stage kidney disease in adults with chronic kidney disease. This systematic 
review followed a pre-specified review protocol, prospectively registered in the International 
Prospective Register of Systematic Reviews (PROSPERO)21 and reported using the preferred 
reporting items for systematic reviews and meta-analysis (PRISMA).22 
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4.4.1 Data sources and Searches 
We searched Medline, Embase, and reference lists of retrieved studies for prospective cohort 
studies available online reporting the association between dietary patterns and clinical 
outcomes among adults who have chronic kidney disease on November 30, 2015. We did not 
have any language or date restriction for the search. The search terms are shown in Appendix 
G. 
4.4.2 Study Selection 
Dietary patterns were defined as overall habitual food intake ascertained by healthy eating 
guidelines or a priori diet quality score; dietary pattern analysis; and/or consumption of whole 
food groups such as fruit and vegetables. We excluded single nutrient or food-group based 
modifications from this review including isolated protein or sodium restriction. We required 
follow up for at least 24 weeks to ensure sufficient follow-up of dietary patterns on patient-
level outcomes, and explicit reporting of outcomes either as raw data or adjusted effect 
estimates with 95% confidence intervals. We used definitions of chronic kidney disease 
according to international clinical practice guidelines.4 
4.4.3 Data Extraction and Quality Assessment 
Two authors (JK, SW) independently reviewed all retrieved records for eligibility using 
reference management software. The two authors extracted data and adjudicated risk of bias, 
with differences resolved by discussion. We contacted authors for information missing or 
unclear from included studies. The risk of bias was assessed using the Newcastle-Ottawa 
tool.23 We then used the grading of recommendations assessment, development, and 
evaluation (GRADE) methodology to rate the quality of the evidence for mortality as high, 
moderate, low or very low.24 Observational studies begin as low quality evidence, but can be 
rated upward to moderate or high quality evidence if they collectively demonstrate a large 
magnitude of effect, or a dose-response gradient. Outcomes were death, health-related quality 
of life, end-stage kidney disease, major cardiovascular events, blood pressure, serum 
cholesterol, and major adverse events. 
4.4.4 Data Synthesis and Analysis 
We carried out analyses according to a pre-defined protocol to compare healthy eating 
patterns (generally higher intake of fruit, vegetables, cereals, legumes, whole grains and fiber, 
and fish, and lower intake of red meat, salt, and refined sugar) versus dietary intake less 
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representative of these eating patterns. We then summarized adjusted risks (hazard ratio, odds 
ratio or relative risk) provided in studies using random-effects inverse variance meta-analysis. 
A fixed-effect model was also used to ensure robustness of the model chosen and 
susceptibility to outliers. Estimated numbers of events incurred or avoided with dietary 
change was calculated as a risk difference based on a five year risk of mortality reported in a 
systematic review of cohort studies.25 We used the I2 statistic to assess heterogeneity – the 
proportion of total variation observed in the association of dietary intake and outcome among 
studies beyond that expected by chance, with an I2 value less than 25% considered as low 
heterogeneity and more than 75% as high heterogeneity. We assessed for small study effects 
in analyses for mortality by visual evaluation of the funnel plot for symmetry. 
Sensitivity analyses were done excluding studies in which the same cohort of participants 
may have been represented more than once and excluding studies involving adults with end-
stage kidney disease. We planned subgroup analyses based on gender, duration of follow up, 
study quality, and geographical region. Analyses were performed using Stata 13, with 95% 
confidence intervals excluding a risk ratio of 1.0 used to denote statistical significance. 
4.5 Results 
4.5.1 Study Selection and Baseline Characteristics 
The systematic search yielded seven cohort studies (Figure 4-1) involving 15 285 patients 
with chronic kidney disease (Table 4-1).17 26-31 The participants were followed for between 4 
and 13 years on average, totalling approximately 91 000 patient years of follow up. All but 
one study involved people with chronic kidney disease defined as an estimated glomerular 
filtration rate below 60-70 ml/min per 1.73 m2 body surface area or albuminuria.17 26-30 One 
study enrolled adults treated with dialysis.31 Studies involved people living in the United 
States,17 26 27 29 30 Sweden,28 and Japan.31 Healthy dietary patterns were reported as generally 
consistent with a higher intake of fruits and vegetables, legumes, cereals, whole grains and 
fiber, and fish, and lower intake of red meat, and products containing sodium and refined 
sugars (Table 4-2). All studies were published between 2013 and 2015. There were 3983 




Figure 4-1: Flow chart describing process of study selection. 
4.5.2 Risk of Bias and Evidence Quality 
Risks of bias in the included studies is shown in Figure 4-2. Overall, studies were considered 
at low risk of bias for characteristics considered important to the reliability of cohort studies. 
When GRADE (directness, precision, consistency, and study limitations) recommendations 
were considered, the evidence quality for all-cause mortality was considered low based on the 
non-randomized study design, without incurring further downgrades in evidence quality for 
indirectness, imprecise results, heterogeneity, or study reporting limitation. 
  
Number of records identified 




Number of additional 
records identified 
through other sources 
(N=1) 
Number of records after 
duplicates removed 
(N=9876) 
Number of records screened 
in title and abstract 
(N=9876) 
Number of articles assessed 
in full text (N=126) 
Number of records excluded on 
the basis of title and abstract 
review (N=9750) 
Number of articles excluded on 
reading full-text (N=119) with 
reasons: 
Not population (N=18) 
Not dietary pattern (N=79) 
Not study design (N=16) 
Not study outcomes (N=2) 
Secondary publication of 
included study (N=4) 
Number of studies included 
in systematic review (N=7) 
Number of studies included 
in meta-analysis (N=6) 
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Figure 4-2: Quality assessment of included studies using Newcastle-Ottawa scale. 
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4.5.3.1 All-cause mortality  
When compared with other dietary patterns, a dietary pattern richer in vegetables, fruit, fish, 
cereals, whole grains and fiber, legumes, and nuts and seeds and lower in red meat, sodium 
and refined sugars was associated with a lower risk of death. In six studies among 13 930 
participants followed for between 4 and 13 years the relative risk of all-cause mortality was 
0.73 (95% confidence interval 0.63 to 0.83) (Figure 4-3). There was no heterogeneity between 
studies (I2 =0%) and no evidence of small study effects (Figure 4-5). Based on an estimated 
five year mortality of 17% in people with chronic kidney disease,25 the risk difference with a 
healthy dietary pattern compared to other dietary patterns was 46 fewer deaths per 1000 
people (29 to 63 fewer) over 5 years. 
 
Figure 4-3: Risk of all-cause mortality associated with healthy dietary patterns among adults 
with chronic kidney disease. 
4.5.3.2 End-stage kidney disease 
There was no evidence of an association between a healthy dietary pattern and risk of end-
stage kidney disease in three studies (n=10 071 people) with follow up ranging between 4 and 
6.4 years. The risk of end-stage kidney disease among people with chronic kidney disease was 




Figure 4-4: Risk of end-stage kidney disease associated with healthy dietary patterns among 
adults with chronic kidney disease.  
4.5.3.3 Major cardiovascular events, health-related quality of life, adverse events, 
blood pressure 
There were insufficient numbers of studies to conduct meta-analysis for risks of major 
cardiovascular events. In one study involving 3006 people, a healthy diet score was not 
associated with risk of atherosclerotic events (1.01, 0.47 to 2.18).17 In a single study among 
1355 dialysis patients, an “unbalanced dietary pattern” with high sodium intake and higher 
vegetable and lower fish and meat intake, was associated with a higher risk of a composite of 
hospitalization due to cardiovascular disease or death due to any cause.31 
There was no reporting of health-related quality of life, or cardiovascular-related death, 
adverse events, or hyperkaliemia as individual endpoints. There was no information about the 
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Figure 4-5: Funnel plot for the meta-analysis of the risks of all-cause mortality for healthy 
eating patterns compared to other eating patterns 
4.5.4 Sensitivity analyses 
Results were similar when single studies were removed to exclude the possibility that 
participants had been included in analyses more than once (Table 4-3). There was no evidence 
that results in meta-analyses for mortality were different based on country of origin, age, 
duration of follow up time, or quality of studies (Table 4-4). 
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201626 
NHANES III 0.77 (0.66 to 0.90) 0.001 -- -- 
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NHANES III - Third National Health and Nutrition Examination Survey; REGARDS -  Reasons for 
Geographic and Racial Differences in Stroke study; Uppsala - Uppsala Longitudinal Study of Adult 
Men; CRIC - Chronic Renal Insufficiency Cohort (CRIC) Study. The remaining study by Tsuruya et al 
was not included in the meta-analysis.  
Table 4-4: Subgroup analysis for all-cause mortality 
Variable (No of studies) Relative risk (95% CI) 
Duration:  
<6.3 years (3) 0.63 (0.48 to 0.78) 
>6.3 years (3) 0.81 (0.67 to 0.95) 
Country of origin:  
USA (5) 0.73 (0.61 to 0.85) 
Other (1) 0.73 (0.63 to 0.83) 
Age:  
> 60 years (3) 0.69 (0.57 to 0.82) 
< 60 years (2) 0.73 (0.63 to 0.83) 
Study quality:  
Lower (4) 0.72 (0.55 to 0.89) 
Higher (2) 0.73 (0.63 to 0.83) 
  
4.6 Discussion 
This meta-analysis comprising approximately 90 000 person years of follow up and including 
3983 mortality events showed that dietary patterns rich in vegetables and fruits, legumes, 
whole grains, and fiber together with lower consumption of red meat, sodium, and refined 
sugars were consistently associated with lower mortality in people with chronic kidney 
disease.  Existing cohort studies provide evidence of the association of healthy dietary 
patterns with risks of end-stage kidney disease, and major cardiovascular complications, or 
health-related quality of life, although there is considerable uncertainty in the results for these 
outcomes due to wide confidence intervals from meta-analyses that included few studies. To 
our knowledge this is the first cumulative assessment of whole dietary patterns and their 
association with mortality and clinical complications in people with chronic kidney disease. 
The association of healthy dietary patterns with lower mortality in people with chronic kidney 
disease is in contrast with the lack of association between restrictions of individual dietary 
components for food groups including serum phosphorus,7 32 33 sodium6 and protein34 intake 
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and mortality, although individual studies addressing these questions have had small sample 
sizes and low power to discern the relative association of nutritional modifications on clinical 
outcomes. The findings of the current meta-analysis are consistent with accruing large-scale 
evidence of consistent mortality benefits with adherence to a plant-based dietary pattern 
among people without existing chronic disease35 although in a large randomized controlled 
trial of Mediterranean diet, a primarily plant-based diet including extra virgin olive oil or nuts, 
there was no statistical evidence of lower mortality alone in people at high risk of 
cardiovascular events, while a Mediterranean dietary pattern lowered the risk of a composite 
of non-fatal and fatal cardiovascular events.11 To date, randomized trials testing the effects of 
dietary patterns rich in fruits and vegetables or a Mediterranean diet in adults with kidney 
disease are preliminary and have not examined mortality as an endpoint.18 36 37 As in our 
study, there is limited evidence for the association of eating patterns with risks of end-stage 
kidney disease in the literature, although cohort studies suggest dietary patterns rich in fruit 
and vegetables may lower risks of progression to chronic kidney disease and decrease 
albuminuria and blood pressure.38-42 
Recent research in chronic kidney disease has seen a shift from the decades-long focus on 
assessing and modifying single nutrient components of diet among people with chronic 
kidney disease reflecting in practice guidelines,4 to an increasing analysis of whole dietary 
patterns. As a result, this study shows accumulating evidence over the last five years of 
analyses that consider all food groups thought to be important for health. While existing 
single-nutrient approaches have had limited impact on health in people with kidney disease, 
this study of the building evidence for healthy dietary patterns on mortality risk suggests that 
this shift to wider dietary approaches across several food groups is appropriate and aligns with 
existing patient priorities.10 Given the prevalence of chronic kidney disease in the community, 
data supporting specific dietary patterns potentially has an important public health impact, and 
warrants the prioritization of additional resources to support a randomized trial of dietary 
intake in this population. Highly-efficient trial design, embedded within registries or 
electronic health records might increase the feasibility and reduce the costs of an adequately 
powered dietary trial in the wider population with kidney disease. This is particularly relevant 
given the progressive shift toward more Western dietary patterns43 and the relative lack of 
treatments proven to lower the burden of premature death and kidney failure among people 
with kidney disease. A recent additional cohort study showing a dose-dependent association 
between red meat intake and risk of end-stage kidney disease and lower risks when other 
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sources of protein are substituted further adds weight to the need to understand the association 
of whole food dietary patterns with clinical outcomes in the setting of kidney disease.44 
While this study was prospectively planned and conducted independently by two authors, 
providing highly consistent findings among studies, and precise risk estimates for the 
mortality endpoint, some limitations of this study can be identified. First, the healthy dietary 
patterns we identified were not standardized, and represent a heterogeneous range of dietary 
intake. For example, some dietary patterns included milk products as healthy food groups27 
whereas others defined milk and milk product intake as less desirable.26 28 30 However, the key 
elements of greater fruit and vegetable intake were present in all studies. Second, these studies 
were based on dietary self-recalls via differing methods (food frequency questionnaires versus 
food records), although the results among all studies were consistent, and not apparently 
influenced by this factor. Third, included patients had a range of kidney function, although all 
had an estimated glomerular filtration rate below 60-70 ml/min per 1.73 m2 or albuminuria. 
Fourth, all the studies included in meta-analysis for mortality were conducted in United States 
or Sweden, and thus the results may not be generalizable to other global regions including 
lower resourced regions. Fifth, we did not find any association of dietary change with end-
stage kidney disease. End-stage kidney disease is a rarer complication of chronic kidney 
disease due to the competing risk of death; accumulated studies evaluating the associations of 
diet with this outcome had relatively few recorded events as would be expected, even when 
linked to dialysis census databases. Sixth, it was not possible to assess for evidence of 
publication bias. Finally, this study is based on non-randomized data leading to the potential 
for the findings to be partly explained by residual confounding and leading to lower quality 
evidence. The results are hypothesis-generating and represent an important indication for a 
future randomized trial and public policy, particularly as dietary and lifestyle interventions are 
highly ranked research priorities by patients and clinicians. 
In summary, this meta-analysis shows that adherence to dietary patterns rich in fruit and 
vegetables, fish, legumes, cereals, whole grains and fiber, and lower in red meat, and products 
containing sodium and refined sugars is associated with lower mortality in people with 
chronic kidney disease. This finding represents a shift in evidence from management of single 
nutrient or food groups in the care of kidney disease and aligns with the experiences of 
patients who describe nutritional advice as frequently complex and difficult to follow. This 
evidence might prompt the prioritization of randomized trials of dietary patterns among 
 
85 
people with kidney disease and re-evaluation of dietary advice as a public health tool to lower 
mortality in people with kidney disease. 
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 - Telehealth methods to deliver dietary interventions in adults 
with chronic disease: a systematic review and meta-analysis 
5.1 Preface 
As outlined in Chapters 3 and 4, adherence to single nutrient dietary interventions is 
notoriously poor in people with CKD. With suggestions in the literature that this may relate to 
a lack of regular support and contact with health care professionals, it is important to evaluate 
the effectiveness of telehealth delivery methods for the delivery of complex dietary 
interventions and whether this could impact dietary change outcomes.   
As shown in Table 2-8 and discussed in Chapter 2, there have been a number of telehealth 
systematic reviews conducted in chronic diseases. However, no review to date has 
investigated complex dietary change, in which a multitude of nutrients and/or foods are 
typically advised to be modified in the diet simultaneously. This is the type of dietary 
education reflective of true dietary management in clinical care and chronic disease 
management and requires regular and on-going support to facilitate sustained behaviour 
change.   
Chapter 5 seeks to systematically address thesis research question 2, to determine what 
telehealth programs have been conducted in chronic disease populations, what content has 
been utilised, and what is their overall effectiveness on facilitating dietary change. The study 
reported in this chapter may assist in the understanding of what dietary interventions can be 
delivered using telehealth and what telehealth modalities may be more appropriate in complex 
chronic disease (such as CKD). 
This chapter contains the accepted version of an original manuscript published in the peer-
reviewed journal The American Journal of Clinical Nutrition. The paper formatting has been 
modified in accordance with a consistent thesis style. However, the grammar, headings, and 
references (in-text and bibliography) are unaltered in accordance with the journal publishing 
guidelines. 
Citation: Kelly JT, Reidlinger DP, Hoffmann TC, Campbell KL. Telehealth methods to 
deliver dietary interventions in adults with chronic disease: a systematic review and meta-
analysis. The American Journal of Clinical Nutrition. 2016; 104(6), 1693–1702. 
 
92 
5.1.1 Related work to this Chapter completed by the candidate  
Two other manuscripts relating to this chapter have also been published by the candidate, in 
the form of a) a systematic review protocol (available in Appendix A) describing the methods 
for the paper presented below; and b) a (descriptive) original research article which is not a 
primary publication within this thesis, but was originally conceived by the candidate and 
supervisory team as a research study to build on the understanding of telehealth intervention 
reporting. This second paper reports on the study which evolved into a student project, for 
which the candidate took a supervisory role and assisted in completing the template for 
intervention description and replication (TIDieR) checklist for all studies included in Chapter 
5, and those excluded due to not reporting dietary outcomes. The descriptive study findings 
are directly related to the research question this chapter addresses and is available in 
Appendix H.  
• Kelly JT, Reidlinger DP, Hoffmann TC, Campbell KL. Telehealth methods to deliver 
multifactorial dietary interventions in adults with chronic disease: A systematic review 
protocol. Systematic Reviews. 2015; 4(1), 1-7.  
• Warner M, Kelly JT, Reidlinger DP, Hoffmann TC, Campbell KL. Reporting of 
telehealth-delivered dietary intervention trials in chronic disease. Journal of Medical and 




5.2 Abstract  
5.2.1 Background 
The long term management of chronic disease requires adoption of complex dietary 
recommendations, which can be facilitated by regular coaching to support sustained behavior 
change. Telehealth interventions can overcome patient-centred barriers to accessing face-to-
face programs and provide feasible delivery methods, accessible regardless of geographic 
location.   
5.2.2 Objective 
We performed a systematic review to assess the effectiveness of telehealth dietary 
interventions for facilitating dietary change in adults with chronic disease. 
5.2.3 Design 
A structured search was conducted in Medline, EMBASE, CINAHL, and PsychINFO (from 
inception until November 2015). Randomized controlled trials which evaluated multifactorial 
dietary interventions in adults with chronic disease which provided diet education in an 
intervention longer than four weeks in duration were considered. Meta-analyses were 
performed using random-effects model on diet quality, dietary adherence, fruit and 
vegetables, sodium intake, energy and sources of dietary fat.  
5.2.4 Results 
A total of 25 studies were included, involving 7,384 participants. Telehealth dietary 
intervention was effective at improving diet quality (Standardised Mean Difference (SMD) 
0.22 [95% confidence interval: 0.09, 0.34]; p=0.0007), fruit and vegetable intake (Mean 
difference (MD) 1.04 servings/day [0.46, 1.62];p=0.0004), and dietary sodium intake (SMD -
0.39 [-0.58, -0.20]; p=0.0001). Single nutrients (total fat and energy consumption) were not 
significantly modified by telehealth intervention, however important clinical outcomes were 
significantly improved by following a telehealth intervention, such as systolic blood pressure 
(mean difference (MD) -2.97mmHg [95% CI: -5.72, -0.22];p=0.05), total cholesterol (MD -
0.08 mmol/L [95% CI: -0.16, -0.00]; p=0.04), triglycerides (MD -0.10 mmol/L[95% CI: -
0.19, -0.01];p=0.04), weight (MD -0.80kg [95% CI: -1.61, 0]; p=0.05), and waist 




Telehealth-delivered dietary interventions which targeted whole foods and/or dietary patterns 
can improve diet quality, fruit and vegetable intake, and dietary sodium intake and where 
applicable should be incorporated into health care services for people with chronic conditions.  
5.2.6 Keywords 





Chronic diseases are the leading cause of ill health, accounting for over 68% of all deaths 
worldwide (1). Chronic diseases are characterised by a multi-factorial aetiology (1), which is 
often diet-related, including obesity, heart disease, diabetes, hypertension, stroke, and kidney 
disease (2). Self-management and the adoption of a healthy lifestyle, such as improved dietary 
habits, increased physical activity, and other health related behaviors (e.g. smoking cessation) 
are considered essential for the management of chronic diseases (3, 4). However, standard 
chronic disease care models are only followed by a minority of patients for many reasons 
including poor compliance and high patient burden (5). This suggests the long term 
maintenance of dietary behaviors is unable to be facilitated using traditional models of care.  
Individuals with multiple risk factors for cardiovascular disease (CVD) and other chronic 
diseases have been identified as having higher levels of non-attendance in face-to-face (FTF) 
consultations (6, 7). Patient-centred barriers including limited transport and geographical 
isolation, working hours, and forgetting about appointments can contribute to appointment 
non-attendance (8). Additional healthcare barriers which can further hinder access to 
traditional FTF care include administrative error, access to clinic facilities, parking and 
unfavourable opening hours of clinics (7).  
Telehealth technologies can be used to provide education and self-management support to 
facilitate and sustain lifestyle changes and have several advantages over traditional FTF 
models of care (9). Telehealth strategies may assist with achieving dietary behavior change in 
chronic disease (9-11) and are flexible in time and location, with the potential to offer 
intensive interventions that may not be feasible with traditional care models. According to the 
World Health Organisation (12), the term ‘telehealth’ refers to the delivery of health care 
services from a distance synchronously (i.e. same time, different location) and/or 
asynchronously (i.e. different time, different location), using information and communication 
technologies to exchange health information (12). A telehealth lifestyle intervention may offer 
flexibility in delivery mode involving the provision of health education or counselling 
individuals or group remotely via the telephone (13), computer or the internet (14-16) video 
(17), email (18), and/or mobile applications including text and photo messaging (19, 20). 
Whilst there have been a number of systematic reviews covering different combinations of 
telehealth in healthy (21-23) and chronic disease (24-27) populations, none have specifically 
evaluated interventions that attempt to change dietary patterns or target multiple dietary 
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changes simultaneously (such as multiple food groups or nutrients). These diet interventions 
represent the dietary advice typically provided to chronic disease populations (28). This 
systematic review therefore aimed to assess the overall effectiveness of telehealth dietary 
interventions for facilitating multifactorial dietary change in adults with chronic disease.  
5.4 Methods 
This systematic review followed a pre-specified review protocol, previously published 
elsewhere (29), detailing the rationale, purpose and methodology. It was prospectively 
registered in PROSPERO: The International Prospective Register of Systematic Reviews 
(CRD42015026398).  
5.4.1 Literature search 
A literature search was performed in the electronic databases, MEDLINE, EMBASE, 
CINAHL, and PsychINFO (since inception until November 2015), using a variety of subject 
headings, free text terms and synonyms relevant to the review in consultation with an 
experienced systematic review search librarian, and published in the protocol (29). There was 
no date or language restriction in the search strategy. A multi-step search approach was taken 
to retrieve relevant studies using forward and backward citation searching, expert 
correspondence, searching conference abstracts, theses and dissertations (ProQuest), and the 
International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov to identify 
ongoing trials. This review follows the format recommended in the Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis: The PRISMA Statement (30). The screening of 
articles was independently by two review authors, with disagreements in judgement resolved 
by consensus or a third reviewer. 
5.4.2 Study selection 
All search results were merged into EndNote™ and de-duplicated before screening. Studies 
were included in the review if they met all of the following criteria: 1) randomized controlled 
trial (RCT), cluster RCT, or quasi-RCT; 2) adult participants (>18 years of age); 3) conducted 
in a population with an established diet-related chronic disease defined as obesity (BMI 
≥30kg/m2), diabetes mellitus, heart disease, hypertension, stroke, or kidney disease (29, 31); 
4) involved the provision of multifactorial dietary education where the dose of total 
intervention contact hours and/or the total number of interaction contacts was at least 50% 
delivered by at least one telehealth strategy; 5) developed or delivered by a qualified health 
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professional (such as a nurse, dietitian, or physician); 6) reported on any measure of dietary 
intake at baseline and at least four weeks later at follow-up. 
We defined a multifactorial dietary intervention as targeting more than a singular nutrient 
and/or food group. Multifactorial dietary interventions included: those aimed at overall 
dietary quality (assessed as any outcome which objectively scores adherence to dietary 
guidelines) (32-34) and patterns, such as the Mediterranean diet (35), and/or the Dietary 
Approaches to Stop Hypertension (DASH) diet (36), or those which educate about two or 
more dietary components (nutrients and/or food groups) simultaneously. Studies that targeted 
two or more diet changes within the same nutrient (e.g. manipulation of categories of fatty 
acids) were excluded as the dietary components related to one nutrient only, and thus were not 
classified as multifactorial.  
Studies were included if they compared a telehealth intervention to usual care (as defined by 
trial authors); to dietary education in a FTF or group-based environment with no telehealth 
component; or via methods where less than 50% of the intervention was delivered by 
telehealth; or to a non-dietary focussed intervention.  
The primary outcome was dietary intake (any measure), with secondary outcomes relating to 
clinical outcomes such as all-cause mortality; cardiovascular mortality; hospitalizations; and 
clinical markers of chronic disease progression, such as blood pressure, weight, and blood 
lipid profiles. 
5.4.3 Data extraction and management 
The following data were extracted from included studies: intervention details (following the 
components outlined in the Template for Intervention Description and Replication (TIDieR) 
checklist) (37), participant characteristic (chronic disease, age and gender), attrition, sample 
size, and study design and duration. Risk of bias was assessed by two review authors 
independently using Cochrane methodology (38) to categorise selection bias, performance 
bias, detection bias, attrition bias, and reporting bias in each study as low, unclear or high risk 
of bias. Mean, standard deviation, standard error or 95% confident intervals (CI) for all pre-
specified primary and secondary outcome data that were reported at baseline and follow-up 
were extracted for analysis. When a study presented adjusted and unadjusted values, the most 
adjusted value was extracted for analysis. 
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5.4.4 Statistical analysis 
To calculate the overall treatment effect on primary and secondary outcomes, the difference 
between the intervention and comparison groups’ change scores from baseline to the end of 
follow-up was extracted. If change from baseline values was not available, end of intervention 
values were extracted, assuming baseline values were similar. The variance was calculated 
from the standard deviation or standard error from the difference between baseline and 
follow-up, or from confidence intervals when these values were not available (38). When 
interventions and associated outcomes were assessed as sufficiently homogeneous and when 
sufficient information was available from the studies, quantitative data were pooled into 
Revman (Version 5.3, The Cochrane Collaboration 2014) for meta-analysis using the 
DerSimonian and Laird random-effects model (39) and checked using the fixed-effect model 
to ensure robustness and susceptibility to potential outliers. The I2 statistic was used to assess 
the inconsistencies between studies and describe the percentage of variability in effect. 
Heterogeneity was considered substantial if the I2 statistic was ≥50%. 
Effect sizes (for combined fruit/vegetables servings, energy intake, blood pressure, weight, 
and lipid profiles) were converted to standard units and calculated as mean differences (MD). 
Effect sizes for diet quality scores, dietary adherence, sources of dietary fat and sources of 
dietary sodium intake were calculated as standardised mean differences (SMD) due to the 
variability in outcome measures. We imputed missing standard deviations for one study in the 
dietary sodium and systolic blood pressure (SBP) analysis (40) using data from a similar 
included study utilizing similar methods and sample sizes (41, 42), as recommended (43). 
Egger’s plot was explored to assess potential publication bias. Sensitivity analyses were 
conducted to explore statistical heterogeneity for results of studies that appeared 
heterogeneous to the results of other analysed studies including large studies and high risk of 
bias studies. Subgroup analyses were also conducted on different chronic health conditions 
(e.g. diabetes, CVD); studies using different telehealth strategies; studies targeting specified 
single food groups or nutrients (e.g. modifying sodium, fat, fruit and/or vegetables 
interventions) versus dietary patterns, and multiple lifestyle education interventions versus 
solely dietary education.  
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5.5 Results  
5.5.1 Characteristics of included studies 
The flow of study identification and selection is detailed in the PRISMA flow chart (Figure 
5-1). The search identified 6967 studies. After duplicates were removed and non-relevant 
studies (n=5608) were excluded, a remaining 370 were subject to full text review. After this, 
345 studies were excluded, leaving 25 for inclusion, involving 7,384 participants. Table 5-1 
details the characteristics of the included studies including the frequency of contact, delivery 
provider, and type of dietary education. In all but four studies (42, 44-46), dietary education 
was delivered as part of a multifactorial lifestyle intervention. Studies were conducted in 
CVD (15 studies) (40-42, 46-57), diabetes (five studies) (44, 58-61), end-stage kidney disease 
(ESKD) (two studies) (45, 62), obesity (one study) (14), and in a mix of CVD and diabetes 
(two studies) (13, 63). The duration of studies ranged from eight weeks (46, 48, 56) to eight 
years (61). Telehealth delivery varied from the telephone (13 studies) (13, 40-42, 48, 50, 54, 
56, 57, 59, 61-63), short message service (SMS; four studies) (45, 49, 51, 58), the internet 
(three studies) (14, 53, 55), video (one study) (47) or videoconferencing (one study) (60), and 
using a mix of telehealth methods (three studies) (44, 46, 50). The percent of the interventions 
delivered by telehealth methods varied across the included studies from 66-100 percent. 
All included studies reported measures of dietary intake at baseline and follow-up. Studies 
varied in dietary outcome measures used and included: diet quality (three studies), dietary 
adherence (seven studies), energy intake (three studies), measures of dietary fat (eight 
studies), dietary sodium (seven studies), and intake of fruit and/or vegetables (nine studies). 
Ten studies were unable to be statistically pooled into meta-analysis and are therefore 





Figure 5-1: PRISMA flow chart describing process of study selection 
5.5.2 The effect of telehealth interventions on dietary change  
5.5.2.1 Diet quality  
A total of three studies involving a total of 992 participants measured diet quality (40, 41, 59) 
using a diet quality score (40), the Australian Healthy Eating Index (59), and the DASH diet 
score (41). Telehealth intervention improved diet quality (SMD 0.22 [95% CI: 0.09, 
0.34];p=0.0007; I2= 0%) compared to non-telehealth comparators (Figure 5-2 ). The results 
remained significant in two trials with 12 (40) and 24 (59) month follow-up (SMD 0.18 [95% 




Figure 5-2: Forest plot of the effect of telehealth dietary intervention on diet quality and 
dietary sodium. The effectiveness of telehealth is presented using random effects. The mean 
and SD of changes from baseline are reported for trials. Effects of trial are presented as 
weight (%) and standardised mean difference (95% CI).  
5.5.2.2 Diet adherence 
Dietary adherence outcomes (seven studies) (45, 48, 52, 56, 58, 60, 62) were unable to be 
pooled into meta-analysis due to the variation in outcome reporting statistics which could not 
be standardised, and are presented narratively in Table 5-2. Overall, telehealth intervention 
significantly improved diet adherence compared to non-telehealth comparators as reported by 
trial authors in 57% (n=4) of the studies.  
5.5.2.3 Fruit and vegetable intake 
A total of nine studies reported on fruit and vegetable intake (13, 14, 44, 46, 49-51, 53, 54). 
Telehealth intervention significantly increased fruit and vegetable intake by 1.04 servings per 
day ([95% CI: 0.46, 1.62]; p=0.009; I2= 70%) in four studies with five comparisons (2147 
participants), and by 2.94 servings ([0.91, 4.97];p=0.005; I2= 84%) per week in two studies 
with four comparisons (1682 participants) (Figure 5-3). Three studies were unable to be 
pooled statistically and are reported in Table 5-2. The one trial with longer term 12 month 




Figure 5-3: Forest plot of the effect of telehealth dietary intervention on servings of fruit and 
vegetable intake. The mean and SD of changes from baseline are reported for trials. Effect of 
trial are presented as weight (%) and mean difference (95% CI). 
In the per day analysis, four of the five comparisons used the telephone and one used the 
internet (14), a sensitivity analysis showed intervention using the telephone resulted in an 
increased fruit and vegetable intake by 0.77 servings per day ([95% CI: 0.39, 1.14]; 
p=0.0001), with heterogeneity reduced (I2= 35%) in the four comparisons (2057 participants). 
Dose of intervention showed weekly contact led to a higher intake (MD 1.32 servings/day 
[95% CI: 0.38, 2.26];p=0.006; I2=85%) in three studies (46, 50, 53), than monthly contact 
(MD 0.27 servings/day [95% CI: 0.02, 0.52];p=0.03;I2=0%) (13, 44). The one trial with 






















Materials and procedure: Video Guide on self-care 
behaviours and self-management actions. 60 min 
duration; 6 chapters: (a) basic CHF definition and 
symptoms; (b) treatment plan; (c) core HF 
medications; (d) nutrition (2000 mg sodium diet and 
fluid restriction); (e) active exercise and (f) lifestyle 
(regular activity and visits with healthcare provider). 
Location: Participant’s home 
(community/ambulatory setting) 
Dose and timing: Participants free to watch at own 






1. Forget to restrict sodium 
intake (%) 

















Materials and procedure: SMS messages designed 
to enhance motivation, self-efficacy, and ability to 
perform self-care behaviour.  SMS Scheduling: (a) 
1/day Education and motivational (based on the 
national DM education program) for BGL, BP, TC, 
healthy eating (increase fruit/vegetable & 
wholegrains, less saturated fat), PA, recipes and 
social support. (b) Medication reminders (3/week). 
(c) Healthy living challenges (2/week). (d) Trivia 
(2/week) to engage participants. Compensation for 
participants $175 during the 6 months 
Location: community/ambulatory setting. 
Dose and timing: Two daily unidirectional SMS 





1. SDSCA general diet 
score 
2. SDSCA specific diet 
score 
3. SDSCA exercise score 




















Materials and procedure: Telephone calls assessed 
participant’s knowledge and behaviour in BP 
control, use of medication, BP home monitoring, 
exercise, diet, smoking, alcohol consumption, body 
weight control and stress management; reinforcing 
health self-management behaviours, providing 
health advice, and assessing the need for referrals;  
reviewing and revising the health goals. Dietary 
adherence education (sodium restriction, control of 
fat intake, and adequate fruit/vegetable 
consumption). Treatment for co-morbidities and/or 
stress were referred to other members in the 
healthcare team if needed. 
Location: In nurse clinic and 
community/ambulatory setting 





1. Diet adherence (sodium, 
fat restriction and 
consumption of fruit & 
vegetable score) 
2. Exercise adherence 
(score) 
3. SBP (mmHg) 















Materials and procedure: Text messages were 
regularly sent (semi-personalized) providing advice, 
motivation, and education based on the Australian 
Heart Foundation Healthy Living Guidelines. 
Message content was developed for 4 modules: 
smoking, diet, physical activity, and general 
cardiovascular health (non-smokers did not receive 
stop smoking SMS messages). The general module 
of messages included information generally 
provided by secondary prevention programs, such as 













providing  their 
1. Fruit (servings/week) 
2. Vegetables 
(servings/week) 
3. SBP (mmHg) 
4. DBP (mmHg) 
5. TC (mg/dL) 
6. LDL (mg/dL) 
7. HDL (mg/dL) 
8. TG (mg/dL) 
9. BMI (kg/m2) 
10. WC (cm) 









Telehealth intervention content Comparator Outcomes 
Location: community/ambulatory setting. 
Dose and timing: SMS messages delivered to 




details, and a 
reminder prior 











Materials and procedure: The recommendations 
were based on guidelines on healthy lifestyle and 
included: a diet rich of vegetables, lower sodium, 
saturated fat intake and TC, moderate PA (no 
guideline listed), smoking cessation, moderate 
alcohol consumption (no guideline listed), blood 
pressure self-monitoring and medication adherence.  
Location: community/ambulatory setting. 
Dose and timing: Weekly contact with participants. 
Usual care, 
routine follow-
up visits 1, 3 
and 6 months 
after 
enrollment. 
1. Fruit intake 
(servings/day) 
2. Salt consumption 
(teaspoon/day) 
3. PA (minutes/day) 
4. SBP (mmHg) 
5. DBP (mmHg) 
6. TC (mg/dL) 
7. LDL (mg/dL) 









Materials and procedure: Semi-tailored, 
bidirectional messaging was used - participants 
were prompted to SMS in their weekly pedometer 
step counts and to ask questions. Recommended 
lifestyle changes included stopping smoking, 
limiting alcohol consumption (< 14 drinks/week), 
eating 5 servings of fruit/vegetables per day while 
decreasing sodium and saturated fat content, and 
encouraging regular PA (150 minutes of moderate-
to-vigorous intensity/week). Reponses to step 












1. Vegetable/fruit intake >5 
servings/day (%) 
2. PA (% physically active) 
3. BMI (kg/m2) 
4. SBP (mmHg) 
5. DBP (mmHg) 
6. TC (mmol/L) 
7. LDL (mmol/L) 









Telehealth intervention content Comparator Outcomes 
steps achieved, whereas individual questions were 
responded to personally by the research team. 
Participants were reimbursed for any costs 
associated with SMS messaging. 
Location: community/ambulatory setting. 
Dose and timing: Participants received 7 





















Materials and procedure: Participants were mailed 
a workbook containing information on PA and 
nutrition, along with a pedometer. Telephone 
coaching followed motivational interviewing 
techniques and the constructs of social–cognitive 
theory. Personalized plan provided for modifying 
PA and diet; arranging telephone follow-up support. 
Intervention followed Australian National 
Guidelines for PA (150 minutes/week over five or 
more sessions of moderate-level PA), nutrition (2 
fruit 5 vegetables, >30% E from fat, >10% E from 
saturated fat). 
Location: community/ambulatory setting. 
Dose and timing: Dietary coaching provided in 
every telephone call once/month. 
Control group 





brochure for PA 
and nutrition. 
1. Fat intake (% EEI) 
2. Saturated fat intake (% 
EEI) 
3. Vegetable intake 
(servings/day) 
4. Fruit intake 
(servings/day) 
5. Fibre intake (grams/day) 









Materials and procedure: Participants sent a 
pedometer and a set of digital scales. Telephone 
coaching aimed to increase PA, reduce energy 





1. Diet quality (0–100) 
2. Energy intake (MJ) 
3. PA (min/week) 









Telehealth intervention content Comparator Outcomes 
n=249 loss (5–10%), setting short term goals for PA (30 
min/day moderate-intensity, resistance 2-3 
sessions/week), dietary intake, tracking progress, 
and problem solving discussed each call. Each 
participant received individualized advice to 
encourage a decrease energy intake by 2,000 kJ by 
following a low-fat diet (i.e. total fat <30% energy; 
saturated fat <7% energy) with sufficient dietary 
fibre (25 g/day for women; 30 g/day for men).  
Location: community/ambulatory setting. 
Dose and timing: Dietary coaching provided in 
every telephone call which was weekly for 1 month, 







5. Weight loss (kg) 
6. WC (cm) 
7. TC (mmol/L) 
8. LDL (mmol/L) 
9. HDL( mmol/L) 
10. TG (mmol/L) 
11. SBP (mmHg) 










Materials and procedure: Telephone calls utilized 
to reinforce the content of an education booklet 
(describing HF, importance of drug and diet 
compliance, self-control and non-scheduled medical 
appointments are important). The intervention had 5 
objectives: diet compliance, drug therapy, 
monitoring symptoms, PA, and fluid control. Nurses 
could adjust diuretic dose and suggest unscheduled 
visits to the cardiologist, and them as needed during 
the performance of the program. 
Location: community/ambulatory setting. 
Dose and timing: Calls were fortnightly then 
determined by the nurse, which was governed by a 






1. Issues with following 
healthy diet (%) 
2. HF admissions (n) 
3. ACM (n) 
4. CVD admission (n) 
5. All-cause admission (n) 
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targeted diet, exercise, and medication, tailored and 
targeted to behaviours based on their current stage 
of change. Specific recommendations, such as 
trimming visible fat from meat and asking for 
sauces on the side in restaurants were provided each 
month, and any additional dietary questions were 
answered if patients were having trouble. Advice to 
increase fruit/vegetables and reduce dietary sodium 
was also given. PA adherence was defined as self-
reported aerobic exercise for ≥3 days/week for ≥20 
minutes each time. 
Location: community/ambulatory setting. 
Dose and timing: Dietary coaching was provided at 
every call once a month. 
detail not 
defined 











Materials and procedure: The computer interaction 
assessed, immediately analysed and provided 
feedback on the participant's dietary patterns, 
barriers and support for dietary self-management, 
and preferences for different intervention strategies. 
A tailored dietary fat reduction goal based on the 
participant's eating patterns and preferences was 
provided with a 1-page goals printout. Telephone 
follow up provided ongoing support and 
reinforcement to participants. The phone calls also 
provided personalized problem-solving based on 
barriers to dietary self-care identified via the touch-
screen assessment.  















1. Fruit & vegetables 
(Kristal scale) 
2. Fat (Kristal scale) 
3. HbA1C (%) 
4. TC (mg/dL) 
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interaction), and community/ambulatory setting for 
telephone follow-up. 
Dose and timing: once off computer interaction, 











FTF and website 
(internet) 
Dietitian 
Materials and procedure: Participants were 
provided with a scale, pedometer, and home BP 
monitor, and DASH education. After the visit, 
dietitians maintained communication with 
participants using secure online messaging. 
Participants were asked to share their self-
monitoring data with the dietitian – dietitian 
responded to questions via this system and provided 
resources (e.g. recipes and websites) and 
encouraged participants to reach their goals.  
Weight loss was encouraged by substituting high 
calorie foods for fruits/vegetables, and general 
cooking advice. Dietitians met with the study team 
by phone every 2 weeks to review treatment plans 
and debrief. 
Location:  community/ambulatory setting. 
Dose and timing: Participants shared self-
monitoring data with the dietitian once a week for 2 
months, every 2 weeks for 2 months, and then every 




1. F+V (servings/day) 
2. HbA1c (%) 
3. TC (mmol/L) 
4. LDL (mmol/L) 
5. HDL (mmol/L) 
6. SBP (mmHg) 
7. DBP (mmHg) 









Materials and procedure: Participants were posted a 
ProActive Heart handbook outlining the program 
goals for CHD risk factors. The health coaching 
Usual care (the 
educational 
resource ‘My 
1. Vegetables (>5/day) 
2. Fruits (>2/day) 









Telehealth intervention content Comparator Outcomes 
n=337 details NP sessions were based on the current guidelines for 
CHD.  The health coaching sessions included 
guiding participants through a series of steps 
beginning with an assessment of their CHD risk 
factor profile at the commencement of the program 
followed by feedback on their profile. Subsequent 
sessions included (a) introduction and identification 
of any cardiac symptom changes, (b) assessment 
and health coaching on relevant CHD risk factors, 
(c) follow-up on progress towards previous actions 
and goals, and (d) session review and action plan. 
Location: community/ambulatory setting. 
Dose and timing: The intervention commenced 
within the first 2 weeks of hospital discharge. 
Contact was made at a time convenient to the 
participant (up to ten telephone calls made lasting 
30 minutes each) weekly for 3 weeks, fortnightly for 
3 weeks, then monthly. 
Heart My Life’ 
and a quarterly 
information 
newsletter). 
4. Saturated fat (<10% 
EEI) 
5. Sodium (<2300mg/day) 











Materials and procedure: Medical nutrition therapy 
goals included improved glycaemic, blood pressure, 
and lipid control. Initial videoconference aimed to 
educate on self-management techniques and 
problem solving, before counselling with a dietitian.  
A document camera was used to review nutrition 
education materials, discuss home blood glucose 
patterns, and display food models and sample meal 
plans. Dietitian videoconferences were conducted to 








1. Diet/exercise (combined 
non-adherence score) 
2. BMI (kg/m2) 









Telehealth intervention content Comparator Outcomes 
review strategies. Weight loss was also encouraged, 
behaviour change goals (such as eat less 
carbohydrate, choose low fat foods, eliminate 
snacks) were set to achieve these goals. 
Location: community/ambulatory setting. 
Dose and timing: monthly videoconferences, and 
follow-up videoconference visits were scheduled 


















Materials and procedure: An online system directed 
participants to content for each week of the cardiac 
rehab program.  One-one online chat sessions were 
used to discuss progress, symptoms, and give 
exercise prescription, and dietary recommendations, 
based on the Stages of Change and Behavioural 
Cognitive Theory. The patients also had access to 
the staff via email after these sessions. The dietary 
aspect to the intervention was individualised based 
on the participant’s current diet and risk factors. The 
dietitian would ensure that the participant was 
eating sufficient protein, complex carbohydrates and 
healthy fats while emphasizing limitations on 
refined carbohydrates and fats. 
Location: community/ambulatory setting. 
Dose and timing: There was weekly education 
sessions in the form of interactive slide 
presentations, as well as monthly 'asks an expert' 




1. Fat (% calories) 
2. Saturated fat (% 
calories) 
3. SBP (mmHg) 
4. DBP (mmHg) 
5. TC (mmol/L) 
6. LDL (mmol/L) 
7. HDL (mmol/L) 
8. Triglycerides (mmol/L) 
9. WC (cm) 
10. BMI (kg/m2) 
11. PA (calories/week) 
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lifestyle guidelines in treating obesity, offering a 
combination of dietary advice, PA advice and 
behaviour therapy. The website was designed with 
tools and sections that provided this. Dietary 
education was to reduce calories by reducing fat and 
carbohydrates. Education on energy value of 
different foods; label reading, preparation and food 
purchase; adequate water intake; and limiting 
alcohol consumption. The website also offered 
personalized advice to participants, based on their 
responses to a series of online questions regarding 
eating and activity habits and current weight. 
Automatic e-mails were generated if participants did 
not visit the website regularly. 
Location: community/ambulatory setting. 
Dose and timing: Education provided at each logon 






of usual care. 
2. Vegetables 
(servings/week) 
3. Weight (kg) 















Materials and procedure: Participants received a 
manual describing HTN, dietary recommendations, 
recipes, and local resources for exercise, and 
provided information to support medication 
adherence. The first three calls introduced the 3 
targeted behaviours and their role in BP control, and 
described the online system.  Content of calls: (a) 
introduction, (b) reporting health measurements 
(pedometers, BP monitor, weight scales), (c) theory-
based interactive education and counselling. The PA 




5. Diet quality score 
6. PA (min/week) 
7. SBP (mmHg) 
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greater intensity PA. The diet module consisted of 
one overview call and two calls for each of four 
topics: fruits/vegetables, fibre, sodium, and fat. The 
content of these calls was designed to promote the 
DASH diet. Medication adherence was emphasised. 
Location: community/ambulatory setting. 
Dose and timing: The automated telephone 
intervention delivered one call/week for 32 weeks. 
The PA module consisted of 12 calls, the diet 
module consisted of nine calls, and the medication 













Materials and procedure: Key aspects of the 
intervention were the DASH diet and included a 
$30/week allowance for the purchase of high-
potassium foods from a provided list. Coaches 
discussed self-management and individual food 
preferences, including the DASH diet. Intervention 
participants choose from an extensive high K+ list 
of food that aimed to provide 17000mg/week K+. 
Coaches tailored education to food preferences, 
needs and assisted with online ordering when 
required. 
Location:  In clinic and community setting and 
online ordering. 
Dose and timing: Participants received a 1 FTF 
session with a study coach who delivered a 
dietitian-developed module on the DASH diet 







in total to spend 




2. Fibre (g/day) 
3. Fat (% calories/day) 
4. Potassium (g/day) 
5. SBP (mmHg) 
6. DBP (mmHg) 
7. TC (mg/dL) 
8. LDL (mg/dL) 
9. HDL (mg/dL) 
10. TG (mg/dL) 



















Materials and procedure: Three elements to the 
intervention: F2F nurse consultation session, a self-
management workbook, and telephone follow-ups. 
Participants reviewed their own dietary habits 
relevant to their CHD risk and made appropriate 
goals.  Workbook: made by dietitians taking into 
account financial means, personal preference, and 
expected health benefits. A logbook was provided 
which contained mutually agreed dietary goals and 
an action plan treatment. Patients recorded their 
eating diary 3 times per week in the logbook (2 
weekdays and 1 weekend). The telephone follow-up 
reviewed dietary modifications, problem-solving 
skills and provided reinforcement for positive 
changes that resulted.  
Location: Cardiac outpatient clinic and community 
setting 
Dose and timing: FTF: 30-minute face-to-face 
session was conducted by a cardiac nurse within 1 
week after the dietary class in usual care. Telephone 
calls provided monthly. 
Usual care and 
standard 
cardiac rehab, 






1. Saturated fat (score) 
2. Salted and preserved 
food intake (score) 
3. Heart healthy food 
intake (score) 
4. TC (mg/dL) 
5. LDL (mg/dL) 
6. HDL (mg/dL) 











Materials and procedure: The dietary 
recommendations were individualized to cultural, 
economic, and social habits, and based on the 
results of a 24 h dietary recall and FFQ. Patients 
were encouraged to ask questions about their food 
choices, cooking, and how to cope with fluid 
(restricted to 1.5L/day) and salt restrictions (to 2-
Received minor 
dietary advice 
from a nurse. 
1. Urinary sodium 
(mmol/L) 
2. Urinary potassium 
(mmol/L) 
3. Weight (kg) 









Telehealth intervention content Comparator Outcomes 
3g/day). Patients were contacted by telephone after 
10–12 months by a dietitian without prior 
announcement.  
Location: Follow-ups were performed at a home 
visit with the study nurse after 4 weeks and by 
telephone, without prior announcement in the 
ambulatory setting.  
Dose and timing: Follow-ups were performed at a 
visit with the study nurse after 4 weeks and by 
telephone, without prior announcement, by the 











dietitians and  
psychotherapists 
Materials and procedure: Dietary advice was 
provided by an dietitian using the ‘Food Exchange 
Lists Dietary Guidance for Persons with Diabetes’ 
and included individual counselling on dietary 
habits, PA and adherence to medications. 
Participants tracked lab values for feedback and 
therapeutic results. Goals were set for patients in the 
intervention group and their physicians: i.e. HbA1c 
level <6.5%; BMI <22 kg/m2; BP <140/85 mmHg; 
serum TC level <5.72 mmol/l; serum TG level 
<1.65 mmol/l; serum HDL cholesterol >1.04 
mmol/l; WHR <0.9 for men and <0.8 for women; 
smoking cessation; and abstinence from alcohol. 
Participants identified as having poor control or not 








were treated as 
they were 
before the study 
started. 
 
1. Energy (KJ) 
2. Fat intake (grams) 
3. HbA1c (%) 
4. BMI (kg/m2) 
5. SBP (mmHg) 
6. DBP (mmHg) 
7. TC (mmol/L) 
8. HDL (mmol/L) 
9. TG (mmol/L) 
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Location: Outpatient centres and ambulatory 
setting. 
Dose and timing: Regular outpatient visits, with 
fortnightly telephone calls. Additional counselling 
sessions were also encouraged at any convenient 











Materials and procedure: The electronic dietary 
self-monitoring application provided individualized 
information to assist patients with dietary and fluid 
self-monitoring. A feedback screen displayed 
participants’ intake in relation to their dietary 
prescriptions. Participants scan food barcodes –app 
checks if the scanned food complies with their diet 
recommendations. A 24-hour telephone number was 
provided in case participants had questions or 
problems with the application at home. 
Location: Dialysis clinics and ambulatory setting. 
Dose and timing: Participants entered data daily. 
Research assistants would provide extra education 
as needed throughout the intervention and met with 
participants at each dialysis session to download the 
intake data during the intervention period. 
Control group – 
same time spent 
using the app – 
but only 
monitoring PA. 
– received the 
same training 
and process as 
intervention 
just without diet 
intervention 
 
1. Diet self-efficacy (score) 










Materials and procedure: Participants were 
counselled using a stage of change behavioural 
model and motivational interviewing with the aim 
of: (a) Weight reduction following the Australian 
Nutrition Foundation guidelines. (b) In drinkers a 




1. Urinary sodium 
(mmol/L) 
2. Weight (kg) 
3. SBP (mmHg) 









Telehealth intervention content Comparator Outcomes 
(10 g) for women and 2 standard drinks daily (20 g) 
for men. (c) Salt restriction to less than 
90mmol/day. (d) Less than 30% daily energy 
dietary fat with restriction of saturated fat intake to 
10%. (e) An increase in regular PA. (f) Smoking 
cessation.  
Location: community/ambulatory setting. 
Dose and timing: Received 1 FTF appointment 
receiving initial results and then five telephone 











Materials and procedure: The program aimed to 
control weight, increase PA, nutrition advice to 
reduce fat and salt intake and increase fibre 
consumption, moderate alcohol intake and achieve 
cessation of smoking using principles from 
transtheoretical model, motivational interviewing, 
and self-efficacy.  
Location: community/ambulatory setting. 
Dose and timing: Received 1 FTF counselling 
session and telephone (10–15 min consultations) 
every month. The high level intervention group 










the care of the 
general 
practitioner and 
had no further 
intervention. 
1. Energy (KJ) 
2. Total fat (% EEI) 
3. Saturated fat (% EEI) 
4. Sodium (grams) 
5. Weight (kg) 
6. BMI (kg/m2) 
7. WC (cm) 
8. TC (mmol/L) 
9. LDL (mmol/L) 
10. HDL( mmol/L) 









Materials and procedure: Telephone calls were 
guided by a structured format: (a) overall health 
condition; (b) monitoring changes from the specific 
health concerns identified in the previous 






1. Diet Non- adherence 
days (5-point Likert 
scale) 
2. Fluid Non-adherence 









Telehealth intervention content Comparator Outcomes 
advice, reinforcing health self-management 
behaviours, and assessing the need for referral; (c) 
reviewing and setting mutual health goals; (d) 
arranging next call. Follow-up calls reinforced 
behaviours and identified potential complications 
and needs, and reviewed the mutual goal-setting. A 
renal nurse made the final call to review the health 
goals with the patient and provided advice if 
needed. 
Location: community/ambulatory setting. 
Dose and timing: Prior to discharge a renal nurse 
conducted an initial assessment with participants 
and provided health education. The first call then 
occurred 72 hours after discharged. There was no 
set time limit for each call. General nurses made 
subsequent calls every week for 4 weeks. 
scale) 
1 BP, Blood pressure; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; BMI, Body mass index; CVD, Cardiovascular disease; SEM, Standard 
error of the mean; TC, Total cholesterol; HF, Heart failure; CHF, Congestive heart failure; BGL, Blood glucose level;  PA, Physical activity; ADA, American 
Diabetes Association; MDT, Multi-disciplinary team; SMS, Short message service; DM, Diabetes mellitus; HTN, Hypertension; TC, Total cholesterol; LDL, 
Low-density lipoprotein; HDL, High-density lipoprotein; TG, Triglycerides; WC, Waist circumference; FTF, Face-to-face; %, percent; EEI, Estimated energy 
intake; HbA1C, Glycosylated haemoglobin; T2DM, Type 2 diabetes mellitus; ACM, All-cause mortality; DASH, Dietary approaches to stop hypertension; 





5.5.2.4 Measures of dietary sodium intake 
A total of seven studies measured dietary sodium intake. Five studies were pooled (total of 
570 participants) (42, 50, 56, 57, 63) showing telehealth intervention reduced dietary sodium 
intake on urinary and/or self-assessed scores (SMD -0.39 [95% CI: -0.58, -0.20];p=0.0001; 
I2=19%) compared to non-telehealth interventions (Figure 5-2). All seven studies used the 
telephone as the telehealth delivery method and were conducted in CVD.  Two studies used 
non-validated tools for determining daily sodium intake, measuring teaspoons of salt (1 
teaspoon being approx. 6 g of sodium chloride or 2300mg sodium) (50) and a salted food 
score (56). Exclusion of these studies from the analysis left 3 studies reporting on mmol/L of 
urinary sodium per day (42, 57, 63), which did not reach significance (MD -8.27mmol [95% 
CI: -17.34, 0.79];p=0.07;I2=24%). Two studies were unable to be pooled statistically and are 
reported in Table 5-2. The results remained significant in two trials with 12 month (42, 63) 
follow-up (MD -6.00 [95% CI: -10.41, -1.59; p=0.008; I2= 0%]. 
5.5.2.5 Energy intake  
A total of three studies (total of 2172 participants) measured energy intake (59, 61, 63) all 
with long-term durations (12 months to four years). Telehealth intervention did not 
significantly reduce energy intake (MD -10.48 kcal [95% CI: -67.20, 46.25];p=0.72; I2=15%) 
compared to usual care. All three studies used the telephone as the telehealth delivery method 
and were conducted in participants with diabetes.  
5.5.2.6 Sources of dietary fat intake 
A total of eight studies reported on measures of dietary fat intake (13, 44, 46, 54-56, 61, 63) 
including total fat per day (13, 61, 63), percent calories from total fat (55), saturated fat intake 
per day (13, 56, 63), percent calories from saturated fat (55), and the Kristal Fat and Fibre 
Behavior Scale (44). Telehealth intervention did not significantly reduce total dietary fat 
intake (MD -0.10g [95% CI: -1.90, 1.70]; p=0.91; I2=76%) in four studies (2427 participants), 
but did significantly reduce saturated fat compared to non-telehealth comparators (MD -0.93g 
[95% CI: -1.51, -0.32]; p=0.002; I2=0%) in two studies (572 participants). Three studies were 
unable to be pooled statistically and are reported in Table 5-2. Long term trials (durations 12 
months to four years) were not significant (55, 61, 63). 
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5.5.3 Telehealth dietary intervention and clinical outcomes 
Twenty one studies measured clinical outcomes which were able to be pooled into meta-
analysis.  
5.5.3.1 Blood pressure 
Telehealth intervention significantly reduced SBP by MD -2.64 [95% CI: -5.12, -0.16]; 
p=0.04; I2= 83% in 12 studies with a median duration of 6 months (total of 4202 participants) 
(40, 41, 46, 48-51, 53, 55, 57, 59, 61) (Figure 5-4). A subgroup analysis by chronic disease 
condition showed the result for SBP was more pronounced in people with diabetes (59, 61) 
(MD -5.91mmHg [95% CI: -11.14, -0.68]; p=0.03; I2= 69%), than in people with CVD (40, 
41, 46, 48-51, 53, 57) (MD -1.31mmHg [95% CI: -3.39, 0.77]; p=0.22; I2= 60%). Diastolic 
BP was not significantly reduced following telehealth intervention (MD -1.60mmHg [95% 
CI: -3.42, 0.22;p=0.1; I2= 87%] in 10 studies (encompassing 3512 participants) (46, 48-51, 
53, 55, 57, 59, 61). Subgroup analysis by chronic disease condition did not alter the result for 
diastolic BP (data not shown). Four long term trials (durations 12 to 24 months) did not result 
in a significant change in both systolic and diastolic BP (40, 55, 59, 61). 
5.5.3.2 Weight, BMI and waist circumference 
Weight was significantly reduced by dietary telehealth intervention (MD -0.80kg [95% CI: -
1.61, 0]; p=0.05; I2= 79%) in eight studies encompassing 974 participants (14, 42, 44, 46, 53, 
57, 59, 63) (Figure 5-4). Seven studies reported non-significant changes in BMI (data not 
shown) in 3560 participants (14, 42, 50, 51, 54, 55, 60, 61, 63) and five studies reported a 
significant reduction in waist circumference in 1659 participants (49, 55, 59, 60, 63) of MD -
2.08 [95% CI: -3.97, -0.20]; p=0.03; I2=84% (Figure 5-4).  BMI and weight were not 
significantly changed in longer term studies, however, waist circumference remained 
significant in four trials with durations 12 months to 24 months (55, 59, 60, 63) MD -0.51 




Figure 5-4: Effects of telehealth dietary interventions on systolic blood pressure (mmHg), 
weight (kg) and waist circumference (cm). The mean and SD of changes from baseline are 
reported for trials. Effects of trials are presented as weight (%) and mean difference (95% CI). 
5.5.3.3 Serum lipids and HbA1c 
Changes in serum lipids and HbA1c were reported in 11 studies. Telehealth intervention 
significantly reduced total cholesterol (44, 46, 49-51, 53, 55, 56, 59, 61, 63) in 11 studies of 
3697 participants (MD -0.08 mmol/L [95% CI: -0.16, -0.00]; p=0.04; I2=52%) (Figure 5-5). 
No changes in LDL (49-51, 53, 56, 59, 63), HDL cholesterol (49, 51, 53, 56, 59, 63), or 
HbA1c (44, 59, 61) were observed (data not shown). Triglycerides were significantly reduced 
following dietary telehealth intervention compared with usual care (MD -0.10 mmol/L [95% 
CI: -0.19, -0.01];p=0.04; I2= 70%) in seven studies encompassing 3268 participants (46, 49, 
50, 56, 59, 61, 63) (Figure 5-5). Sensitivity analysis excluding durations ≥2 years follow up (2 
studies), of 2 (59) and 8 (61) years reduced the heterogeneity and gave a MD -0.16 mmol/L 
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[95% CI: -0.26, -0.06]; p=0.001; I2=39%. Long term trials (durations 12 months to four years) 
did not result in significant change in biochemical outcomes (55, 59, 61, 63). 
Figure 5-5: Effects of telehealth dietary interventions on total cholesterol and triglycerides 
(mmol/L). The mean and SD of changes from baseline are reported for trials. Effects of trials 
are presented as weight (%) and mean difference (95% CI). 
5.5.3.4 Mortality and hospitalisations  
Two studies reported clinical endpoints and rates of hospitalisations (47, 52). Ferrante and 
colleagues (52) conducted a 16 month telephone intervention in heart failure patients with 
contacts determined by severity of condition. The study was assessed as a low risk of bias and 
lead to significantly reduced all-cause mortality in the telehealth group (15.3%) compared to 
usual care (16.1%; p<0.05), heart failure (HF) admission (16.8% and 22.3%, respectively; 
p<0.005), CV admission (24.1% and 30.1%, respectively; p<0.006), and all-cause admission 
(34.3% and 39.1%, respectively; p<0.05). However in the study by Albert et al (47) a three 
month multifactorial lifestyle video and telephone based intervention in HF did not 
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significantly reduce rates of HF hospitalisations between groups, and was a moderate risk of 
bias study. 
Table 5-2: Results for dietary outcomes unable to be pooled into meta-analysis 
Author, Year Chronic 
disease 
Telehealth method Results 
Telehealth versus control 
Dietary adherence measures 
Arora, 2013 (58) DM Telephone ↑ 0.31 points (SDSCA) 
Chiu, 2010 (48) HTN Telephone ↑ 1 point (diet adherence 
score)2 
Ferrante, 2010 (52) CVD Telephone ↑ 44.7% (dietary 
adherence score)2 
Izquierdo, 2010 (60) DM Videoconference ↑ 2.64 points (dietary 
adherence score) 
Mok,2013 (56) CVD Mobile (SMS) ↑ 1.69 points2 (Chinese 
Eating Habit Assessment 
Questionnaire)  
Welch, 2013 (45) ESKD PDA ↑ 4.4 points (The Cardiac 
Diet Self-Efficacy  
Instrument) 
Wong, 2010 (62) ESKD Telephone ↑ 0.71 points2 
Fruit and Vegetables measures 
Dale, 2015 (51) CVD Mobile (SMS) ↑ 28% of participants 
consuming >5 servings of 
fruit and/or vegetables per 
day2 
Hawkes, 2013 (54) CVD Telephone ↑ 8.6% participants 
consuming >5 servings of 
vegetables per day2 
Hawkes, 2013 (54) CVD Telephone ↑ 4.9% participants 
consuming >2 servings of 
fruit per day 
Glasgow, 2000 (44) DM Telephone  ↑ 0.2 points  
Dietary sodium measures 
Albert, 2007 (47) CVD Video ↓ 11% of participants not 
adhering to a sodium 
reduced diet2 
Hawkes, 2013 (54) CVD Telephone ↓ 0.3% participants 
consuming <2300mg 
sodium per day  
Welch, 2013 (45) ESKD PDA ↑ 0.6 points (perceived 
benefits of sodium 
adherence) 
Dietary fat measures 
Hawkes, 2013 (54) CVD Telephone ↑ 3% of participants 
consuming >30% energy 
from fat per day 
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Author, Year Chronic 
disease 
Telehealth method Results 
Telehealth versus control 
Lear, 2015 (55) CVD  Internet ↓ 0.48% energy from 
saturated fat intake2 
Lear, 2015 (55) CVD  Internet ↓ 0.29% energy from total 
fat intake 
Glasgow, 2000 (44) DM Telephone  ↑ 0.25 points  
Mok,2013 (56) CVD Mobile (SMS) ↓ 3.09 points2 
1 Abbreviations: DM, Diabetes mellitus; CVD, Cardiovascular disease; HTN, hypertension; ESKD, 
end-stage kidney disease; SMS, short message service; PDA, personal digital assistant; SDSCA, 
Summary of Diabetes Self-care Activities; mg, milligrams. 2 Results were statistically significant. 
5.5.4 Risk of bias 
Figure 5-6 shows the risk of bias of the included studies. Risk of bias was low to moderate 
across the included studies. The majority (92%) of studies had adequate randomization; 
however concealed allocation was only reported in 48% of the included studies suggesting 
potential selection bias. Double blinding was only achieved in one study (49), and blinding of 
participants to treatment arm only was done in one study (41) however intervention staff were 
aware of treatment allocation. All other trials were unable to blind participants given the 
nature of dietary intervention to facilitate and modify behavior change. However this means 
that detection bias was high in 80% of the dietary measures as they were self-reported. 
Attrition bias (through high loss to follow-up and no explanation of how such data were dealt 
with) was judged as high in 32% of studies. Furthermore there appears to be reporting bias in 
at least 20% of the included studies as they did not report outcomes which were stated in 
methods or protocol papers; six were rectified upon contact to corresponding authors. When 
GRADE (directness, precision, consistency, and study limitations) recommendations were 
considered, the evidence quality for diet quality and fruit and vegetables intake was 
considered moderate given the dietary intake data was all self-reported.  
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Figure 5-6: Risk of bias across the included studies showing the summary percentage in each 
domain.  
5.6 Discussion 
This systematic review assessed the effectiveness of complex telehealth dietary interventions 
for facilitating dietary change in adults with chronic disease. The primary finding was that 
dietary interventions delivered by telehealth effectively improved dietary adherence on a 
moderate scale, and small improvements in diet quality (38). Single macronutrients were less 
likely to be modified by telehealth intervention, including energy and total dietary fat intake 
which were not significantly different between groups in the pooled analysis. 
Telehealth intervention resulted in significant reduction in dietary sodium intake compared 
with non-telehealth interventions (SMD -0.39;p=0.0001) which is considered a moderate 
effect statistically (38). All dietary sodium outcomes showed improved compliance to a 
reduced sodium intervention using telehealth, which has clinical implications for telehealth as 
it may provide a useful tool in future intervention studies given sodium modification is 
hampered by poor compliance in clinical practice (64). The finding that fruit and vegetables 
increased by one serving per day following telehealth intervention support the potential for 
the use of telehealth to improve diet quality, which is a similar finding to a previous 
systematic review in telephone based interventions in the general population (65). Although 
significant heterogeneity was observed, sub-analysis by type of technology reduced the effect 
size to 0.8 servings, but remained significant. Fruit and vegetable consumption is a strong 
predictor of mortality, and the magnitude of change we found may reduce the risk of all-cause 
mortality (66). The EPIC-Heart study estimated that an increase in every 80g portion of fruit 
and vegetables was associated with a 4% reduction in risk of death (67). 
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Whole-of-diet approaches, as opposed to isolated single nutrients interventions, reflect how 
foods within the diet are consumed, and have an impact on other nutrients when manipulated 
(for example a change to fat intake will often result in a concomitant increase in the 
proportion of energy derived from carbohydrate). Developments in nutrition science 
recognize the complexity of foods consumed in combination on long-term CVD risk, weight 
regulation, and disease progression (68). Such approaches appreciate the interaction of foods 
and nutrients which may be more relevant to chronic disease when examining the cumulative 
effect of food on health over time (69, 70). This shift in nutrition focus suggests single 
nutrient interventions will become less utilised clinically and in public health practice (68), 
which is an important consideration for emerging telehealth interventions in the design of 
dietary educational content. Although we observed only small changes in diet quality, the 
magnitude of change demonstrated may result in a large public health benefit if adopted for 
secondary prevention of chronic disease (71). For example a higher diet quality has been 
linked to a reduced risk of all-cause mortality in people aged over 65 years (72). Although a 
stronger association was found when comparing the highest to the lowest quartiles, the risk 
reduces at each quartile above the lowest diet quality (72). Furthermore, if improving fruit and 
vegetable intake to better reflect dietary guidelines and therefore overall dietary quality, this 
may reduce the complications of chronic disease (33), which has been demonstrated to result 
in a reduction in all-cause mortality of 21% over a 15 year follow-up period (73).  
Dietary change through telehealth interventions can translate to small improvements in some 
clinical outcomes, such as a reduction in SBP of 3mmHg. Although this is slightly less than 
larger scale meta-analysis of all dietary sodium interventions in hypertension of -5mmHg, the 
effect size is similar to people without hypertension (74). A sustained change in SBP of 2-
3mmHg over a period greater than 6 months has been suggested to translate into a reduced 
risk of cardiovascular events (75). Other risk factors such as weight, waist circumference, 
total cholesterol and triglycerides improved significantly in some studies following telehealth 
intervention, whereas LDL, HDL and HbA1c did not. The long term studies (>12 months) 
included were not adequately powered to detect BP and weight change at final follow up, and 
the inclusion criteria meant some larger trials were excluded due to the lack of reporting of 
diet outcomes. For example, the POWER study (76) observed a between group change in SBP 
of -1.8mmHg and weight change of -4kg after 24 months in the telephone coaching group but 
was not able to be included. This well-designed trial supports the effects of telehealth on 
surrogate CVD outcomes in chronic disease.  
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A previous systematic review demonstrated technologies such as telephone and video contact 
improved adherence to diet (31), which we have now extended to improved dietary quality, 
fruit/vegetable intake and reduction in sodium intake when compared to usual chronic disease 
care. Telehealth may facilitate compliance to diet via a variety of mechanisms beyond the 
provision of regular review and behavior prompting, although it is likely the most influential 
to sustained dietary change in our review (9, 77). Telehealth strategies offer feasible ways to 
facilitate dietary changes, and have advantages over FTF consultations, including flexibility 
(78) and a high rate of patient acceptability (20, 79).  Smart phones are used by over 75% of 
the population (80, 81), highlighting the widespread potential telehealth methods provide to 
improve access, coverage, and implantation methods, particularly in low socio-economic 
populations (24). As primary healthcare may hold the key to the dissemination of telehealth 
dietary delivery methods, evaluation studies are needed. Process evaluation frameworks 
should be incorporated into future telehealth trials, reporting attendance/participation, 
acceptability and costs, which will ultimately assist their translation into clinical practice (82). 
This study is the first systematic review of telehealth strategies for facilitating multifactorial 
dietary change. Further strengths were: the comprehensive search strategy used, the use of 
two independent review authors throughout the review, and the use of Cochrane methodology 
to appraise the risk of bias. The TIDieR checklist (37) was used to extract data, allowing 
multiple sources of heterogeneity and intervention reporting inadequacies to be identified. 
There are several limitations of the review, including that multifaceted dietary changes were 
usually a component to multiple lifestyle recommendations (22 of the 25 included studies), 
making it difficult to delineate the effect of isolated dietary intervention on clinical outcomes. 
Half the included studies utilized telephone delivery methods, with other telehealth 
technologies, such as smart phone applications and internet use are underrepresented, and 
may reduce the generalizability of the findings. 
This review highlights the need for future trials that aim to change dietary behavior using 
telehealth strategies other than telephone – such as mobile, internet or videoconference 
methods. The application of the TIDieR checklist highlights a need for better reporting of 
telehealth interventions, as many trials did not report important logistical data relating to 
intervention conduct. Finally, although favourable changes were reported in some surrogate 
clinical outcomes such as blood pressure and lipid profiles following telehealth intervention, 
this may not translate to hard clinical endpoints. Due to a lack of studies, conclusions cannot 
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be drawn about effects on mortality and hospitalisations. Future well-designed intervention 
studies with adequate length of follow up are required to assess these important end-points.  
In conclusion, adults with a diet-related chronic disease may experience improvements in diet 
quality, fruit and vegetable intake, and dietary sodium intake if provided with dietary 
intervention using telehealth. While large variations in findings may be explained by 
differences in intervention conduct, it is difficult to explore due to suboptimal reporting of 
dietary interventions. Single macronutrients (calories and total dietary fat) were not 
significantly modified following telehealth intervention, which may highlight the benefit of 
delivering complex dietary intervention that target the quality of the diet and/or dietary 
patterns facilitated by convenient telehealth technologies. The results of this review support 
the changes in nutrient focus and may inform the future development of evidence-based 
telehealth programs, which ideally can be tailored to specific chronic disease conditions.  
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 - Patient experiences of dietary management in chronic kidney 
disease: A focus group study 
6.1 Preface 
The primary finding of Chapter 5 was that telehealth methods are effective at facilitating 
complex dietary change in chronic disease. However, Chapter 5 could only identify two 
dialysis studies in the ESKD population and found no eligible study conducted in people with 
CKD. To understand whether other technologies, such as the internet and mobile phones are 
suitable delivery methods for dietary education in CKD, patient engagement was required.  
Chapter 6 details a patient engagement project which utilised focus groups to collect data 
about CKD patients’ perspectives of their dietary recommendations, and the use of technology 
to support their self-management. The premise of this project was to engage people with CKD 
in the co-creation of a telehealth program which was patient-centred and structured 
specifically to overcome their biggest challenges to adhering to a healthy diet.  
Informing this chapter was a state-wide cross-sectional survey (Appendix C), which was 
conducted to identify the potential for using the mobile phone and internet in CKD 
populations. This survey found that the mobile phone and internet were used by over 88% of 
people with CKD. Of the entire sample, 60% had a preference for telehealth-delivered dietary 
support. What remained to be answered, however, was how telehealth can be used to improve 
dietary intervention delivery, and what are the challenges that patients identify to making 
dietary changes. Therefore, Chapter 6 was designed, specifically to address thesis research 
questions 3 and 4. 
This chapter contains the accepted version of an original manuscript published in the peer-
reviewed journal The Journal of Renal Nutrition. The paper formatting has been modified in 
accordance with a consistent thesis style. However, the grammar, headings, and references 
(in-text and bibliography) are unaltered in accordance with the journal publishing guidelines. 
Citation: Kelly JT, Campbell KL, Hoffmann TC, Reidlinger DP. Patient experiences of 
dietary management in chronic kidney disease: A focus group study. Journal of Renal 
Nutrition. 2017 [In-Press]  
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6.1.1 Related work to this Chapter completed by the candidate  
One other manuscript relating to this chapter has also been published by the candidate, in the 
form of a (cross-sectional) original research article. While this paper is not a primary 
publication within this thesis, the candidate was involved in the ethics application, data 
collection and analysis, with the findings being directly related to the research question this 
chapter addresses, and is available in Appendix C. Specifically, the relevant focus of the paper 
to this chapter is the patient-engagement aspect determining what technology people with 
CKD are willing to use, and what the barriers to technology use may be.  
• Bonner A, Gillespie K, Campbell KL, Corones-Watkins K, Hayes B, Harvie B, Kelly JT, 
Havas, K. Evaluating the prevalence and opportunity for technology use in chronic kidney 






People with chronic kidney disease (CKD) contend with complex dietary recommendations. 
The challenge in practice is for clinicians to provide individualized support with the frequency 
and consistency required to sustain dietary changes. This study aimed to describe the 
experiences of patients with managing dietary recommendations, including their perspectives 
on the potential to use telehealth to support dietary management in CKD. 
6.2.2 Design 
Focus group study.  
6.2.3 Setting 
Two nephrology units in Queensland, Australia.  
6.2.4 Subjects  
21 adult patients with CKD (non-dialysis) and 3 caregivers (total N=24) purposively sampled 
to achieve diverse demographic and clinical characteristics. 
6.2.5 Methods 
Five focus groups were conducted, audio recorded and transcribed. Transcripts were analyzed 
using thematic analysis drawing on the principles of grounded theory. 
6.2.6 Main outcome measure 
Themes aligned with the research question.  
6.2.7 Results 
We identified five themes: exasperating stagnancy (patronized by redundant advice, confused 
and unprepared for dietary change, inevitability of failure, and barriers to accessing dietetic 
services); supporting and sustaining change (receiving regular feedback, incremental and 
comprehendible modification, practical guidance on food, flexibility in monitoring schedule, 
and valuing peer advice); fostering ownership (seeking kidney diet information, enacting 
behaviour change, making reminders, and tracking progress against targets); motivators and 
positive learning instruction (relying on reassurance, positive reinforcement, focusing on 
allowable foods, and involving family); threats and ambiguities of risk (sugar as the culprit, 





Patients with CKD desire a preventative approach to CKD progression and maintaining their 
health however are stymied by dietary restrictions and a lack of reliable dietetic advice. Easy-
to-use telehealth options have the potential to overcome the shortcomings in current health 
service delivery which may be limiting factors to providing these approaches. They provide 
patients with pragmatic tools, comprehensible and consistent information which fosters 
ownership and self-monitoring.  
6.2.9 Keywords 





Diet has long been considered a modifiable risk factor for chronic kidney disease (CKD), with 
poor dietary habits representing a key modifiable risk factor for CKD progression.1 
Historically, dietary guidelines for CKD advise the restriction of individual nutrients, such as 
protein, sodium, phosphate and potassium.2 However, these guidelines have been criticized 
because they are difficult to achieve,3 and are underpinned by limited evidence for 
effectiveness in preventing important clinical complications including cardiovascular disease 
and progression to end-stage kidney disease (ESKD).4-7 
Dietary advice is often multifaceted, complex and requires individualized support.8,9 Dietary 
and fluid restrictions can be disorienting, overwhelming, and an intense burden for patients 
across all stages of CKD.3 The majority of dietary interventions for pre-dialysis patients are 
one-off dietary education sessions, without ongoing follow up.10 In contrast, regular 
interaction has been shown to be a key strategy for self-management and highly valued by 
people with CKD.3 This mismatch in patients’ needs and current clinical service provision 
highlights a pressing need to consider alternative strategies to support dietary change. 
Emerging evidence suggests that use of technology such as telehealth is effective in 
promoting dietary adherence,11,12 and has the potential to meet rising service demands.13 
Telehealth modalities may provide an alternative framework for frequent and structured 
contact that is needed to support the complex dietary change required in CKD.  
There is growing recognition of the value of patient engagement in healthcare provision, and 
the need to focus on their experience of services, to improve efficiency and ‘patient-centered 
care’.14 However, as far as we are aware, no study to date has focused on exploring pre-
dialysis patients’ experiences of receiving CKD dietary advice, nor their preferred service 
modalities for accessing current healthcare services. This approach might help in the 
development of patient-centered interventions. The aim of this study was to describe 
experiences of patients with CKD in managing dietary recommendations, including their 
perspectives on the potential to use technology to support dietary management. 
6.4 Materials and methods 
6.4.1 Participant selection 
Participants with CKD were recruited from two nephrology units from an urban hospital 
outpatient service in Queensland, Australia. Eligible participants were adults aged 18 or over, 
had access to a mobile phone or the internet, were able to understand and speak English, not 
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receiving dialysis treatment with CKD stage 3-4 (eGFR 15-60mL/min) and including long 
term-post transplant (Stage 5T).15 Long term post-transplant patients, who had a stable GFR 
which met our inclusion criteria were deemed eligible on the premise that their dietary 
management is similar as per current best-practice guidelines.16 Patients with a cognitive 
impairment who were unable to provide informed consent were excluded. Participants were 
purposively sampled to achieve diverse demographic (age, gender, and socio-demographic 
status) and clinical characteristics (time since diagnosis and comorbidities). Caregivers were 
not excluded from attending where requested by the participant in recognition of their key 
role in supporting the individual to self-manage and the potential insights they might provide 
to the research question. Participation was voluntary and written informed consent was 
obtained from patients and caregivers. All participants were provided with a retail gift 
voucher (AU$50) to acknowledge their time. Ethical approval was granted by the (blind) 
Gold Coast University Hospital and Bond University Human Research Ethics Committees. 
6.4.1.1 Data Collection 
The focus group guide was based on a review of the literature relating to patient experience of 
dietary change, and use of telehealth for dietary change (Appendix I). We also included visual 
prompts to stimulate in-depth discussion, including an introduction to telehealth methods to 
all groups using photos (of interactions between patient and clinician) of telephone 
consultation, text messages and email communication, online workshops and 
videoconferencing. We also showed a YouTube video to demonstrate an example of a 
telehealth intervention.17 No real life examples were used in our study, and all telehealth 
examples discussed were hypothetical. Prior to study commencement, the topic guide was 
piloted with three hemodialysis patients whose results were not included in the analysis, and 
only used to test the depth, understanding and flow of questions. The focus groups were 
approximately two hours duration and conducted in a private meeting room, which provided a 
confidential environment. They were facilitated by the lead investigator (JK), and another 
researcher (DR) recorded field notes. Each group was audio recorded and later transcribed 
verbatim. Transcripts were de-identified and checked against the audio recording by one 
researcher to ensure accuracy of transcription and facilitate immersion in the data. At the 
conclusion of the fifth group, the authors agreed that theoretical saturation was reached (i.e. 




The transcripts were entered into NVivo 10 (QSR International, 2012) software to facilitate 
data analysis. Thematic analysis drawing on the principles of grounded theory was 
undertaken. Two researchers (JK, DR) independently reviewed the transcript line by line to 
inductively identify initial codes, and through discussion and a process of constant 
comparison within and across focus groups, developed preliminary themes. This ensured that 
the preliminary analysis captured the full breadth and depth of data. A third researcher 
reviewed the preliminary themes and supporting quotations. Relationships among themes 
were developed and illustrated using a thematic schema. 
6.5 Results 
Twenty-four participants (21 patients, 3 caregivers) participated in 5 focus groups (3 to 8 
participants per group), which were conducted between November 2015 and March 2016. 
Participant characteristics are provided in Table 6-1. Three participants were kidney 
transplant recipients, however still met the GFR inclusion criterion for the study.  
We identified five themes: exasperating stagnancy; supporting and sustaining change; 
fostering ownership; motivating and positive learning; and threats and ambiguities of risk. 
The themes are described in detail in the following section. Selected quotations that exemplify 
each theme are provided in Table 6-2. Figure 6-1 shows the conceptual links and relationship 




Table 6-1: Chronic Kidney Disease Participant characteristics (n=21) 
Characteristics n (%) 
Gender  
   Male 14 (66) 
   Female 9 (34) 
Age (years) 66 (49-80) 
41-50 2 (9.5) 
51-60 2 (9.5) 
61-70 12 (57) 
    71-80 3 (14) 
Marital status  
    Married/de-facto 14 (66.6) 
    Divorced/separated/never married 7 (33.3) 
Employment  
    Currently working 3 (15) 
    Retired 18 (85) 
Stage of CKD  
   3a 7 (33.3) 
   3b 7 (33.3) 
   4 5 (23.8) 
   5 2 (9.5) 
Co-morbidities   
   Diabetes 8 (40) 
   Hypertension 8 (40) 
   Cancer 5 (25) 
   CVD 5 (25) 
Abbreviations CKD, chronic kidney disease; CVD, cardiovascular disease. 
6.5.1 Exasperating stagnancy 
6.5.1.1 Patronized by redundant advice  
Participants believed that their priorities were misunderstood by the clinicians, including non-
dietitians, who provided nutrition education. They felt patronized and given repetitive dietary 
advice from clinicians who would tell them the “same thing over and over and over”. They 
believed the advice was in-actionable and “very out of date”, and that they could more easily 
have “looked it up on the net” themselves.  There was a preference for innovative dietary 
approaches which participants perceived to be more aligned with modern day research and 
that they had heard about in the media.  
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Figure 6-1: Thematic schema of patients’ perspectives of dietary recommendations and 
telehealth. The dotted lines represent supporters and solid lines represent inhibitors pertaining 
to each theme. The top circles represent patient-centered characteristics, and the bottom 
circles clinician and health service characteristics. 
6.5.1.2 Confused and unprepared for dietary change  
Participants felt “disheartened” and confused by the lack of specific CKD dietary advice 
which lacked an individualized focus. They felt unprepared and given little-to-no support on 
how to implement changes: “I don’t know what the heck I’m doing”. They also expressed 
frustration that they had not been prepared for potential dietary changes when they first 
entered into the nephrology service, “instead of learning as you go” and before their kidney 
condition progressed. 
6.5.1.3 Inevitability of failure  
Participants described the predicament of multiple, and often conflicting, dietary 
recommendations for their co-morbidities. These conflicts were viewed as an impossible 
burden; “what in the world am I going to eat?”  They expressed the view that they were being 
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set-up to fail due to the in-cohesive approach. "[They tell you] don't do this for that complaint 
and this for that complaint", and they felt “what's left over I can either eat or drink is an ice 
cube.”   
6.5.1.4 Barriers to accessing dietetic services  
Participants mostly experienced healthcare consultations face-to-face. These appointments 
presented numerous barriers including taking time off work, cost of petrol, parking, and long 
waiting times. When participants were prompted on using telehealth for dietary education, 
they expressed that simple and familiar technology methods such as “a quick phone call or a 
quick text or something, or Skype” was low cost, easy and something they felt confident to 
use.  
6.5.2 Supporting and sustaining change  
6.5.2.1 Receiving regular feedback  
Participants valued “regular contact” and “a bit of feedback” to track their progress as they 
saw it supporting their dietary change over time.  They desired regular, more intense follow 
up in the early stages of modifying diet “just until you got your plan under way and under 
control” which could “spin out a bit more” (become less intensive) when their confidence 
increased. They highlighted the importance of the time between feedback being “individually 
tailored” to their condition and transitioning life circumstances.  
6.5.2.2 Incremental and comprehendible modification 
Participants stressed the need for dietary change to be taken “one footstep” at a time.  They 
described their experience of instructional and overwhelming advice as like a “rubber-stamp 
on the forehead”. They suggested technology might play a complementary role to face to face 
contact through methods such as SMS and/or telephone follow up to highlight the “basic stuff 
[diet education] first” and then “further detail as you go along”.  
6.5.2.3 Practical guidance on food  
Many participants wanted a “list [or] guideline of what foods you could have… and what to 
leave out and maybe what to have occasionally”. Participants favored “the practical advice...  
you don’t hear that very often from anybody”. They wanted focused practical food-based 




6.5.2.4 Flexibility in monitoring schedule  
Participants wanted the power to decide their own monitoring schedule. They wanted this to 
be two-way with “the option to ring the dietitian”. While they highly valued regular review, 
they believed increasing review appointments would add to their existing and competing 
problems accessing current healthcare. They were interested in how technology consultations 
could give them flexibility including the option to request that clinicians “ring you another 
day”. 
6.5.2.5 Valuing peer advice  
Many participants had never spoken about dietary challenges with other people with CKD. 
They thought the strategies and advice from peer support groups “sticks in your mind more, 
[and allows you to] cross-fertilize ideas”, but were unaware of group services available to 
them. Peer advice from dialysis patients was highly valued, and many described the prospect 
of dialysis as “scary”, something they wanted to avoid. They preferred to talk to their peers 
who were already on dialysis because they “knew what it was about” in a way that a clinician 
could not.  
6.5.3 Motivating and positive learning instruction  
6.5.3.1 Relying on reassurance  
The potential nurturing role of the clinician was highly valued. They wanted to “feel 
reassured, [to] ask questions [and get a sense of] I’m okay”. Part of “feeling reassured [was 
knowing] that things can be done to improve [or] stabilize” their kidney problems. They felt 
they currently did not have an ongoing supportive partnership with their healthcare provider. 
They saw telehealth as one method to provide reassurance, to complement face-to-face, such 
as “a text saying ‘you're okay’, that’s terrific feedback”. 
6.5.3.2 Positive reinforcement  
Participants talked about both positive and negative experiences of clinicians giving them 
dietary advice. They preferred advice that was respectful, and “never… put you down” which 
they believed reinforced the changes they had to make. They avoided punitive and instructive 
approaches such as "you eat this", “you stick to this”. Clinicians that were “gentle” and 
“friendly” were viewed positively and they felt more comfortable, and happy to listen to 
dietary advice from them.  
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6.5.3.3 Focusing on allowable foods  
Participants felt a CKD diet was very restrictive. They wanted information on “what foods 
you could have” rather than being told what nutrients to avoid. They described feeling 
“disheartened” by dietary restrictions which were viewed as “pretty severe”. Because they 
didn’t know what they were allowed to eat, they talked of using technology, such as the 
internet, however this wasn’t always successful; “all they [internet sources] seem to list is 
high potassium foods” (and not the low potassium foods allowed). 
6.5.3.4 Involving family  
Participants felt that family and caregivers were gatekeepers to change. They discussed the 
importance of involving family members or friends, describing how they “regulate” their 
diets. They saw dietary advice as “a two-person-thing”, which should include both “the cook 
and the patient”. If family were not involved in dietary decisions or lacked understanding, 
they described having to prepare separate meals; “I can't feed anyone else the same stuff as I 
eat… you've got to take into consideration what they're going to eat”.   
6.5.4 Fostering ownership 
6.5.4.1 Seeking kidney diet information  
Participants described how they liked “picking up stuff off the internet”, specifically for 
information not well explained by their clinician. Other participants sought answers through 
sources like “Google Scholar”, “books”, “newsletter” and “the news” in a quest to self-
educate on dietary change. They felt that their doctors “don’t have time” to answer all their 
questions, and favored “instant” and “non-invasive” methods to seek their information, such 
as the telephone and text messaging services.  
6.5.4.2 Enacting behaviour change  
When prompted to the types of dietary education commonly provided to patients with CKD, 
participants believed “a dietitian's got that stuff [dietary information] already out there”. They 
argued that achieving dietary behaviour changes requires them as individuals to “want 
ownership of the problem”, to “tell them [the dietitian] how I'm going myself” and drive their 
own change “if you want it, if you need it”.  
6.5.4.3 Making reminders  
Participants discussed a desire “to get a sort of a reminder” as a tool to improve their own 
self-monitoring and efficacy. Participants discussed the importance of being reminded about 
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their recommendations for dietary change, but also their clinic appointments. This included a 
reminder of dietary education delivered by phone or face-to-face; “how about a reminder 
about the call they were going to receive?”; or a text saying “I called you the other day, how 
are you going?”. 
6.5.4.4 Tracking progress against targets  
Participants preferred to “track” the results of their blood tests to “physically see” the progress 
made. They discussed that they often ask their doctor “what’s my readings?” for reassurance 
that they were “heading in the right direction”, and this was a motivator to make dietary 
adjustments. Participants suggested record keeping methods using technology so it was 
possible to track “the results of your last blood test” by using the internet and mobile apps 
such as “Carb Count [mobile app] or something like that”.  
6.5.5 Threats and ambiguities of risk   
6.5.5.1 Sugar as the culprit 
All participants described sugar as “poison”, believing “white [sugar] is death” and it was a 
very important dietary belief to protect their kidneys from further damage. Many participants 
were of the opinion that ‘brown’ and ‘raw’ sugars were healthier choices and would use these 
in place of white sugar, whereas others “just stop sugar full stop”. Participants discussed 
many challenges to finding suitable “substitutes that is going to be interesting or tasty” in 
place of regular sugar.  
6.5.5.2 Ubiquity of salt  
Participants discussed that there “seem to be a lot of things on the market that have salt in 
them”. They described it as “pretty frustrating” and impossible to “find anything that hasn't 
got any salt in it”. While most participants were very “conscious of my salt”, some thought 
“it’s not good if you’re without salt… your body needs the salt”.  
6.5.5.3 Illegible food labelling  
Many participants recognized label reading as important to make better food choices. They 
faced the dilemma of identifying a low sugar product, only to find it was high in salt. They 
believed food “labels should be changed” particularly regarding their size and format to “be a 
decent legible size”. Many participants required glasses to read labels, and were frustrated 
about taking “twice as long to do the grocery shopping”.  
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6.5.5.4 Avoiding processed foods  
Participants reported a common belief that the food supply was dominated by processed 
foods. They reported having “trouble” with avoiding “all the processed stuff, which is really 
difficult to do without these days”. They discussed what would “be the best [would be] if 
some of the processed food had less salt [and weren’t] full of preservatives” which they 
described made it “so hard” to rationalize what to prioritize.  
6.5.5.5 Questioning credibility of sources  
Participants were seeing many different healthcare professionals, and regularly received new 
and sometimes conflicting advice. Those who frequently sought out information themselves 
described the need to “check with somebody that knows what they’re talking about” to 
question the reliability of information they found, particularly if it was food related and 
something they had not been previously advised about. They discussed how they would 
“research something [on the internet] and know that I could be possibly getting the wrong 
information [so they would] print it out and run it by the doctor”. 






Last time I got a piece of paper that said this this this and I really come away with 
very little information.”  So I just thought no, I would like to have somebody with 
newer ideas. (Woman, FG4) 
Well, they tell me the same thing over and over and over and they - as you said 




dietary change  
Well, they got me early, reasonably early I guess.  And, yes, it would have helped 
to have a bit of learning about it all.  We learnt as we went along. So yeah, if I was 
able to learn a bit more about it then instead of learning as you go, that would've 
been good. (Woman, FG4) 
In the past [earlier stage of CKD] it would have been interesting I guess, but I 
don’t know.  A few – Is diet is gonna bring, diet isn’t going to bring creatinine 
down, is it? (Man, FG3) 
Inevitability of 
failure  
There's probably other [diet changes] things that I should have given up too, but I 
can't remember them all. I used to love my seafood but I also suffer from gout so 
all I have to do is add up the things for the kidney, the heart, the diabetes and the 
gout and what's left over I can either eat or drink it as an ice cube. (Man, FG1) 
I mean, this diet business is always "You don't do this for that complaint and this 





Yeah, but also, it would be annoying for you to come and see a dietitian every 
three weeks or four weeks because you got to take time off work, you know?  
Yeah, you gotta get in the car, drive down there, park, blah, blah, blah, blah.  You 
know, you wouldn’t do it.  You'd just find an excuse not to do that all the time.  
But, yeah, a quick phone call or a quick text or something, or Skype or whatever, 
yeah, would be easy. (Woman, FG5) 
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When you first start she's ringing up all the time, could be weekly, and that was 
seeing how you're going and then as you're getting better it gets - as usual, you 
know, it spins out a bit more.  (Woman, FG1) 
“A way of… getting in touch every six weeks and asking your readings and all 




I reckon, the basic stuff first of all.  What they’ve really gotta work on.  And then 
we come later on to these things, it would be nice if you didn’t eat these things, 
label reading and so on and so forth.  But I think the first plunge is sort of what’s 
important, cut out salt, maybe less of the potassium and so on.  And then I think 
you get into further detail as you go along.  But I think there’s a few basic things 




I would suggest that, you know, if you were advising someone on cutting back 
salt, I would also try to advise them on their overall dietary guidelines, you know, 
like, the old pie chart, two thirds of your meal is fruit and vegetables and, you 
know, one third is protein and stuff like that. And concentrate on foods that don’t 
have the high salt content so don’t fill yourself up with cereal first thing in the 
morning or have a sausage roll at lunch time.  Go for a go for a salad sandwich 




It would definitely be better than coming into the hospital every single review, 
especially if it’s just a simple, “How are you going?  How are you coping?” 
(Man, FG3) 
That sort of thing because sometimes if you - if you ring they mightn't be feeling 
well and you just cannot be bothered.  But if they give you the opportunity of 
saying "Can I call you another day?"  "Yes, please do."  You know, but just that 




Yeah.  I’ve seen [group based education] – it’s quite relevant ‘cause it’s very – 
you pick up more than a one to one with a group.  Definitely, it’s experience of 
different things.  It sticks in your mind more anyhow, put that way and – yeah. 
(Man, FG5) 
[My HCP] who works there who's a lovely guy, he's as slim as anything, and 
openly talks about his diabetes and you sort of feel "Ah, he's the same as me, I 
feel good."  (Woman, FG3) 
Motivating and positive learning instruction 
Relying on 
reassurance  
I can ask questions, because the important thing is to leave your doctor, your 
specialist, to feel reassured.  Now, I say now, “Look, my potassium level, my 
this level –“he said, “Look, for your person and your age, considering you have 
that and that, it’s fine.  Because it’s been very stable for three years.”  “Okay.  
Thank you doctor, I feel reassured.”  So, let’s not panic about my kidney 
anymore, other than what aggravates it, the diet and this and that now.  So I'm 
doing a bit better, but it’s all back to communication, reassurance. (Man, FG5) 
Only just reassurance. Reassurance that things can be done to improve things. 
(Woman, FG5) 
Yes.  I think reassurance is very important. (Man, FG4) 
Positive 
reinforcement 
And recognition.  If you - like, it sounds silly but if you lose a kilo in a month 
and the dietitian says to you "Oh, wow, you've lost a kilo, that is fantastic, what 
do you put it down to?  What was the main cause for you losing that?"  Make 
the person think about what they've done to lose that.  (Man, FG2) 
And they don't tell you off.  You know how you don't want to go because you 
think "Oh, God" but they never do put you down which is a big benefit, yeah, 
because if they did I wouldn't go. (Woman, FG1) 
Focussing on 
allowable foods  
Well, it gives them options. Saying, “Cut the salt out,” is pretty severe, like cut 
your nose off to spite your face, you know?  Instead of eating so much with all 
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the all the salt in it, why not cut that out and substitute it with something else 
and give them something to substitute that is going to be interesting or tasty.  
Let’s say that everything that’s bad for you tastes good.  Let's go there.  If it 
tastes good, it’s bad for you. (Man, FG3) 
Involving family  You've got to involve the partners, because there's two people involved. 
(Woman, FG2) 
But the other suggestion, I have, which has worked for me – is take a partner 
with you when you go to see a dietitian.  Because the partner can often 
remember things that you don’t hear properly.  (Man, FG4) 
Fostering ownership 
Seeking kidney 
diet information  
So I think – when I was researching about high potassium and they said, “High 
fibre white bread is better for me than wholemeal or multigrain,” or any of 
those. So I switched to high fibre white bread now rather than rye or multigrain 
or something. (Man, FG3) 
Use a lot of herbs and spices.  Of course, I pick up stuff off the Internet, ‘cause I 
often have a look at articles that come through.  My nutritionist very often sends 
me stuff and says, “Read this”. (Man, FG4) 
Enacting 
behaviour change  
I’d find out what is the motivation behind the person.  What is the person’s 
motivation?... You need to find that out… Get to the motivation for whatever 
that wants to keep them going, then educate them on how to do it, and then give 
them the tools to do it, but make it their responsibility.  I think you have to have 
ownership. (Woman, FG4) 
Making 
reminders  
I've got in my handbag always how much salt I'm allowed to have on a little 
piece of paper… 10 grams of fat per 100 grams. 3 grams of saturated fat per 
hundred grams, 15 grams of refined sugar per hundred grams, 120 grams of 
sodium chloride and three grams of fibre per serve. (Woman, FG2) 
It would be good for me to get a sort of a reminder about, you know, fat or 
sugar and I could say to my husband "Look, I just got a reminder, remove all fat 
from meat" blah blah blah.   (Woman, FG2) 
Tracking progress 
against targets  
I have them [blood tests] done quarterly and he does each quarter and he – 
whenever he gives me one, it’s got four quarters on it.  So, I can at least track 
how I’m doing at the time. (Man, FG4) 
And I can physically see it.  It was only small per day but over a month and - 
and that sort of registered pretty quick and I sort of analysed that and I could see 
that I was heading in the right direction.  (Man, FG2) 
Threats and ambiguities of risk 
Sugar as the culprit  I remember reading somewhere or hearing somewhere that anything white is 
death.  Like white rice is bad for you, white bread is bad for you.  Anything 
that’s white is worse for you than say whole grain.  Yeah, so, avoid white 
bread and go for whole grain.  That’s a healthier alternative.  Salt is gonna kill 
you.  White rice is not good for you, but brown rice is better for you and 
things like that. (Man, FG3) 
Ubiquity of salt  Trying to find salt - salt-free - I'd love a salt-free soy sauce or a low-salt soy 
sauce.  There just seem to be a lot of things on the market that have salt in 
them.  And that's my bugbear, is trying to find something that doesn't have - 
well, I can't find anything that hasn't got any salt in it. You know, even you go 
to buy - get a salad, get a salad at a restaurant, that's without - with cheese and 
all that sort of stuff, and you can't have cheese because it's got too much salt in 
it, dah, dah, dah, dah, dah.   (Man, FG1) 
Illegible food 
labelling  
No, for many things, like, yeah, the labels have a lot of information and I 
think the labels should be changed slightly too in different areas for sure. For 
example, that shouldn’t be so small, they should be a decent legible size, like, 
nearly, probably, as twice the size of the advertising material, ‘cause if they're 
a good company, they'd be proud of what they've got. (Man, FG4) 
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Yeah, I - I think the dietitians actually educating us to read the back of the 
packets [is important]. (Woman, FG2) 
Avoiding processed 
foods  
It’s pretty frustrating.  I think.  Yes.  I just think I buy lentil burgers and I 
think they'd be good for me, but they blow me up too and I think there's a lot 




I’m somewhat sceptical on some of the stuff.  So, I then tend to check it with 
somebody that knows what they’re talking about because there’s lots of 
claims made on the Internet about various things.  A lot of them are not 
researched properly. (Man, FG4) 
Usually the government websites are okay, usually.  But once you go outside 
of that, it’s like, no, just forget it. (Man, FG4) 
6.6 Discussion 
This qualitative study explored the experiences of CKD participants in relation to dietary 
management, and their perspectives on the potential for telehealth to support dietary change. 
Participants in our study described feeling misunderstood by clinicians providing dietary 
advice, and felt confused with conflicting guidance from different clinicians. In addition, they 
highlighted many barriers to seeing clinicians in face-to-face settings, which did not meet 
their preference for regular review and feedback. Participants desired practical guidance on 
foods and a flexible monitoring schedule to support and sustain dietary change. They 
preferred clinicians who provided reassurance, were positive, involved their family and/or 
caregivers, and focused on foods that were allowed in the diet, as opposed to imposing food 
restrictions. To gain control of their diets, they felt responsible for seeking out additional 
dietary information, enacting dietary changes and self-tracking their progress over time. This 
was an exceptional challenge for participants whose health care delivery experience was not 
conducive to making dietary behaviour change.  
This is the first qualitative study to describe the CKD patient experience with dietary advice 
provided in nephrology services. Although we know that patients struggle with adhering to 
their diet and fluid recommendations, and desire more flexibility and individualised support,3 
our study has focused on the source of these recommendations as well as their delivery 
setting. For the first time, we show that diet recommendations come from a myriad of sources 
(and rarely from qualified dietitians). People with CKD find this a disorienting and confusing 
experience. Our study suggests that telehealth may be viable options to overcome these 
patient-centered care barriers. Importantly, patients did not show preference for what 
telehealth options would be ‘the best’, as long as these were cheap, easy to use, and gave them 
flexibility. We believe this will help future intervention development and continued efforts to 
improve patient-centered care in nephrology services.   
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Participants felt their priorities for dietary change were neglected by the wider healthcare 
community (including primary care and nephrology services). They described an inflexible, 
outdated, and patronizing consumer experience, not aligned to patient-centered care. Such 
shortcomings in delivering patient-centered care in nephrology services has been reported 
previously18,19 and is increasingly recognized as a barrier to delivering effective clinical care, 
to improve patient-clinician communication and overall health outcomes.20  
The findings of this study highlight that people with CKD want advice and greater emphasis 
on prevention and progression of CKD in the early stages. Therefore, a coordinated model of 
care fostering ownership over their dietary self-management and supporting change long-term 
is needed. General practitioners and nephrologists are best placed to initially highlight the 
importance of diet to newly diagnosed patients, and to refer to a dietitian shortly after 
diagnosis. A coordinated and multidisciplinary approach to patient care has been shown to 
improve patient outcomes,21 is a strong service need and reflects patient’s desires. There is 
evidence to support healthy dietary change in CKD, including the reduction of dietary sodium 
for lowering blood pressure and proteinuria,4 and protein modification for protecting residual 
kidney function.22 Furthermore, the adoption of a healthy dietary pattern may reduce incident 
CKD in the general population23 and mortality in established kidney disease.24 Yet despite an 
evidence-base for prevention, this patient population feel unable to access dietary services, at 
a time they are motivated to prevent their disease progression.  
The current healthcare workforce and models of care appear unable to meet patient 
expectations of patient-centered care. With current service delivery unable to adjust to 
increasing consumer demand,25 many patients will never see a renal dietitian. Instead, patients 
may only receive these services if they reach ESKD, where they may be referred to manage 
acute concerns, such as hyperkalemia. However, ESKD is the patient-centered endpoint they 
describe being desperate to avoid. While services continue to neglect this prevention focus, 
patients perceive stagnancy in healthcare delivery, are innately confused, and feel unprepared 
to make dietary change. This can impede patients’ self-efficacy for integrating dietary self-
management, leaving them to seek diet information online which often lacks evidence and 
may cause harm.26 If current service models cannot address people’s self-efficacy in the early 
stages of CKD, this may lead to faster progression to ESKD.27  
Using telehealth shows considerable promise for improving self-efficacy in people with CKD, 
and may overcome current healthcare limitations and improve patient-centered care. Our 
group of CKD participants expressed interest in telehealth methods that would complement 
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their traditional care rather than replace it, providing the delivery modality was relevant and 
familiar to their skills and level of health literacy. Participants preference for telehealth 
primarily centered on overcoming the incoherent dietary advice in current health service 
delivery. Many participants were already using mobile devices and the internet, particularly 
for seeking information outside of their usual care, therefore these modalities were often 
preferred and acceptable to support self-mangement.28 These methods were seen as ways 
‘Receive regular feedback’, having ‘Flexibility in the monitoring schedule’, able to ‘Involve 
family’, and overall ‘Foster ownership’; while overcoming the growing ‘Barriers to accessing 
dietetic services’. Using telehealth has been shown to facilitate dietary change12 and could 
overcome the common healthcare barriers experienced in face-to-face settings, including 
demographic isolation, working hours, and forgetting appointments.29 Additionally, telehealth 
methods could decrease commonly reported healthcare access barriers, specifically 
administrative errors, access to clinic facilities, parking and unfavorable opening hours of 
clinics in face-to-face settings.19,30   
It is important to note that telehealth may introduce the opportunity for health services to 
utilize non-dietary trained personnel in its delivery. However, the results of this study indicate 
that the majority of participants had never seen a renal dietitian, leading to many of their 
dietary challenges, and the health service perceived as stagnant and unsupportive. Based on 
these findings, we recommend any telehealth dietary intervention should involve a dietitian, at 
least in the development of materials (text messages; call scripts; resources) and preferably in 
the subsequent delivery of the intervention content. Given telehealth’s novelty in CKD, any 
program should be pre-tested with the patient demographic and ideally trialed for feasibility 
and cost-effectiveness prior to implementation. 
As far as we are aware, this is the first study to describe the experiences of people’s dietary 
management in pre-dialysis CKD and perspectives on the potential to use telehealth to 
support dietary change. The use of a semi-structured questioning approach, to encourage 
participants to discuss their feelings and attitudes (both positive and negative) was a strength 
which somewhat mitigates the inherent researcher bias. However, this study is not without 
limitations. Given its qualitative design, the generalizability of themes to other populations 
with CKD is uncertain. Although we attempted to achieve a demographic reflective of current 
prevalence in Australia, we did not recruit participants of Indigenous heritage, or those living 
outside metropolitan areas. However, the results are generally consistent with similar ESKD 
qualitative studies.3 Future research should specifically target these populations, who are 
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known to have higher burden of CKD and who may experience different barriers to dietary 
change and technology use. 
In summary, people with pre-dialysis CKD desire a preventative approach to CKD 
progression however, are stymied by restriction-focused dietary advice and a lack of dietetic 
service provision in early stage CKD. Clinicians need to be positive and motivating, and 
consider the individual’s goals for dietary change, to empower patients to better cope with 
dietary recommendations, which could help improve patient-centered outcomes. Telehealth 
methods such as the telephone and text messaging were viewed acceptable over other 
telehealth options (and to complement face to face care) to facilitate dietary follow up. These 
modalities appear to meet the patients’ expectations of service delivery, and may assist in 
dietary change. 
6.6.1 Practical application 
Patients with CKD experience a range of barriers to enacting dietary behaviour change. These 
partly stem from the characteristics of health professionals and barriers to traditional 
healthcare delivery. Clinicians should align with a patient’s priority for dietary change, and 
avoid patronizing advice focused on nutrient restrictions. This patient-engagement study can 
be used to develop patient-centered telehealth programs, and guide its implementation in a 
CKD service. To use telehealth to support dietary change, clinicians should consider text 
messages and phone calls, as they are viewed to facilitate regular, repeated interaction and 





1. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical 
Practice  Recommendations for Diabetes and Chronic Kidney Disease. American 
journal of kidney diseases : the official journal of the National Kidney Foundation. 
2007;49(2 Suppl 2):S1-S180. 
2. Levey AS, Rocco MV, Anderson S, et al. K/DOQI clinical practice guidelines on 
hypertension and antihypertensive agents in chronic kidney disease. American Journal 
of Kidney Diseases. 2004;43(5 SUPPL. 1). 
3. Palmer SC, Hanson CS, Craig JC, et al. Dietary and Fluid Restrictions in CKD: A 
Thematic Synthesis of Patient Views From Qualitative Studies. American journal of 
kidney diseases : the official journal of the National Kidney Foundation. 
2014;65(4):559-573. 
4. McMahon EJ, Campbell KL, Bauer JD, Mudge DW. Altered dietary salt intake for 
people with chronic kidney disease. Cochrane Database of Systematic Reviews. 
2015;2:Cd010070. 
5. Liu Z, Su G, Guo X, et al. Dietary interventions for mineral and bone disorder in 
people with chronic kidney disease. The Cochrane database of systematic reviews. 
2015. 
6. Fouque D, Laville M, Boissel J. Low protein diets for chronic kidney disease in non 
diabetic adults. Cochrane Database of Systematic Reviews. 2009;3. 
7. Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B. Omega 3 fatty acids and 
cardiovascular outcomes. Systematic review and meta-analysis. Circ Cardiovasc Qual 
Outcomes. 2012; 5: 808-18. External Resources Pubmed/Medline (NLM) CrossRef 
(DOI). 2016. 
8. Smyth A, O'Donnell MJ, Yusuf S, et al. Sodium intake and renal outcomes: a 
systematic review. Am J Hypertens. 2014;27(10):1277-1284. 
9. Mozaffarian D. Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, 
and Obesity A Comprehensive Review. Circulation. 2016;133(2):187-225. 
10. St Peter WL, Schoolwerth AC, McGowan T, McClellan WM. Chronic kidney disease: 
issues and establishing programs and clinics for improved patient outcomes. American 
journal of kidney diseases. 2003;41(5):903-924. 
 
161 
11. Desroches S, Lapointe A, Ratte S, Gravel K, Legare F, Turcotte S. Interventions to 
enhance adherence to dietary advice for preventing and managing chronic diseases in 
adults. The Cochrane database of systematic reviews. 2013;2:Cd008722. 
12. Kelly JT, Reidlinger DP, Hoffmann TC, Campbell KL. Telehealth methods to deliver 
dietary interventions in adults with chronic disease: a systematic review and meta-
analysis. The American Journal of Clinical Nutrition. 2016;104(6):1693–1702. 
13. Daly R. Transitioning health systems for multimorbidity. Transplantation. 
2012;93:348-353. 
14. Australian Commission on Safety and Quality in Health Care. Patient-Centred Care: 
Improving Quality and Safety by Focusing Care on Patients and Consumers — 
Discussion Paper. In: Care ACoSaQiH, ed. Australia2010. 
15. Eknoyan G, Lameire N, Eckardt KU, et al. KDIGO 2012 clinical practice guideline for 
the evaluation and management of chronic kidney disease. Kidney Int. 2013;3:5-14. 
16. Chan M, Patwardhan A, Ryan C, et al. Evidence-based guidelines for the nutritional 
management of adult kidney transplant recipients. Journal of Renal Nutrition. 
2011;21(1):47-51. 
17. YouTube. - Looking up your results in PatientView. [Cited 18 Jan 2016.]; 
https://www.youtube.com/watch?v=Ri1wXrCGH9c&index=2&list=PLGk58HmEpP7
IIM1wP1FlbpGxEfEaxO-Ft  
18. Bear RA, Stockie S. Patient engagement and patient-centred care in the management 
of advanced chronic kidney disease and chronic kidney failure. Canadian journal of 
kidney health and disease. 2014;1(1):1. 
19. Lo C, Ilic D, Teede H, et al. The Perspectives of Patients on Health-Care for Co-
Morbid Diabetes and Chronic Kidney Disease: A Qualitative Study. PloS one. 
2016;11(1). 
20. Mead N, Bower P. Patient-centred consultations and outcomes in primary care: a 
review of the literature. Patient education and counseling. 2002;48(1):51-61. 
21. Goldstein M, Yassa T, Dacouris N, McFarlane P. Multidisciplinary predialysis care 




22. Kasiske BL, Lakatua J, Ma JZ, Louis TA. A meta-analysis of the effects of dietary 
protein restriction on the rate of decline in renal function. American Journal of Kidney 
Diseases. 1998;31(6):954-961. 
23. Smyth A, Griffin M, Yusuf S, et al. Diet and Major Renal Outcomes: A Prospective 
Cohort Study. The NIH-AARP Diet and Health Study. Journal of Renal Nutrition. 
2016;26(5):288-298. 
24. Kelly J, Campbell K, Wai S, et al. Healthy Eating Patterns, Mortality and End-Stage 
Kidney Disease in CKD: A Systematic Review and Meta-Analysis. Clin J Am Soc 
Neprol. 2016;12(2):272-279. 
25. Campbell KL, Murray EM. Allied health services to nephrology: an audit of current 
workforce and meeting future challenges. J Ren Care. 2013;39(1):52-61. 
26. Ande P, Chiu D, Rayner S, Coward RA, Woywodt A. What's on the web for 
nephrology? NDT plus. 2009;2(2):119-126. 
27. Curtin RB, Walters BA, Schatell D, Pennell P, Wise M, Klicko K. Self-efficacy and 
self-management behaviors in patients with chronic kidney disease. Advances in 
chronic kidney disease. 2008;15(2):191-205. 
28. Cueto-Manzano AM, Gallardo-Rincón H, Martínez-Ramírez HR, et al. A pilot study 
of a mobile phone application to improve lifestyle and adherence of patients with 
kidney disease. Journal of telemedicine and telecare. 2015;21(2):119-120. 
29. Murdock A, Rodgers C, Lindsay H, Tham TCK. Why do patients not keep their 
appointments? Prospective study in a gastroenterology outpatient clinic. J Royal Soc 
Med. 2002;95(6):284-286. 
30. Paterson BL, Charlton P, Richard S. Non‐attendance in chronic disease clinics: a 





 - The Evaluation of Individualized Telehealth Intensive 
Coaching to Promote Healthy Eating and Lifestyle in Chronic Kidney 
Disease (ENTICE-CKD): A Mixed Methods Process Evaluation 
7.1 Preface  
In the previous chapter (Chapter 6), people with CKD shared their experiences with dietary 
challenges and the potential of a telehealth program to overcome these dietary challenges. 
From this study, it was clear that clinicians needed to deliver up-to-date nutritional advice but 
keep it relevant to the patient’s diet priorities. Participants wanted flexible services that could 
offer continued support and monitoring, until they were feeling confident in self-managing 
themselves. Chapter 6 introduced the concept of using telehealth and showed that people with 
CKD were open to using these methods, providing they could meet these needs, were tailored 
to their condition, and delivered using familiar technologies. 
The findings from Chapter 6, as well as the evidence synthesis in Chapters 3, 4, and 5 were 
used to inform the development of a patient-centred telehealth-delivered dietary intervention 
in the stage 3-4 CKD population. The telephone and mobile phone were identified as the best 
delivery methods, as participants in the qualitative study were most comfortable using these 
telehealth modalities. The delivery schedule was decided to be fortnightly with weekly text 
messages to ensure contact and feedback was regular, and the diet advice was not restriction 
focused, but was comprehensive and delivered in steps across each phone call.  
Chapter 7 details the first randomised controlled trial of a telehealth-delivered dietary 
intervention in CKD. This chapter describes a pilot study testing the feasibility and 
acceptability of the telehealth-delivered intervention which was developed following the work 
reported in Chapters 3, 4, 5, and 6. This chapter addresses the absence of quality evidence 
regarding the feasibility and acceptability of this intervention strategy, as well as provides 
insight into the preferred delivery mode for text and telephone-based counselling. As a pilot 
study, it is intended to provide critical evidence for future large-scale dietary intervention 
studies. 
7.1.1 Publication status 
The manuscript presented in this chapter is currently under review by the peer-reviewed 
journal the Journal of the Academy of Nutrition and Dietetics. The manuscript presented in 
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this chapter is formatted to a consistent thesis style. However, the grammar, headings, and 
references (in-text and bibliography) are unaltered in accordance with the journal publishing 
guidelines. 
Citation: Kelly JT, Warner MM, Reidlinger DP, Hoffmann TC, Craig J, Tong A, Reeves M, 
Johnson DW, Palmer SC, Campbell KL. The evaluation of individualized telehealth intensive 
coaching to promote healthy eating and lifestyle in chronic kidney disease (ENTICE-CKD): 
A mixed methods process evaluation. [Under Review] 
7.1.2 Related work to this Chapter completed by the candidate  
One other manuscript relating to this chapter is currently in draft, which the candidate is a co-
author. This work is the qualitative follow-up relating to the experiences of participants who 
completed the trial this proceeding chapter discusses. While this paper is not a primary 
publication within this thesis, the candidate was directly involved in the study design and 
recruitment of participants and supervised the student researcher during this project. The 
findings complement the overarching aim of this thesis, and is available in Appendix B.  
• Warner MM, Kelly JT, Reidlinger DP, Tong A, Campbell KL. Patient acceptability and 
experiences of a telehealth coaching program to improve diet quality in CKD: A semi-




7.2 Research snapshot  
7.2.1 Research question 
What is the feasibility and acceptability of a personalized telehealth intervention to increase 
diet quality in adults with stage 3-4 chronic kidney disease (CKD)?  
7.2.2 Key Findings 
In this pilot randomized controlled trial involving 80 participants with stage 3-4 CKD, a 
personalized telehealth intervention was found to be feasible and acceptable. Ninety-six 
percent of telephone calls were successfully completed, and retention was 95% after six 
months. All (100%) participants in the tailored intervention viewed the text messages as 
useful in supporting their dietary change, compared to 69% of participants in the non-tailored 
text message (control) group (p<0.01). 
7.3 Abstract  
7.3.1 Background 
Telehealth interventions have the potential to support dietary management in people with 
chronic kidney disease (CKD).  
7.3.2 Objective 
To evaluate the feasibility and acceptability of a personalized telehealth intervention to 
increase diet quality in adults with stage 3-4 CKD. 
7.3.3 Design 
Mixed-methods process evaluation of a randomized controlled trial (RCT). 
7.3.4 Participants/setting 
People with stage 3-4 CKD were recruited to an RCT from three hospitals in Australia. 
7.3.5 Intervention 
The intervention group received one telephone call per fortnight and 2-8 tailored text 
messages for three months, and then 4-12 tailored text messages for three months without 
telephone calls. The control group received usual care for three months then non-tailored 
education-only text messages for three months. 
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7.3.6 Main outcome measures  
Feasibility (recruitment, non-participation and retention rates, intervention fidelity, and 
participant adherence) and acceptability (questionnaire and semi-structured interviews). 
7.3.7 Statistical analyses performed 
Descriptive statistics and qualitative content analysis. 
7.3.8 Results 
Overall, 80/228 (35%) eligible patients who were approached consented to participate (mean 
age 61.5±12.6 years). Retention was 93% and 98% in the intervention and control groups, 
respectively, and 96% of all planned intervention calls were completed. All participants in the 
intervention arm identified the tailored text messages as useful in supporting dietary change. 
In the control group, 27 participants (69%) reported the non-tailored text messages were 
useful in supporting change. Participants in the intervention group reported that the telehealth 
program delivery methods were practical and able to be integrated into their lifestyle. 
Participants viewed the intervention as an acceptable, personalized alternative to face-face 
clinic consultations, and were satisfied with the frequency of contact.   
7.3.9 Conclusions  
The ENTICE dietary coaching program is a feasible and acceptable intervention for 
supporting dietary change in stage 3-4 CKD. A larger-scale randomized controlled trial is 






Chronic kidney disease (CKD) is a progressive condition affecting over 10% of the 
population worldwide.1 Diet is a modifiable risk factor for the progression of CKD to end-
stage kidney disease (ESKD).2,3 Typical dietary advice includes restricting individual 
nutrients, such as sodium, protein, potassium and phosphate. However, there is little evidence 
regarding the adherence to, and efficacy of, nutrient-specific dietary advice.4 Recent evidence 
shows that following a healthy dietary pattern, as a whole food-based dietary pattern is 
associated with a reduced risk of death in established CKD.5 A focus on foods rather than 
single nutrients may also facilitate increased adherence to dietary change in CKD5,6 which is 
otherwise a challenging due to dietary complexity and competing demands of self-
management.7 Overcoming these barriers to implementation of sustained dietary change are 
necessary to test whether improving diet quality alters patient-centered outcomes. 
Providing regular and individualized dietary support required for those with CKD comes with 
geographical, time and financial barriers.8 To test whether increasing diet quality (through 
dietary pattern) may attenuate the progression of CKD and elevated cardiovascular risk on a 
sufficient scale for a randomized controlled trial (RCT), alternative modalities that are 
effective in supporting dietary management are needed. Telehealth modalities, particularly 
telephone-based and text message coaching, present an opportunity to overcome barriers and 
challenges that people with CKD encounter in accessing health care services.7,9 Telehealth 
interventions may facilitate an increased frequency and quality of contact between the patient 
and healthcare professional,10,11 which may improve acceptability, uptake and adherence to 
interventions12 and better align with a patient-centered model of care.9 Compared to face-to-
face consultations,11 telehealth modalities are effective in reducing chronic disease risk, 
including improving diet quality, fruit and vegetable consumption and reducing dietary 
sodium intake.10 Text messaging has been utilized to ‘extend contact’ after an intervention 
and has been shown to maintain clinical outcomes and minimize intervention decay.13,14 A 
systematic review of text message health interventions highlighted the need for better 
evidence on the relative effectiveness of text-based interventions including message delivery 
(incorporating frequency and timing), level of interaction (i.e. response and feedback) and 
impact of additional interventions (such as a combination with telephone, face-to-face, video 
or internet).15  
While dietary patterns aligned with a higher diet quality are associated with improved lower 
mortality in CKD, the level of coaching required to achieve and support this dietary change is 
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largely unknown. Furthermore, evidence to support the level of tailoring, and the delivery 
method that is most feasible and acceptable for patients with CKD, is lacking. Therefore, this 
pilot study aimed to evaluate the feasibility and acceptability of telehealth-delivered dietary 
coaching to support the improvement of dietary quality in stage 3-4 CKD.  
7.5 Materials and methods   
We used a mixed methods design, whereby qualitative data on the patient experience were 
embedded within quantitative data relating to participants recruited into the Evaluation of 
iNdividualized Telehealth Intensive Coaching to promote healthy Eating and lifestyle in 
Chronic Kidney Disease (ENTICE-CKD) program. All data was prospectively collected. This 
pilot randomized controlled trial was prospectively registered (ACTRN12616001212448) and 
reported based on the CONSORT checklist.16 This trial was approved by the Metro South 
Health Service District Human Research Ethics Committee (EC00167) and Bond University 
Human Research Ethics Committee (EC00357). All participants provided written informed 
consent.  
7.5.1 Design 
This multi-center, randomized controlled trial was conducted from November 2016 to 
November 2017. The dietary intervention was designed using the social cognitive theory,17 
with a patient-centered focus on improving self-management to reduce dietary sodium intake 
(<2300mg/day) and increase dietary quality in accordance with the Australian Dietary 
Guidelines (see Table 7-1 for intervention guidance).18 Interventions were adjunct to usual 
nephrology care from treating physician(s) and renal team members, including ad hoc 
referrals to allied health practitioners during the study.  
7.5.2 Participants 
Participants were recruited from three tertiary nephrology units in Queensland, Australia over 
a 6-month period (November 2016 until May 2017). Inclusion criteria were: adults over 18 
years of age; stage 3-4 CKD (eGFR 15-60mL/min/1.73m2); and access to a mobile device 
capable of receiving text messages and telephone calls. Exclusion criteria were: anticipated 
dialysis commencement or kidney transplant within the following 12 months; pregnancy; 




Eligible participants were randomized on a 1:1 ratio into one of two groups (stratified by 
recruiting site and diabetes status). Randomization was completed by computer-generated 
random numbers carried out by an independent statistician not involved in the study.  
7.5.3 Study treatment 
The ENTICE-CKD program was completed in two three-month phases in both the 
intervention and control arm of the study as detailed in Figure 7-1. The intervention group 
received fortnightly telephone calls for three months (phase 1) and tailored text messages for 
six months (phase 1 and 2). The control group received usual care for three months (phase 1), 
followed by non-tailored education-only text messages for three months (in phase 2). Each 
participant was involved in the trial for six consecutive months. All participants were 
provided with an ENTICE-CKD workbook at the baseline visit (Appendix J). The 90-page 
workbook included information on setting specific, measurable, achievable, realistic, and 
time-bound (SMART) goals; eating well for kidneys (based on the Australian Dietary 
Guidelines);18 active living (based on the Australian Physical Activity Guidelines);19 role of 
diet in kidney disease, strategies for planning, self-monitoring checklists, and a list of useful 
websites, apps, and recipes for further reference. 
 
  Screening and recruitment 
      ↓ 
  Randomization 
       ↙   ↘    










6x fortnightly telephone 
calls + tailored text 
messages 
+ workbook 
Usual Care  
(workbook only) 
12  Mid-point visit + telephone call  
 
 
Phase 2  
14 
16 
Tailored text messages Educational text 
messages 
18 Telephone call 
20 
22 
Tailored text messages 
24  End-point visit  
 
Figure 7-1: Summary of ENTICE-CKD program delivery. 
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7.5.3.1 Telehealth coaches 
Each participant was assigned to a telehealth coach at baseline. The participant had the same 
coach for the duration of the program. The telehealth coaches were registered dietitians 
(Australian equivalent) with additional training in renal nutrition, behavior change, and 
motivational interviewing; were external to the recruiting sites and had never met the 
participants; and were not involved in any outcome data collection.  
Table 7-1: Dietary targets adopted in the ENTICE-CKD intervention workbook, telephone 





Grains/cereals  3-6 (>50% whole grain) Replacing refined carbohydrates for 
wholegrains  
Vegetables and fruit 5-7 Low potassium alternatives as appropriate 
Low fat dairy 2 250mL milk, 40g cheese, 200g yoghurt 
Lean meat, poultry 
and fish 
<2 (130-200g) Modified for protein (aiming for 1.0 
g/kg/day) 
Fats and oils 20 to 40g  Emphasise healthy oils 
Dietary sodium <100mmol/day (6g salt) Replace takeaway and processed foods for 
fresh food and healthy cooking methods  Added sugars <10% total calorie 
intake 
Discretionary choices  <2 Limit where possible 
Abbreviations – g: grams, kg: kilogram, mL: millilitre.   
7.5.3.2 Phase 1 
The participants in the intervention group received six fortnightly telephone calls in phase 1 
which were scheduled on weekdays at a time of the participants choosing (from 7am to 7pm). 
The first call was scheduled for 45 minutes and five subsequent for approximately 30 
minutes. Each call was based on established protocols and call scripts. The telephone call 
content was guided by the workbook topics, structured according to the 5A’s framework 
(Assess, Advise, Agree, Assist, Arrange),20 and individually tailored to participants using 
relevant educational strategies, and in consideration of the participant goals and co-
morbidities. Where required, 24-hour dietary recalls were undertaken during coaching calls to 
track adherence and progress with goals. Coaches used Microsoft Excel21 to document 
progress of each call and log information including goal setting, implementation intentions, 
self-monitoring tools, call attempts and durations, and text message preferences.  
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In addition, participants in the intervention group received from two to eight text messages 
scheduled between coaching calls with the actual number and time of day determined by each 
participant’s preference. Text categories included: educational; self-monitoring; and goal 
setting. The schedule of text messages for the intervention and control group in phase 1 and 2 
is detailed in Table 2. The text messages were sent using a web-based, semi-automated text 
message management platform (Propelo, www.propelo.com.au), developed and administered 
by The University of Queensland's School of Public Health.22 The investigators, in 
collaboration with local nephrologists, dietitians and evidence-based practice guidelines, 
designed the library of text messages, which were then reviewed for comprehension by a 
group of patients, nephrologists and members of the investigator team. The text message 
library was imported into the software platform, which was designed to tailor text messages 
based on: participant’s name; individual goals; barriers to achieving goals; and, participant-
identified solutions to overcoming those barriers. These tailoring variables were modified as 
required following each coaching call. 
As shown in Table 2, participants in the intervention group could receive one ‘goal check’ 
(per goal) per fortnight in phase 1 and up to 2 goal checks (per goal) per fortnight in phase 2. 
These goal checks required the participant to respond to the text with a “yes” or “no” which 
prompted the software to send a pre-determined response. An incoming text reply outside 
protocol (i.e. not a “yes” or “no” response) was classified as an ‘unrecognized response’. This 
triggered an email to the participant’s coach and was only responded to where participants 
expressed considerable risk to their health (e.g. symptoms needing medical attention).    
Participants in the control group received no coaching or text messages between the baseline 
visit and three months (phase 1). The control group continued to receive standard care under 
their treating nephrologist and were encouraged to work through the ENTICE-CKD 
workbook at their own pace.  
7.5.3.3 Phase 2 
At three months, participants in the intervention group completed a tailoring telephone call to 
determine individual preferences for the timing and frequency of text messages for phase 2. 
At 18 weeks (i.e. half way through phase 2), participants received a second tailoring call 
where they could modify the timing and frequency of text messages and could update their 
goals. Intervention group participants chose text message frequencies for the same types of 
texts that they received in phase 1 (educational tips, self-monitoring, goal checks). 
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Participants in the control group received non-tailored education-only text messages 
(described in Table 7-2). 
Table 7-2: Text messaging framework and related social cognitive theory constructs in the 
24-week ENTICE-CKD trail.  
a NA = not applicable 
b Educational permutations were only available for coaches to use if a participant experienced 
hyperkalaemia or hyperphosphataemia  
7.5.4 Data collection 
Each participant attended a baseline, three-month mid-point, and six-month end-point visit 





construct Example text 
Intervention 
group Control group 








Dietary fibre intake 
reduces ur cholesterol 
levels and controls ur 
blood sugar. Include 
wholegrain breads & 
cereals, fruits & veg 
regularly  












Hi [name], are you 
keeping track of ur 
fruit/vegetable intake 
every day? Remember ur 
goal to meet at least 5 
serves this week  






Hi [name], did you reach 
ur goal to eat 5 
fruits/vegetables 4 times 
this week? Text me back 
yes or no to let me know  








Choose high fibre, low 
potassium breakfast 
cereals. Good choices are 
Multigrain Weetbix, 
Rolled Oats, Guardian, 
Oatbritz, Special K  
0-2b 0-2 b NA 0-2 b 
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site to collect all clinical objective data (not reported here). All participants’ study visits were 
scheduled on separate days or hours apart to avoid risk of contamination bias. Basic 
demographic data (including participant’s age and gender) were recorded at baseline. Socio-
economic status was estimated from participants’ postcodes, according to the Index of 
Relative Socio-economic Advantage and Disadvantage (IRSAD).23 Baseline health literacy 
was collected using the single item Literacy Screener which classifies Health Literacy as good 
or limited based on the single question, “How often do you need to have someone help you 
when you read instructions, pamphlets, or other written material from your doctor or 
pharmacy?”.24 
7.5.5 Reach and retention 
Recruitment and non-participation rates were captured across the three recruitment sites, with 
a goal to achieve the target sample size of 80 participants in the six month recruitment time 
frame. Retention rate was measured at three and six months in both study groups, with 
successful retention defined as 80% at the six-month study end.  
7.5.6 Intervention delivery 
Individual cases were discussed fortnightly between the coaches and the lead investigator to 
support consistent intervention delivery. All coaching calls were audio recorded, from which 
10% were assessed for consistency by peer-review by an individual external to the project. 
The following fidelity data were collected and stored in a Microsoft Excel21 database 
throughout the trial: number, duration and content of coaching telephone calls; number and 
type of text messages delivered; number and type of text message responses; and time spent 
by coaches for each interaction. 
7.5.7 Intervention adherence 
Adherence was defined as successfully completing five of the six telephone calls for the 
intervention group. We also collected data on individual participant adherence to the 
prescribed dietary intervention, collected by coaches in each telephone call using a call log 
template in Microsoft Excel.21 In the call logs, coaches described evidence of the participant’s 
overall progress, evidence of self-monitoring, goals set and implementation intentions 
(behaviours implemented to achieve goals) during each call, which was quantified in counts 




A utility and acceptability survey of the text message component of the ENTICE-CKD trial 
was collected from all participants at the six-month end of study visit (Appendix K). The 
survey included 13 items, developed specifically for the study, with five items asking 
participants to rate on a 5-point Likert scale from 1 ‘strongly disagree’ to 5 ‘strongly agree’, 
four items asking participants yes/no questions, and four multiple choice questions, based on 
previous methodology in cardiac patients.25 In addition to this, during the sixth telephone call 
(three-month study mid-point; for intervention participants only), coaches obtained verbal 
consent of participants to be approached to complete an interview relating to their experiences 
of the intervention. 
Semi-structured interviews were conducted in-person and by telephone. We recruited 
participants based on consecutive sampling of completing participants until data saturation 
was achieved. The interviews were conducted by investigator (MW), who had not previously 
never met the participants and was not involved in the planning of the intervention. The 
interview guide included questions on: barriers and facilitators of program adherence; 
telehealth delivery methods and frequency of contact; usability of the program; goal setting, 
self-monitoring, behavior change; and experiences (Appendix L). Modification of the 
interview guide occurred after each interview to broaden scope of the data collected. 
Interviews were audio-recorded and transcribed verbatim. 
7.6 Data analysis 
The sample size was determined for the purpose to inform a future studies. Therefore, a target 
of 30-40 participants per arm should allow for meaningful and reliable data which can be used 
to power future trials.26 Quantitative data were analyzed using simple descriptive statistics 
(counts and percentages). To determine the difference in the utility and acceptability between 
the two study groups, a standard Chi square test was used with a significance level determined 
as p< 0.05. Statistics were conducted in SPSS Statistics for Windows (version 22.0. Chicago: 
SPSS Inc.) and Microsoft Excel.21 Inductive content analysis27 of the semi-structured 
interview transcripts regarding acceptability of the intervention was conducted by a researcher 
(MW) who was not involved in quantitative data planning, collection and analysis. After 
familiarization with the data, an open coding approach was adopted to identify, develop and 
finalize categories and subcategories within the data. A dietitian and qualitative researcher 
(DR) familiar with the data then finalized and confirmed emerging categories that were 
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relevant to the process evaluation. Verbatim quotes were collected and used to represent 
attributes demonstrated for both the feasibility and acceptability of the ENTICE-CKD 
program. Microsoft Word28 was used to facilitate data management (tables) and basic content 
analysis (comments relating to attributes demonstrating feasibility and acceptability) of data.   
7.7 Results 
7.7.1 Characteristics of participants   
The baseline characteristics of the participants are reported in Table 7-3. Of the 80 
participants who completed their baseline visit, 64% were men and had a mean age of 62 
years. The stage of CKD varied within the sample, with 31% having stage 3a (eGFR 45-
59ml/min/1.73m2), 44% stage 3b (eGFR 30-44ml/min/1.73m2) and 25% stage 4 (eGFR 15-
29ml/min/1.73m2). The most common comorbidities were hypertension (81%) and diabetes 
(39%) (Table 5). Baseline health literacy was good in over 90% of all participants. 




Table 7-3: Demographics of participants whom completed the six month ENTICE-CKD pilot 
study.  
Characteristic Intervention group (n=41) Control group (n=39) 
Male, n (%) 26 (63%) 25 (64%) 
Age (years) 62.5 ± 12.3 60.5 ± 13.0 
Stage of chronic kidney disease 
3a 10 (25%) 15 (38%) 
3b 19 (46%) 16 (41%) 
4 12 (29%) 8 (21%) 
Body Mass Index, kg/m2 33.4 ± 6.7 31.0 ± 6.4 
Hypertension 34 (83%) 31 (80%) 
Diabetes 15 (37%) 16 (41%) 
Active smoker status 21 (51%) 16 (41%) 
Ethnicity 
Asian 2 (5%) 1 (3%) 
Caucasian/European  37 (91%) 32 (82%) 
Indigenous  1 (2%) 0 
Other 1 (2%) 6 (15%) 
Education 
Lower than 10th grade  17 (42%) 12 (32%) 
Up to 12th grade 4 (10%) 10 (26%) 
Tertiary educated  20 (47%) 16 (41%) 
Socio-economic status 
High 27 (66%) 25 (64%) 
Health Literacy 
Good 37 (90%) 36 (92%) 
7.7.2 Reach and retention 
Participants were recruited between November 2016 and May 2017, from Gold Coast (43%), 
Sunshine Coast (31%) and Brisbane (26%) hospitals. The flow of participants through the 
ENTICE-CKD study is shown in Figure 7-2. A total of 228 potentially eligible individuals 
were approached and invited to participate, of whom 80 participants (35%) were recruited to 
the ENTICE-CKD trial. Of the 146 individuals who declined to participate, not 
interested/other reasons were the most commonly stated reasons for non-participation (49%), 
followed by time commitment issues (14%), medical reasons (11%) and travel limitations to 
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make study visits (11%). Additional reasons why people chose not to participate included: 
already feeling healthy (5%), already seeing a dietitian (5%), believed the intervention did not 
fit their current lifestyle (3%) or preferred not to use technology (1%). A further two 
individuals consented to the study but did not attend a baseline visit and were therefore not 
randomized to a treatment group.  
Seventy-six (95%) of all randomly allocated participants completed the six-month telehealth 
program. A total of four (5%) participants withdrew from the study. All the withdrawals 
occurred in the first three months of the program. Three of the four participants who withdrew 
were from the intervention group (two were unable to be contacted and therefore did not 
commence the program, and one participant was unable to continue due to a family illness). 
The sole participant who withdrew from the control group did not report a reason for doing 
so. There were no appreciable differences in the demographics of those participants who 





Figure 7-2: Consort flow diagram showing the flow of participants through the ENTICE-
CKD study  
7.7.3 Intervention delivery 
Table 7-4 shows the adherence to the planned delivery of the telephone and text message 
components of the ENTICE-CKD intervention. The delivery of the scheduled telephone calls 
was conducted according to protocol with 90% of planned calls being completed as 
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scheduled. The mean duration of the first intervention call was 45.5±10 minutes (range 28 to 
75 minutes). The mean length of the subsequent five calls was 24±10 minutes (range 2 to 62 
minutes).    
Table 7-4: Delivery and response of fortnightly telephone calls and text messages in 
ENTICE-CKD.   
 Intervention group Control group 
TELEPHONE CALLS Phase 1 Phase 2 Phase 2 
Planned  234 - - 
Actual 225 - - 
Call attempts  290 - - 
Missed calls, n (%) 9 (3) - - 
Duration of initial calls, mins (mean± SD) 45±10 - - 
Duration of follow up calls, mins (mean ± SD) 24±10 - - 
Call scheduling text messages outgoing 245 57 0 
TEXT MESSAGES – outgoing  
Total intervention texts sent, per fortnight 1371 1980 1634 
Educationala, median(range) 2(0-6) 4(0-8) 6(0-13) 
Goal checkb, median(range) 2(0-4) 3(0-5) - 
Self-monitoringc, median(range) 0(0-2) 2(0-5) - 
TEXT MESSAGES – incoming  
Total text responses 437 608 55 
Recognized goal check responses, n (%) 174 (39.8) 226 (37.2) 0 
Unrecognized responses 263 382 55 
Requiring tailored text reply from coach, n (%) 7 (2.7) 18 (4.7) 2 (3.6) 
a Outcome expectations (providing information on consequence) 
b Self-regulation 
c Self-regulation (facilitate planned behavior change 
A total of 4,985 intervention text messages were sent to ENTICE participants. The median 
number of text messages sent to participants was within protocol for both groups, with 
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intervention participants receiving a median of four text messages per fortnight in phase 1 and 
seven per fortnight in phase 2. Control participants received a median of six non-tailored 
education-only text messages per fortnight in phase 2 (Table 7-4). The total number of 
incoming text messages (replies from participants) was 1,100 (Table 7-4), 36% (n=400) 
triggered the appropriate goal-check reply, 3% (n=31) required the dietitian coach to send a 
tailored text message to address the concern raised by the sender and 61% (n=669) required 
no reply. 
7.7.4 Intervention adherence 
A total of 38 participants (95%) completed at least five calls, and 36 (90%) completed all six 
calls. Two participants (5%) never received a telephone call. Goal setting was completed by 
all participants in the first call as planned, with 95% of the participants setting two or more 
goals. The coaches’ call logs showed that, throughout the program, participants continued 
setting new goals with 10 (26%) updating at least one goal in call two and 22 (61%) updating 
at least one goal throughout the remaining four calls (Table 7-5). 
A total of 29 (76%) participants showed evidence of self-monitoring by the second call, which 
was sustained throughout phase 1 of the intervention. Evidence of implementation intentions 
indicated that the majority of participants (82%) needed at least two calls to begin putting 
planned dietary intentions in place. This number continued to rise over the next four calls to 




Table 7-5: Participant adherence to the ENTICE interventiona.  
Adherence Call 1 Call 2 Call 3-6  
Total planned calls  







Number of missed calls, n (%) 
Due to withdrawal from trial 
Due to travel 
0 1 (3) 8 (5) 
2 (1) 
2 (1) 
Otherb  1 (3) 4 (3) 
Goal setting, n (%) 
1 goal  
2 goals 
3 goals 
















Self-monitoring, n (%) 22/38 (58) 29/38 (76%) 29/38 (76) 













a – Data are presented as n (%).   
b – 1 participant decided to get tailored text messages only following call 1 
c - In each call only 2 goals could be set or updated.   
d - Implementation intentions were not expected to be evident in the first call  
7.7.5 Acceptability 
7.7.5.1 Utility and acceptability  
There were several differences in ratings for utility and acceptability between the intervention 
(tailored-text) group compared to the non-tailored education-only text message (control) 
group (Table 7-6). Some participants agreed (responses for ‘agree’ and ‘strongly agree’) that 
the text message component: supported their dietary change (intervention 100%; 69% control, 
p=0.003); provided motivation to change their diet (intervention 75%, control 50%; p=0.03); 
and led them to a healthier diet (intervention 81%, control 61%, p=0.06). There were no other 
differences observed in the utility of the text messages between the groups. The majority of 
text messages were saved and not deleted (77% overall), and 62% were shared with family, 
friends or health care providers across the two study groups. Acceptability of the text 
messages was assessed as highly acceptable with 78% of participants reporting that the 
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characteristics of the text messages (language, frequency, program length, time of delivery) 
were satisfactory.  
Table 7-6: Utility and acceptability of ENTICE-CKD text messages by participant groupa.  




Usefulness and understanding   
Q1 - Useful in supporting dietary change 100% 69%** 
Q2 - Messages were easy to understand 100% 100% 
Influence on motivation and behavior change  
Q3 - Messages motivated change 75% 50%** 
Q4 - Healthier diet due to messages 81% 61% 
Q5 - Exercise increased due to messages 38% 33% 
Message saving and sharing   
Q6 - Percent of messages read 100% 100% 
Q7 - Saved messages 81% 72% 
Q8 - Shared messages 56% 67% 
Family member 71% 74% 
Friend 12% 10% 
Health provider 12% 10% 
Appropriate message characteristics   
   Q9 - Suitable language 100% 100% 
   Q10 - Texts were not too regular 94% 86% 
   Q11 - Program length (six months) 88% 78% 
   Q12 - Appropriate time of the day/night 100% 94% 
a - Response rate for this survey was 73 out of 80 participants (91%), tailored text messages (n=43), 
non-tailored text messages (n=39). 
** - p<0.01 between groups   
7.7.5.2 Attributes of feasibility and acceptability  
Twenty-one intervention participants were interviewed upon completion of phase 1, either by 
telephone (n=20) or face-to-face (n=1). Interviews ranged from 20 to 96 minutes (mean 49 
min). Overall, participants had positive experiences with the ENTICE-CKD trial. Attributes 
of the discussions are described in nine categories within components of acceptability and 
feasibility (Table 7-7). The acceptability categories discussed by participants were: acceptable 
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alternative to clinic, preference for voice communication, regular contact via text message, 
and personalized messages valued. In contrast, the categories described under feasibility were: 
program integrated into lifestyle, diverse delivery modes, social accountability, responding to 
dietary advice, and infeasible elements beyond intervention. Participants emphasized the 
importance of social accountability; all participants expressed benefit from the relationship 
built with their coach. Participants identified benefits from telehealth delivery of the 
intervention, with the majority expressing preference for telehealth over face-to-face 
interventions. They appreciated the personable, bidirectional conversation of the calls. The 
degree of usefulness of text messages was rated variably by different participants, although no 
participants described the content or delivery of text messages negatively. Messages that were 
perceived to be personalized were preferred for both calls and text messages. Participants felt 
that receiving information via more than one delivery mode was helpful for making diet 
changes. Some participants discussed challenges which were not addressed by the ENTICE-
CKD intervention, such as participants not being easily able to implement routine dietary 
behaviors whilst travelling, or those lacking social support outside of the program. 
Table 7-7: Acceptability and feasibility of ENTICE-CKD program at completion of phase 1 
(intervention group): qualitative content analysis of semi-structured interviews (n=21). 
Category Attributes Quote 




Overcomes clinic wait times, 
transport logistics 
Flexibility of phone call 
appointment times 
Preferred talking from a familiar 
environment and not feeling rushed 
No identified disadvantages of 
telehealth communication vs face-
to-face  
Building rapport with coach 
“At home I’m more relaxed and I 
have the book in front of me and I 
was able to jot down anything that 
was important, if I was at the 
hospital there’s so many people 
around and you don’t feel very 
relaxed, you feel like everyone is 
listening to your conversation, so 





More benefit from voice calls 
Frequency of fortnightly phone calls 
“I found the calls better than the 
texts … they were more personable 
and kept me on track” Female, 68 
Regular 
contact via text 
message 
Text messages were an acceptable 
mode of communicating information 
Preference for receiving text 
messages with personal 
encouragement and general tips 
All text messages were acceptable 
“We solved a lot of my little issues, 
and it’s given me a lot better 
understanding, and you know the 
more you think about it and 
communicate about it, ah the better 
it is” Male, 71 
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Health professional expertise 
Usefulness of coordinated nutrition 
advice 
Removal of multiple conflicting 
nutrition recommendations 
“It’s given me simple tasks, simple 
methods, or methodologies, to 
improve the situation, and they’re 
not a whole lot of gobbledygook, 
just basic stuff that we can 
understand.” Male, 65 




Length of phone calls easily 
accommodated 
12-week telephone intervention 
enough time for change 
Self-monitoring the behavior of 
choice 
“As long as you’re getting 
information backwards and 
forwards, that’s the more important 
thing than the length of the call, it’s 




Active learning from a range of 
understandable delivery modes 
Hard copy workbook as reference 
tool 
Receiving explanations develops 
understanding and awareness of 
reasons for dietary change 
Quantifiable dietary 
recommendations (food groups, 
“good vs bad” foods, portion sizes, 
sodium levels) 
“You’ve got to eat these foods, food 
groups and that, but you don’t 
actually know the right quantities 
… this program shows it to you and 
it’s like, it’s teaching someone how 
to walk again” Male, 46  
“The book I think was brilliant, 
because you’ve got that to go back 
through all the time, well any time 
you’re doubtful you’ve got 
thoughts, you just look at the book, 
I did, I still do it” Male, 64 
Social 
accountability  
Supportive relationship with one 
coach allows progressive dietary 
change 
Frequent reminders and reinforcing 
goals 
Interaction with coach via text 
messages 
“If I didn’t have the phone calls 
from [my coach] once a fortnight I 
probably wouldn’t have taken it as 
serious as I have” Male, 65 
“The support, even just texting and 
that, it’s still, you know someone’s 
doing it. It’s, it just makes you feel 
better as a person, to know someone 
cares” Male, 64 
Responding to 
dietary advice 
Small changes at a time 
Practical strategies, manipulating 
environment to support behaviors, 
skill development (label reading) 
Setting goals and finding satisfaction 
in quantifiable outcomes (e.g. 
portion sizes, food group servings) 
“The program is delivered in 
segments, you’re just having a bit 
of information at a time, so it’s not 
overwhelming” Female, 68 
“I was astounded at the salt content 
of it all, so when I read that I 
immediately stopped all salt that I 
put on my plate … I’ve not had salt 









Physical comorbidities a barrier for 
lifestyle component of program 
Lack of support from others with 
poor understanding or low interest 
Unstable or unsupportive 
environment for creating healthy 
habits 
“I have just been moving around a 
lot more and not in a stable 
environment of being in familiar 
surroundings, being unable to 
replicate … the menus … due to my 
transient nature of where I am 
presently” Male, 46 
7.8 Discussion  
This mixed methods process evaluation study within a randomized controlled trial evaluated 
the feasibility and acceptability of the ENTICE-CKD telehealth coaching program to promote 
healthy eating among people with moderate CKD. The ENTICE-CKD program was a feasible 
intervention that was delivered according to protocol and enabled participant adherence. The 
tailored telephone calls and text messages were acceptable to participants in this pilot. In 
contrast, the acceptability varied for those in the non-tailored education-only text message 
(control) group.    
The successful recruitment and retention of participants enrolled in the ENTICE trial 
demonstrated feasibility. Although it is important to consider the trial only had a 35% 
recruitment rate, the feasibility was strengthened by the successful recruitment in the 
anticipated six-month recruitment period and very low attrition rate (5%) at six-months. 
Attrition is a common problem in studies of self-management in CKD, which is reported as 
between 11 to 39%, and which reduces the certainty of findings, particularly given the often 
underpowered sample sizes of trials of lifestyle interventions in CKD.29  
The intensive coaching intervention had a high call completion rate (90%) and high 
intervention adherence. This is similar to the 90% call completion rates reported in other 
telehealth studies in weight management,30 breast cancer,31 younger adults in the general 
population,32 and CKD studies.33 A study involving 436 participants with CKD in the UK, 
who received a combination of interactive web-based resources and telephone follow-up 
demonstrated successful recruitment, retention and intervention satisfaction.33 There was no 
specific dietary education provided to participants in that study, however the community 
support intervention, provided through a workbook, online portal, and telephone follow-up 
demonstrated a 69% recruitment rate, and had 85% retention at the six-month follow up. 
Participants reported over 80% usefulness for the workbook, 62% for the telephone calls and 
23% for the interactive website.33 Considering the limited evidence on lifestyle interventions 
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in CKD specifically, the findings from this trial the feasibility of using telehealth coaching to 
support the dietary self-management of CKD. 
The ENTICE-CKD program made participants feel supported and motivated for dietary 
change. However, this was more strongly indicated by participants who received the tailored 
intervention program, as opposed to the control group who received non-tailored education-
only text messages. These results suggest that a tailored approach to text messaging may be 
important to patients with, as it may facilitate the support and regular interaction for dietary 
changes.7 Participants felt that the frequent contact via calls and text messages reinforced 
rapport and built a supportive relationship between participant and coach, which in turn, 
enabled stronger social accountability and progressive dietary change. 
Overall, there is limited evidence on the acceptability of telehealth dietary interventions in 
CKD.34 A pilot study in 47 CKD participants demonstrated over 80% user adherence and 
satisfaction with a smart-phone self-management support program to support the self-
monitoring of blood pressure, medications, symptom recognition, and biochemistry.35 In 
contrast, another study found that text-message based interventions were the least preferred 
telehealth intervention for medication monitoring by CKD participants, compared with web-
based or personal digital assistant-based applications.36 The Effects of Sodium Modification 
on Outcome (ESMO) study, a three-month self-management intervention in 138 adults with 
CKD which provided one-to-one sessions and telephone support, demonstrated relatively high 
(63%) satisfaction from participants. It has been postulated that a key factor for the high 
acceptability of the ESMO intervention was the patient-engagement utilized in the design of 
the trial.37 This was an approach also taken in the ENTICE-CKD study. We have previously 
found that patients with CKD have been confused by dietary advice and need more frequent 
contact to support dietary change.9 They were willing to participate in telephone calls and 
receive text messages, as these were viewed within their comfort zone and levels of digital 
literacy,9 but also raised concerns about the credibility, safety, and lack of personalization in 
mobile apps and internet modalities. The ENTICE-CKD program was developed from the key 
results in this focus group study, which assured a patient-centered approach.38 
Previous thematic synthesis has shown that people with CKD experience many challenges in 
relation to achieving their dietary and fluid recommendations. People express a preference for 
regular coaching, feedback and monitoring to help them understand dietary information and 
become confident in their ability to self-monitor and manage such changes.7 The ENTICE-
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CKD intervention fostered incremental dietary changes, where each call was dedicated to an 
individual topic, as well as being tailored and flexible for participants’ goals for change. 
These attributes may also explain the difference observed in the acceptability compared to the 
non-tailored education only (control) intervention.   
There are limitations to this study. As we had a 35% recruitment rate, the feasibility and 
acceptability only relate to the participants enrolled in this pilot, thus the feasibility for the 
uptake of the program in clinical practice is uncertain. Furthermore, the baseline health 
literacy was ‘good’ in over 90 percent of our participants, which is likely greater than the 
health literacy of the wider CKD population,39 therefore the generalizability of the results to 
people with lower health literacy is uncertain. We also acknowledge that we captured the 
individual participant adherence to the intervention using qualitative methods rather than 
validated surveys. However, given the primary outcome of feasibility, qualitative methods 
were used to minimize the over-use of self-report surveys and participant burden and this was 
an exploratory measure of intervention adherence only. Using this method, we were able to 
capture to reasons for adherence (and non-adherence). We also did not recruit children into 
the ENTICE-CKD study, so our results are not generalizable to children with CKD. Finally, 
we did not interview participants in the non-tailored education-only (control) group, and thus 
could not ascertain the reasons for lower acceptability compared with the intervention group. 
In conclusion, the ENTICE-CKD dietary coaching program is a feasible and acceptable 
intervention for adults with stage 3- 4 CKD. The program facilitated self-monitoring and 
encouraged the adoption of goal setting throughout the intensive coaching period. Findings 
from this study are promising for the use of telehealth to modify dietary practices in future 
clinical practice and research. However, longer-term studies are needed to determine the 
safety, clinical effectiveness, and sustainability before the wider implementation of the 
ENTICE-CKD program is appropriate. This process evaluation can be used by clinicians to 
inform frequent and structured contact through telephone-based and text message platforms to 
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 – A dietary coaching program to improve dietary quality and 
clinical outcomes in CKD: Results from a pilot randomized controlled 
trial 
8.1 Preface 
Chapter 7 demonstrated the ENTICE-CKD program to be feasible and acceptable to people 
with stage 3-4 CKD. The ENTICE-CKD program was delivered to protocol, had good 
participant adherence, and low attrition. Furthermore, the participants in the intervention had 
high acceptability of the text messages supporting a healthy diet (100%) and motivating them 
to eat healthier (81%). However, the process evaluation reported in Chapter 7 is not able to 
show whether the ENTICE-CKD program leads to significant improvements in measures of 
diet quality or clinical parameters (including body weight, waist circumference and blood 
pressure).  
Chapter 8 reports on the safety and effectiveness outcomes from the ENTICE-CKD study 
across the six-month study duration. The ENTICE-CKD study was a pilot study to primarily 
test its feasibility and therefore many of the effectiveness outcomes are underpowered. 
However, these exploratory results can be used to both inform and power a future randomised 
controlled trial.  
8.1.1 Publication status 
This chapter contains a draft manuscript to be submitted to the peer-reviewed journal the 
American Journal of Kidney Disease. This chapter is formatted to a consistent thesis style. 
However, the grammar, headings, and references (in-text and bibliography) are unaltered in 
accordance with the journal publishing guidelines. 
Citation: Kelly JT, Conley M, Johnson DW, Hoffmann TC, Tong A, Craig J, Reidlinger DP, 
Reeves M, Howard K, Krishnasamy R, Kurtoki J, Craig J, Palmer S, Campbell KL. A dietary 
coaching program to improve dietary quality in CKD: The ENTICE-CKD randomized 





8.2.1 Rationale & Objective 
The dietary self-management of chronic kidney disease (CKD) requires regular follow-up to 
support dietary change. This study evaluated the safety and effectiveness of a 6 month 
telehealth-delivered intervention on improving diet quality in people with stage 3-4 CKD. 
8.2.2 Study design 
Two-arm pilot randomized controlled trial. 
8.2.3 Setting & Participants 
Eighty stage 3-4 CKD (GFR 60-15/min/1.73m2) participants, recruited from 3 nephrology 
units in Australia.  
8.2.4 Intervention 
The intervention group received fortnightly phone calls for 3 months and tailored text 
messages for 6 months to achieve a diet consistent with the Australian Dietary Guidelines. 
The control group received usual care for 3 months followed by a non-tailored education-only 
text message intervention for 3 months.  
8.2.5 Outcomes 
The primary outcome was change in diet quality (measured by the Australian Recommended 
Food Score [ARFS] and food groups). Secondary outcomes were change in weight and blood 
pressure.  
8.2.6 Results 
No significant change in ARFS or blood pressure was observed at any time point. The 
intervention group participants significantly increased the proportion of calories from core 
foods consumed (5.2% [95% confidence interval (CI) 0.6, 9.9]), vegetable intake (1.4 
serves/day [CI 0.3, 2.1]), dietary fiber (5.5g/day [CI 2.7, 8.2]), and reduced body weight (-
1.7kg [CI -3.1, -0.3]) at 3 months compared to control group participants. At 6 months, the 
proportion of calories from core foods remained significant (4.3% [CI 0.3, 8.2]). No 
intervention-related safety concerns occurred throughout the study. 
8.2.7 Conclusions 
Telehealth coaching improved dietary intake of core foods, vegetable and fiber intake, and 
decreased body weight at 3 months in this pilot study. Extended contact sustained core food 
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intakes at 6 months. A larger and longer term randomized trial is required to determine the 
effect of this intervention on quality of life, renal, and cardiovascular outcomes.  
8.2.8 Funding 
Support grant from the Australasian Kidney Trial Network and Bond University.  
8.2.9 Trial Registration 
ACTRN12616001212448.  
8.2.10 Keywords 





Chronic kidney disease (CKD) affects over 10% of the world’s population,1 and represents a 
significant public health challenge.2,3 Dietary modification is a key management strategy in 
CKD. Addressing dietary quality through food based education may be more comprehendible 
than traditional nutrient approaches in CKD, as it focuses less on restriction and is more 
patient-centered.4 Furthermore, improving diet quality through adopting a healthy dietary 
pattern has been associated with a 27-35% improved survival in populations with established 
CKD.5,6 However, evidence to show how people with CKD can be best supported in 
improving diet quality is unknown.  
The current models of dietetic care are focused on face-to-face appointments which are 
known to be limited in non-dialysis CKD populations, resulting in a lack of individualized 
follow-up that is required to achieve complex dietary change.4,7 Renal clinicians find it 
challenging to provide this individualized follow-up in traditional practice settings due to 
geographical, time, and financial barriers, associated with providing dietary care consistent 
with current renal nutrition guidelines.8,9 To determine whether adopting a healthy dietary 
pattern may attenuate the progression of CKD on a sufficient scale for a randomized 
controlled trial (RCT), alternative delivery modes and settings that are safe and effective in 
supporting dietary management are needed. 
An alternative to face to face appointments is telehealth which includes telephone coaching 
and other m-Health approaches. Telephone coaching is a basic form of telehealth which has 
been shown to be effective at promoting adherence to complex dietary recommendations in 
chronic disease.10 In CKD populations, telephone coaching in combination with one-on-one 
support can reduce dietary sodium intake,11 and increase knowledge of self-management 
behaviour.12 M-Health, which extends more broadly to the use of mobile phones for 
healthcare delivery, is perceived as flexible and cost-effective13 and can improve diet quality 
in people with coronary heart disease.14 From recent patient engagement studies, people with 
CKD are open to using these methods for their dietary self-management.4,15 However, no 
study has established whether telephone coaching interventions can improve diet quality in 
people with stage 3-4 CKD. The aim of this pilot study was to establish the safety and 
potential effectiveness of a telehealth-delivered intervention for improving diet quality in 





8.4.1 Study design 
The ENTICE-CKD study was a single-blinded, two-arm pilot randomised-controlled trial. 
Participants were recruited over a 6 month period across three large teaching hospitals in 
Australia. This trial was conducted according to the Consolidated Standards of Reporting 
Trials (CONSORT) framework16 and reported in-line with the Template for Intervention 
Description and Replication (TIDieR) checklist.17 
8.4.2 Participants  
People were eligible to participate if they were aged over 18 years of age, with stage 3-4 CKD 
(eGFR 15-59 ml/min/1.73m2), had access to a mobile phone, and provided written informed 
consent. People were also considered eligible if they had previously received a kidney 
transplant greater than 12 months prior to recruitment, and their nephrologist deemed them 
safe to participate. People were excluded if they were either treated with dialysis, were non-
English speaking, or deemed unsafe to participate by their nephrologist. Potential participants 
were screened for eligibility by a local site investigator or research nurse from daily outpatient 
appointment lists and relevant hospital databases. Following discussion with their treating 
nephrologist, people were approached and invited to participate. If people were unable to be 
contacted at their outpatient appointment, they were mailed a written invitation to participate 
with a phone number to contact if they were interested.  
8.4.3 Randomisation and allocation concealment  
Randomization schedule was created in RedCap18 and allocated on a 1:1 ratio, stratified by 
recruitment site and diabetes status by computer-generated random numbers to conceal 
allocation from recruiters and site investigators. Site investigators involved in recruiting 
participants and outcome assessment were not aware which group participants were 
randomized to and remained blinded for the duration of the study. Ethics was approved by the 
Metro South Health Service District Human Research Ethics Committee (EC00167) and 
Bond University Human Research Ethics Committee (EC00357). The trial was prospectively 
registered (ACTRN12616001212448). 
8.4.4 Study treatment 
The detail of the intervention treatment is outlined in Table 8-1. Primary care physicians and 
treating nephrologists retained full responsibility over their patients’ medical care at all times 
 
197 
during the study. The ENTICE-CKD program was adjunct to the usual care participants 
received. In Australia, usual care typically involves medical care with 3-monthly follow-up of 
patients with stage 4 CKD, and 3-6 monthly follow-up for stage 3 CKD patients. People with 
stage 3-4 CKD do not typically get dietary consultation with a dietitian, unless there is clinical 
indication.19  
Following a face-to-face baseline assessment with the local site investigator, all participants 
received the ENTICE-CKD workbook (summarised in Table 8-1), which was designed by 
renal dietitians, with extensive academic, clinician, and consumer input. Participants 
randomised to the intervention completed the telehealth intervention in two phases (Figure 
8-1). The first phase involved individualized, telephone-based coaching every fortnight for 3 
months (6 calls total). During each coaching call, accredited practising dietitian (registered 
dietitian equivalent) with additional training in behaviour change, motivational interviewing 
and renal nutrition worked collaboratively with patients to develop achievable goals. Each 
participant was coached to reduce dietary sodium intake to < 100mmol/day (or <2300mg) and 
improve diet quality in line with the Australian Dietary Guidelines.20 The dietiian (coach) 
used motivational interviewing techniques, and could tailor the intervention to the 
individual’s set goals, co-morbidities, and current stage of behavior change. The call content 
was guided by Bandura’s Social Cognitive Theory,21 embedding core principles of healthy 
eating patterns into practical strategies for behavior change. Each call was semi-scripted, 
designed in-line with each section of the workbook, and structured based on the 5As 
framework (Assess, Advise, Agree, Assist, Arrange).22 In addition to telephone coaching, 
intervention participants received 2 to 8 fortnightly text-messages to support the telephone 
coaching in phase 1, including goal checks, self-monitoring reminders and dietary education 




Table 8-1: Outline of the intervention description according to the TIDieR checklist.  
Item Name/Number Item Description 
Item 1: Brief name 
ENTICE-CKD 
Item 2: Why 
Diet pattern intervention has not been evaluated in RCT in people with stage 3-4 CKD. 
Telehealth may facilitate the level of education and health professional contact to achieve a complex 
intervention in CKD, but this has not been evaluated in RCTs to date.   
For more detailed description of the background, see introduction (section 8.3) 
Item 3: What 
ENTICE-CKD program workbook (available in Appendix J; sections outlined below) 
About ENTICE Introduction page “The focus of the ENTICE program is to help you make 
gradual changes to your eating and physical activity habits that work for YOU – 
changes that become lifelong.” 
 
Section 1: Setting 
your goals and 
keeping track 
“Use the following steps every time you set a SMART goal…” 
Section 2: Eating well 
for healthy kidneys 
 
“The ENTICE program will help you to gradually make changes to your diet to 
meet the daily recommended serves of fruit, vegetables and wholegrain 
breads/cereals.” 
Section 3: Active 
living 
“Participating in regular physical activity and reducing sitting time is very 
important for your health and well-being.” 
Section 4: Why is 
healthy eating 
important for my 
kidneys? 
Did you know? “Less than 4% of the Australians meet the recommended daily 
intake for vegetables. Research has shown that increasing your intake of 
vegetables by as little as ONE serve per day can help you live longer and 
stronger.” 
Section 5: Plan for 
success 
 
“There are a number of things that affect what we eat and our overall energy 
intake. It is important to be aware of, pay attention to and plan for: How you eat; 
Where/why you eat? 
Section 6: Self-
monitoring and setting 
goals 
Smart snacking  
Reflections 
Tracking my food intake  
Section 7: Additional 
healthy eating 
resources 
Useful websites; Healthy recipes 
Useful apps for mobiles or tablets 
High/low potassium/phosphate foods (if required) 
Healthier verse unhealthy takeaway options  
Item 4: What - procedures 
Intervention:  Each call was designed in-line with each section of the workbook, and structured based on 
the 5As framework (Assess, Advise, Agree, Assist, Arrange).22 




• Welcome to ENTICE-CKD 
• Information about the program 
• Feedback on baseline outcome measures  
• Complete Section 1 – goal setting 
• Discuss section 6 – self monitoring  
• Begin section 2 - introduction the five food groups 
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Item Name/Number Item Description 
Call 2 
• Revisit goals  
• Recap Dietary Guideline food groups – answer any questions 
• Continue section 2 – (plate model, snacks, salt, label reading, potassium and phosphate) 
Call 3 
• Revisit goals  
• Answer any questions on healthy eating 
• Complete section 3 – Active living 
Call 4 
• Revisit goals  
• Revisit any questions about active living/ healthy eating 
• Complete section 4 – Why is healthy eating important for my kidneys  
• Complete section 5 - planning for success - how why and where you eat and managing slips 
Call 5 
• Revisit goals  
• Answer any dietary or Active living questions   
• Discuss section 7 - additional information / resources  
Call 6 
• Revisit goals  
• Revisit any questions participant may have 
• Discuss where to from here 
• Adjust text message frequency if desired 




















Dietary fibre intake reduces ur cholesterol 
levels and controls ur blood sugar. Include 
wholegrain breads & cereals, fruits & veg 
regularly  





Hi [name], are u keeping track of ur 
fruit/vegetable intake every day? Remember ur 
goal to have 5 serves this week  





Hi [name], did u reach ur goal to eat 5 
fruits/vegetables 4 times this week? Text me 
back yes or no to let me know  








Choose high fibre, low potassium breakfast 
cereals. Good choices are Multigrain Weetbix, 
Rolled Oats, Guardian, Oatbritz, Special K  
0-2a 0-2a NA 0-2 a 
Item 5: Provider 
Accredited practicing dietitians (RD equivalent) with additional training in behavior change, motivational 
interviewing and renal nutrition. 
Item 6: How 
Phase 1 (month 0-3) 
 
Intervention: One-one coaching provided through 6 fortnightly phone calls, and 
tailored text messages at a frequency requested by the participant (TIDieR item 4 
– Text message component). 




Item Name/Number Item Description 
Phase 2 (month 3-6) 
 
Intervention: Tailored text messages at a frequency requested by the participant 
(TIDieR item 4 – Text message component).  
Control: Non-tailored education-only text messages at a frequency requested by 
the participant (TIDieR item 4 – Text message component). 
Item 7: Where 
Participants were in locations of their choosing as the intervention was delivered by telephone/mobile.  
Item 8: When and How Much 
Phone calls: Intervention group participants received fortnightly phone calls for 3 months  
Text messages: Intervention participants received fortnightly text messages for 6 months. Control group 
participants received text messages for 3 months (TIDieR item 4 – Text message component). 
Item 9: Tailoring 
Phone calls: Coaches could tailor the dietary guidelines to participants’ individual comorbidities and goals. 
Coaches documented tailoring in call logs.  
Text messages: Tailored text messages were tailored to participants’ names, set goals and barriers to 
achieving each goal (examples can be seen under TIDieR item 4 – Text message component). Non-
tailored education only text messages were education only and contained no tailoring.  
Item 10: Modifications 
Some participants who replied to the goal check text messages in a way the system could not recognize 
(i.e. not a yes/no response) were giving a tailored goal check reply message instead of the automatic 
system generated reply (see Chapter 7 for more details). No other modifications were made to the 
intervention during the course of the study.  
Item 11: How well: planned 
Reported in Chapter 7  
Item 12: How well: actual 
Reported in Chapter 7 
Abbreviations - ENTICE-CKD: The Evaluation of Individualized Telehealth Intensive Coaching to 
Promote Healthy Eating and Lifestyle in Chronic Kidney Disease, SCT: social cognitive theory, RCT: 
randomized controlled trial, NA: not applicable, TIDieR: template for intervention description and 
replication.  a = Educational permutations were only available for coaches to use if a participant 
experienced hyperkalemia or hyperphosphataemia  
Phase 2 of the intervention involved no further telephone coaching calls. Participants 
continued to receive the same tailored text messages as phase 1, except they were able to 
receive from 4 to 12 fortnightly text-messages (Table 8-1). At the end of phase 1 (3 month 
study mid-point), participants completed their final coaching call and discussed their 
preferences for the timing and frequency of the phase 2 text messages. At 18 weeks, 
participants received another tailoring call (no dietary coaching) to make individualized 
adjustments to the text message frequencies for the remaining 6 weeks of the intervention 
(Figure 8-1). 
8.4.5 Control group  
Participants randomized to the control group were wait-listed for 3 months and received 2 
phases of care. In phase 1 (month 0-3), they received the same ENTICE-CKD workbook as 
the intervention group and continued to receive routine usual care, but no other intervention 
(no calls or text messages). After 3 months (end of phase 1) participants commenced phase 2 
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(month 3-6), which was a text-only intervention, with participants only able to choose the 
frequency of text messages per fortnight. The content was educational, based on the 
Australian Dietary Guidelines,20 and CARI guidelines,23 and was based on approaches used in 
cardiac rehabilitation, with proven success on dietary and clinical outcomes.14 
8.4.6 Outcome assessment  
All data was collected at baseline, 3 months and 6 months at each participant’s recruiting 
hospital as shown in Figure 8-1. All participants’ study visits were scheduled on separate days 
or hours apart to avoid the risk of contamination bias. Site investigators were blinded to 
treatment allocation and participants were asked not to disclose which group they had been 
assigned to during their study visits. Self-reported surveys were completed by participants, 
either on site, returned via registered post, or completed via an online email link to minimize 
participant burden and keep the data collection in-line with usual care as much as possible. 
8.4.7 Primary outcome  
Change in diet quality was captured from the Australian Eating Survey.24 This survey is a 
120-item semi-quantitative food frequency questionnaire (FFQ), which estimates daily 
calories consumed from the core-food groups, fiber, and sodium intake per day. The FFQ also 
calculates total serves of fruit and vegetables per day, however, it does not calculate the total 
serves of the other food groups per day (i.e. meat and alternatives, dairy, breads and cereals 
which feature in the Australian Dietary Guidelines20). The Australian Eating Survey produces 
its own overall indicia of diet quality, reported as the Australian Recommended Food Score 
(ARFS), which is a calculation of variety of fruit, vegetables, grains, dairy, meats, chicken 
and fish, condiments, and water consumed each day. Scores are given on a scale of 1-73, with 
score of <33, 33-38, 39-46, and >47 reflecting a diet score which is ‘needing work’, ‘getting 
there’, ‘excellent’, or ‘outstanding’, respectively.25  
8.4.8 Secondary outcomes  
Body weight (rounded to the nearest 0.1kg) and waist circumference (rounded to the nearest 
0.1cm) were collected to a standard protocol.26 Change in clinic blood pressure was measured 
with a calibrated digital blood pressure monitor in accordance with the recommended protocol 
of the American Heart Association.27 Changes in antihypertensive medication requirements 
(total number, dose, class) were collected from participants and verified from patient records 
at each study visit. Quality of life was measured using the ‘Assessment of Quality of Life’ 
questionnaire (AQoL-4D).28 Risk markers of kidney disease progression were collected as the 
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estimated glomerular filtration rate (GFR) from blood serum pathology and albuminuria on 
mid-stream urine samples.  
  Screening and recruitment 
      ↓ 
  Randomization 
       ↙   ↘    
 Week Intervention group Control group 





• Health literacy 
• Dietary intake (FFQ) 
• Body weight and waist circumference  
• Blood pressure  
• Medication requirement 
• Quality of Life 
• Blood Pathology (including electrolytes (Potassium) and 
Creatinine (to assess eGFR)) 






6x fortnightly telephone calls + 
tailored text messages 
+ workbook 
Usual Care  
(workbook only) 
12  Mid-point visit + telephone call   
3-month visit  
Outcomes 
• Dietary intake (FFQ) 
• Body weight and waist circumference  
• Blood pressure 
• Medication requirement 
• Quality of Life 
• Safety 
• Blood Pathology (including electrolytes 
(Potassium) and Creatinine (to assess 
eGFR)) 
• Urinary albumin-creatinine ratio 
• Adverse events 
 
Phase 2  
14 
16 
Tailored text messages 
Educational text messages 18 Telephone call 
20 
22 
Tailored text messages 
24  End-point visit  
6-month visit  
Outcomes 
• Dietary intake (FFQ) 
• Body weight and waist circumference  
• Blood pressure 
• Medication requirement 
• Safety 
• Blood Pathology (including electrolytes 
(Potassium) and Creatinine (to assess 
eGFR)) 
• Urinary albumin-creatinine ratio 
• Adverse events 
 
Figure 8-1: Summary of ENTICE-CKD program delivery 
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8.4.9 Safety monitoring 
Safety monitoring included the monitoring of hypertensive episodes and level of serum 
potassium at each visit. Participants were trained to identify symptoms of hypotensive 
episodes between study visits, defined as systolic blood pressure <100 mmHg or dystolic 
blood pressure <60 mmHg, and instructed to contact their general practitioner or specialist if 
symptoms arose. During fortnightly coaching calls, coaches also monitored symptoms and/or 
large changes in electrolyte intake. If concerns were identified, notification for follow-up was 
made to their general practitioner. 
8.4.10 Sample size 
As a pilot trial which was primarily designed to test the feasibility of the ENTICE-CKD 
program, a power calculation was not necessary. Instead, all effectiveness outcomes were 
considered exploratory and used to power a future study. It is suggested that pilot studies 
should target 30-40 participants in each study group to generate meaningful data for future 
power calculations and reliability of outcome data.29 
8.4.11 Statistical analysis 
All analyses were conducted based on the intention-to-treat principle. Univariate data were 
explored and assessed for normality by visual exploration and confirmed by the Shapiro-Wilk 
test statistic. An analysis of covariance (one-way ANCOVA) was conducted to assess the 
main effects of the categorical independent variable (telephone-coaching versus control; or 
tailored text-messages versus non-tailored education-only text messages) between groups on a 
single continuous dependent variable, after controlling for the effects of the baseline 
covariate. Categorical outcomes were assessed by the standard chi-square test. Within group 
changes of the two study groups were analysed using the paired-sample t-tests for normally 
distributed data, or Wilcox signed ranks tests for non-normally distributed data. A 2-sided p 
value (≤ 0.05) was considered statistically significant. Statistical analysis for effectiveness 
outcomes were performed using SPSS Statistics for Windows (version 22.0. Chicago: SPSS 
Inc.). 
8.5 Results 
The flow of the participants through the ENTICE-CKD study is shown in Figure 8-2. Eighty 
participants were randomized, and 76 participants completed the 6 month study. 
Randomisation was effective at distributing important demographics as shown in Table 8-2. 
Overall, 64% of the sample was male with a mean age of 62 years. There was equal 
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distribution of diabetes (39%), hypertension (81%), and each stage of CKD, stage 3a (31%), 
stage 3b (44%) and stage 4 (25%) between the study groups. Participants had a favourable 
dietary intake at baseline, with an overall ARFS of 39.5 points (rated in the ‘excellent’ 
category), fruit and vegetable intake of 1.8 serves and 4.5 serves, respectively, and mean 
sodium intake of 2.3g per day.  
8.5.1 Change in dietary intake 
Table 8-3 shows the change in dietary intake over the study. The intervention significantly 
improved components of diet quality as reflected by an increase in calories from the core food 
(non-discretionary) groups at 3 months (5.2% [95% confidence interval (CI): 0.6, 9.9]) and 6 
months (4.3% [CI: 0.3, 8.2]) compared to the control group (p=0.029 and p=0.034, 
respectively). However, overall changes in the ARFS were not significant between or within 
groups at 3 or 6 months. At 3 months, the intervention significantly increased vegetable intake 
(1.4 serves/day [CI: 0.6, 2.1]), grams of dietary fiber (5.5 g/day [CI: 2.7, 8.2]) compared to the 
control, however the change was not statistically significant at 6 months. There was no 
significant change for sodium or servings of fruit per day between the intervention and the 
control group.  
Significant within group changes were observed in intervention group participants for the 
servings of fruit per day at 3 months (0.6 serves; p=0.001), and 6 months (0.4 serves; 
p=0.029), but not in control group participants. Both the intervention and control group 
reduced their dietary sodium intake (Table 8-3). The control group also increased the 
proportion of calories from the core food (non-discretionary) groups following the 3 month 
non-tailored intervention (4.4%; p=0.032), but not after 3 months of usual care only.  
8.5.2 Weight and waist circumference 
The intervention group participants significantly decreased weight at 3 months (-1.7 kg [CI: -
3.1, -0.3]) compared to control group participants (p=0.018). There was no significant change 
for waist circumference between the intervention and the control group. 
There was significant within group changes in the intervention for weight (-1.8 kg; p=0.0001) 
and waist circumference (-1.8 cm; p=0.002) at 3 months, which was sustained at 6 months for 
body weight (-1.5kg; p=0.023) and waist circumference (-2.9cm; p=0.001). The control group 




8.5.3 Blood pressure 
There was no significant change between or within the groups in blood pressure in the 
intervention group or control group at either time point. Sixteen percent (n=6) of intervention 
group participants increased their total number of antihypertensive medications compared to 
29% (n=11) in the control at 3 months. One participant (3%) in the intervention group 
decreased their total number of antihypertensive medication use compared to none in the 
control at 3 months. This change in the use of antihypertensive medications was significant 
(φ=0.33; p=0.017) at 3 months but not at 6 months (p=0.1) between the intervention and the 
control (Table 8-4). 
8.5.4 Risk factors for kidney disease progression 
There was no significant change for serum creatinine, urinary albuminuria or eGFR at any 
time-point, in any of the study groups (Table 8-4). 
8.5.5 Quality of life 
Quality of life relating to the mental health domain significantly increased at 3 months (mean 
difference: 0.05; p=0.012) and at 6 months (mean difference: 0.04; p=0.049) in the 
intervention group, but not in the control. There was no significant change between the groups 





Figure 8-2: CONSORT diagram showing the flow of participants through the ENTICE-CKD 
study. 
8.5.6 Safety monitoring and adverse events 
There were no incidences of hypotensive episodes or hyperkalaemia documented throughout 
the 6 month study. In the first 3 months of the study, one intervention participant suffered a 
heart attack which was unrelated to the intervention. The participant was able to continue the 
intervention with no impediment, however they commenced cardiac rehab adjunct to the 











Age, years 62.5 ± 12.3 60.5 ± 13.0 



















Diabetes, %  39.0 39.0 
CVD, % 34.0 31.0 
Hypertension, % 83.0 80.0 
Anti-hypertensive medications, n 74.0 73.0 
ACE 11.0 14.0 
α1-blocker 9.0 1.0 
Β-blocker 13.0 17.0 
CCB 15.0 11.0 
Diuretic 18.0 15.0 
ARB 22.0 18.0 
Other 3.0 6.0 
Anti-hypertensive pill count, n 92.0 87.0 
Serum creatinine, µmol/L 173.4 ± 53.5 164.8 ± 61.4 
eGFR 35.9 ± 11.7 39.0 ± 12.1 
Systolic blood pressure, mmHg 136.4 ± 18.4 130.7 ± 18.7 
Diastolic blood pressure, mmHg 80.2 ± 11.9 77.5 ± 11.0 
Weight, kg 96.4 ± 22.4 90.2 ± 19.0 
BMI, kg/m2 33.4 ± 6.9 31.0 ± 6.4 
Waist circumference 112.8 ± 17.5 106.9 ± 18.0 
Urine albuminuria, mmol/L 120 (8.0, 442.0) 38.5 (13.0, 143.5) 
ARFS 39.2 ± 18.9 39.9 ± 16.9 
Proportion of energy from core food 
groups, % 63.0 ± 17.5 65.4 ± 13.9 
Fruit, serves/day 1.5 ± 0.8 2.0 ± 1.6 
Vegetables, serves/day 4.0 ± 2.1 5.2 ± 2.3 
Sodium, mg 2354.8 ± 1405.3 2285.2 ± 887.3 
Fibre, g 24.1 ± 9.1 26.7 ± 9.5 
Data are reported as mean ± SD or Median (IQR). Abbreviations: CVD: cardiovascular disease, 
ACE: angiotensin converting enzyme, CCB: calcium channel blocker, ARB: angiotensin receptor 





Table 8-3: Changes in indices of dietary quality at 3 months and 6 months, adjusted for baseline values.   
Dietary component 













Australian Recommended Food 
Score 1.2 (-8.0, 5.6) -0.4 (-6.4, 7.2) 1.1 (-6.3, 8.5) -0.9 (-3.9, 5.8) -2.1 (-4.4, 8.5) 0.7 (-5.6, 7.1) 
Proportion of energy from core food  
(non-discretionary) groups, % 9.5 (13, 5.6)** 3.2 (1.0, 7.4) 5.2 (0.6, 9.9)* 
9.7 (6.4, 
13.0)** 4.4 (0.4, 8.4)* 4.3 (0.3, 8.2)* 
Fruit, serves/day 0.6 (0.3¸0.9)** 0.1 (-0.6, 0.3) 0.3 (-0.2, 0.8) 0.4 (-0.7, 0.0)* 0.1 (-0.6, 0.4) 0.1 (-0.4, 0.6) 
Vegetables, serves/day 1.3 (0.7, 1.8)** -0.3 (-0.2, 0.8) 1.4 (0.6, 2.1)** 0.6 (-1.2, 0.0)* 0.0 (-0.7, 0.7) 0.2 (-0.6, 1.1) 


















Table 8-4: Changes in clinical assessment data at 3 and 6 months, adjusted for baseline values.   
Dietary component 













Weight, kg -1.8 (-2.6, -0.9)** -0.1 (-1.0, 1.2) -1.7 (-3.1, -0.3)* -1.5 (-2.8,  0.2)* 0.1 (-1.2, 1.3) -1.5 (-3.3, 0.4)  
Waist circumference, cm  -1.8 (-3.0, -0.7)* 0.8 (-0.9, 2.5) -0.6 (-2.5, 1.4) -2.9 (-4.6, -1.2)** 0.8 (-1.4, 3.1) -1.0 (-3.4, 1.4) 
SBP, mmHg -1.8 (-7.7, 4.1) 2.2 (-3.1, 7.5) -0.9 (-7.3, 5.6) -0.6 (-7.1, 5.9) 1.7 (-4.3, 7.8) -0.8 (-6.9, 8.5) 
DBP, mmHg -2.7 (-5.9, 0.5) 0.4 (-2.7, 3.5) -1.4 (-5.6, 2.8) -1.0 (-4.2, 2.3) -0.1 (-3.1, 2.9) -0.9 (-3.3, 5.0) 
Serum creatinine, µmol/L -4.7 (-13.3, 3.9) 1.4 (-8.7, 11.6) -6.6 (-19.7, 6.5) -3.6 (-12.3, 5.1) 2.0 (-14.7, 18.7) -6.6 (-25.0, 11.8)  
eGFR, mL/min 0.8 (-1.4, 3.0) 1.5 (-0.8, 3.8) 1.1 (-2.1, 4.2)  1.3 (-0.8, 3.4) 2.6 (-0.1, 5.3) 1.4 (-2.0, 4.8)  
Urine albuminuria, mmol/La 86 (8, 304) 29 (8.5, 217.5) - 89 (11, 412)  46 (10, 187) - 
Abbreviations –eGFR: estimated glomerular filtration rate, SBP: systolic blood pressure, DBP: Diastolic blood pressure, kg: kilograms, cm: centimeters 
mmHg: millimetres of mercury  





Table 8-5: Changes in quality of life at 3 months and 6 months. 
Dietary 
component 











living 0.02 (-0.01, 0.06) -0.02 (-0.05, 0.02) 0.04 (-0.01, 0.08) 0.01 (-0.01, 0.03) -0.02 (-0.05, 0.02) 0.02 (-0.02, 0.06) 
Relationships 0.03 (-0.03, 0.09) 0.02 (-0.03, 0.06) 0.02 (-0.05, 0.08) 0.02 (-0.04, 0.08) 0.02 (-0.03, 0.06) 0.01 (-0.05, 0.07) 
Senses 0.01 (-0.01, 0.04) 0.00 (-0.02, 0.02) 0.02 (-0.01, 0.05) 0.01 (-0.02, 0.04) 0.02 (-0.00, 0.04) 0.00 (-0.03, 0.03) 




8.6 Discussion  
The ENTICE-CKD program was a pilot RCT which aimed to establish the safety and 
effectiveness of a telehealth-delivered intervention for improving diet quality in people with 
stage 3-4 CKD. The primary finding is that the intervention was safe and intervention group 
participants had statistically significant improvements in important components of diet 
quality, reflected in the increase proportion of calories from core food groups, servings of 
vegetables, and dietary fiber. However, the overall diet quality metric as measured by the 
ARFS did not significantly change at any time point in this pilot study. Body weight 
significantly reduced in the intervention group compared to the control group, whereas blood 
pressure did not significantly change at any time point. Following 3 months of extended 
contact (month 3-6) the non-tailored education-only text messages (control) group 
significantly increased their proportion of calories from core foods consumed, however the 
tailored text messages (intervention) group change was significantly greater between the 
groups.  
Improving diet quality through consuming a higher proportion of foods from the core food 
groups such as fruit, vegetables, fibre, legumes, and cereals, in CKD is associated with a 
lower risk of all-cause mortality.30 While it is important to note that there was no significant 
change in ARFS as the overall diet quality metric, participants in the intervention group did 
improve important components of dietary quality. Participants in the intervention group 
consumed a higher proportion of calories from foods which came from the core food groups, 
and higher intake of vegetables compared to the control group participants. Previous studies 
have shown that consuming more fruit and vegetables is an independent predictor of lower 
risk of death over a four-year follow-up in Australian adults with stages 3-4 CKD (HR 0.35, 
95% CI 0.15 to 0.83). People with stage 4 CKD randomised to a higher fruit and vegetable 
intervention have also been shown to lower metabolic acidosis, reduce blood pressure and 
reduce body weight, compared to a standard sodium bicarbonate prescription alone.31  
Consuming higher intakes of fruit and vegetables also increases the intake of dietary fiber. In 
the ENTICE-CKD program arm, participants significantly increased their consumption of 
dietary fiber by over 5 grams per day. This increase in fiber takes participants mean fiber 
intake to over 30 grams per day, which is the recommended intake in the current dietary 
guidelines.32 Meta-analysis of 14 CKD controlled-feeding trials showed dietary fiber to 
significantly reduces serum urea and creatinine levels.33 Observational studies in CKD 
populations suggest that higher intake of dietary fiber can reduce inflammation and the risk of 
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mortality.34 Increasing dietary fiber intake may also attenuate imbalance in the gut 
microbiome, which is known to have a role in modification of protein-bound uremic toxins 
and a potential modifier of cardiovascular risk in CKD.35  
Weight loss approaches are effective at improving clinical parameters in CKD. Excessive 
weight gain carries higher burden of cardiovascular risk and CKD progression.36 Compared to 
baseline, participants in the intervention group significantly reduced body weight by 1.7kg at 
3 months, which was sustained at 6 months. This is a similar finding to a recent randomized 
controlled trial, in which 92 CKD patients completed a reduced calorie and activity lifestyle 
intervention over four months. Participants in the intervention group lost 1.8kg body weight 
and 1.6% more in body fat compared to an exercise intervention alone.37 Similarly in another 
CKD lifestyle intervention, 72 patients with stage 3-4 CKD demonstrated a combined 
exercise and diet program to significantly reduced body weight by 1.8kg and improve 
cardiovascular fitness.38 The results of these two studies are of similar magnitude with 
ENTICE-CKD and may demonstrate the effectiveness of dietary coaching through telehealth 
to reduce body weight. However, it is important to note the between group differences were 
not maintained at 6 months in our study. This may be due to the study being underpowered, 
the control group commencing a non-tailored education-only text message intervention, or the 
lack of one-one coaching in the tailored text messages from months 3-6. This needs to be 
explored in future trials before reliable conclusions can be made. 
Blood pressure is an important controllable risk factor for CKD progression but was 
unchanged in the ENTICE-CKD participants. Fundamentally, this study was not powered to 
detect blood pressure changes. While intervention group participants did reduce their overall 
antihypertensive medication pill burden at the 3 months compared to baseline, this was an 
exploratory outcome only and therefore there is no conclusive evidence to support the effect 
of the ENTICE-CKD program on blood pressure control in people with CKD.  
Extended contact was effective at sustaining between-group 6 month changes for the increase 
in proportion of calories consumed from the core food groups (compared to baseline). Using 
extended contact to support sustainable behaviour change is central for effective dietary and 
lifestyle interventions and may delay intervention decay. However, no other changes in 
dietary intake or clinical parameters were sustained compared to the control group. Although 
there were no changes in clinical outcomes in the control group whilst receiving non-tailored, 
education-only text messages (from 3 to 6 months), they did improve the proportion of 
calories consumed from the core food groups they consumed. The fact that there was no 
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between group differences at 6 months may be due to the study being underpowered, an 
active intervention commencing in the control, or the lack of effectiveness of tailored text 
messages to sustain dietary and clinical changes post intensive coaching, or both. Therefore, 
extended contact to improve CKD outcomes and delay intervention decay compared to both 
usual care and non-tailored education-only text messages requires further research in 
adequately powered trials. 
This study has important limitations to consider. First, the ENTICE-CKD study was primarily 
designed to test the feasibility of the ENTICE-CKD program (as reported in Chapter 7). As 
such, many of the clinical outcomes were secondary or exploratory outcomes to generate 
hypotheses for future studies. Therefore, there is the chance of a type I error given the 
ENTICE-CKD intervention may be underpowered to detect changes the diet quality 
outcomes. Second, the ARFS as a measure of diet quality has never been validated in CKD. 
Furthermore, this is the only diet quality metric which does not associate to any renal 
outcomes in the literature, in comparison to the Alternate Healthy Eating Index, the Healthy 
Eating Index, the Mediterranean Diet Score, and the DASH pattern.39 Therefore, there is a 
possibility of a type II error, and that the ARFS is not a suitable tool to assess dietary quality 
in people with CKD, and a more reliable tool should be considered in adequately powered 
future trails. Third, reliable comparisons to usual care can only be drawn at 3 months, as our 
wait-listed control participants started an active intervention from 3 to 6 months. It is 
therefore unclear whether a longer term, lower intensity intervention, such as the non-tailored 
education-only text messages may lead to similar results as observed in the tailored 
intervention over 6 months. Fourth, we measured clinic blood pressure, as a pragmatic 
measure to align with usual care practice. However, 24-hour ambulatory blood pressure is the 
gold standard for blood pressure measurement as it enhances precision, elimination of 
observer bias, and prevents the problematic 'white coat' hypertension. Finally, as is common 
for most dietary intervention trials, the majority of recruited participants were following a 
healthy diet already, which might signify a healthy volunteer bias. 
In conclusion, 3 months of telephone coaching improved important components of diet 
quality for people with CKD, and reduced body weight compared to usual care. Extended 
contact through tailored text messages sustained some (but not all) aspects of improvements 
in diet quality compared to the control. Non-tailored education-only text messages did 
improve some components of diet quality from baseline following a 3 month intervention in 
the control group, but no clinical parameters were significantly changed at any time point. 
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Future trials which are adequately powered are needed to examine the long-term effect of a 
telehealth-delivered dietary intervention patient-centred quality of life, and renal and 
cardiovascular outcomes.  
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 - Overall Discussion and Future Directions 
The aim of this thesis was to develop and test the feasibility and acceptability of a patient-
centred telehealth program for the dietary management of CKD. The preceding chapters detail 
individual studies which each make important and unique contributions to the evidence-base 
for renal nutrition and wider dietetic practice. Each of these chapters outline the successful 
conceptualisation, formative research, pre-testing, pilot and evaluation of the ENTICE-CKD 
program (see Table 9-1) (Whittaker et al., 2012). The framework followed in this thesis 
enabled the illustration of the key gaps in the literature for future research and the successful 
pilot of a randomised controlled trial. Collectively, the results of this thesis add important and 
novel contributions to the renal nutrition body of evidence and can inform future studies to 
develop and assess a telehealth-delivered dietary program in chronic disease populations. 
Table 9-1: Summary of the key findings illustrated using the framework for developing 
telehealth programs  
Development 
phase  















• Chapter 2: Literature 
review  
• Chapter 3: Scoped 
narrative review  
• Chapter 4: 







• Chapter 5: 
Systematic review of 
telehealth 
interventions  
• Key Finding: A healthy dietary pattern may be 
associated with lower risk of all-cause mortality 
in established CKD populations 
• Gap remaining: Not enough studies to 
determine associations to ESKD 
• Gap remaining: No standardised dietary pattern 
used in the literature - characteristics similar to 
recommendations in dietary guidelines 
• Gap remaining: No evidence to show how these 
interventions can be effectively delivered 
 
• Key Finding: Telehealth-delivered dietary 
interventions are effective at improving diet 
quality and fruit/vegetable intake in chronic 
disease 
• Key Finding: Telehealth-delivered dietary 
interventions are effective at reducing dietary 
sodium intake, blood pressure and lipid profiles 
• Key Finding: Telephone coaching is the 
common telehealth-delivered dietary 
intervention in the literature, followed by mobile 
phone interventions  
• Gap remaining: No telehealth-delivered dietary 




















• Chapter 6: Focus 
groups 
 
• Appendix C: Cross-
sectional survey (not a 
primary publication of 
this thesis) 
• Key Finding: People with CKD experience 
many barriers to implementing their diet 
recommendations; themes were patient-centred 
(fostering ownership and threats and ambiguities 
of risk) and healthcare specific (exasperating 
stagnancy and motivators and positive learning 
instruction)  
• Key Finding: People with CKD are open to 
using simple telehealth methods, such as the 
telephone and mobile phone, as long as patient-
clinician relationships are maintained 
• Gap remaining: Generalisability of findings to 










• ‘Beta-testing’ the 
developed telehealth 
program 
• Appendix D: Quality 
testing  
• Obtained feedback on intervention materials 
from people with CKD and expert clinicians 
(face validity) 
























• Chapter 7: Feasibility 





• Chapter 8: 
Effectiveness of a 
telehealth-delivered 
dietary intervention 
• Key Finding: The ENTICE-CKD program was 
feasible and acceptable to participants with stage 
3-4 CKD 
• Gap remaining: The wider uptake of the 
intervention into clinical practice is unknown  
 
• Key Finding: The ENTICE-CKD program 
improved important aspects of diet quality 
(proportion of calories from core food groups, 
vegetable serves and fibre) 
• Key Finding: The ENTICE-CKD program 
reduced body weight and waist circumference 
• Gap remaining: Lacking adequate powered 




























• Appendix B: Follow-





• Key finding: The ENTICE-CKD program was 
acceptable in the stage 3-4 CKD population 
• Key finding: Positive experiences and overall 
acceptance of the fortnightly phone calls, 
tailored text messages and hardcopy workbook. 
• Key finding: Participants valued the 
relationship built with their coach over 12-weeks 
of contact because it increased their trust and 
confidence to discuss diet-disease mechanisms, 
goals, motivators, challenges and fears 
• Gap in the literature: Selection bias. Those that 
did not participate in the ENTICE-CKD 
program may not have because of an aversion to 
using telehealth. Understanding how to 
ENTICE-CKD program would work in clinical 
practice is therefore unknown 
9.1 Conceptualisation  
9.1.1 Dietary approaches 
Chapter 3 was a narrative review which described the common challenges in implementing 
the renal nutrition evidence-based practice guidelines from both healthcare services and 
patients. The primary finding was that there was a paucity of evidence for the effectiveness of 
traditional renal nutrition approaches. Adopting a healthy plant-based dietary pattern may 
associate with reduced risks of important clinical outcomes in CKD and be easier for 
clinicians and patients to implement in clinical practice.  
Chapter 3 hypothesised that it might be the collective effects of macro- and micro-nutrients 
consumed within the overall pattern of eating has one of the key mechanisms by which a 
healthy dietary pattern may improve clinical outcomes in CKD. For example, adopting a 
plant-based dietary pattern may reduce uremic toxins accumulation and promotes higher 
saccharolytic fermentation in the gut which produces short chain fatty acids which can 
improve lipid profiles and insulin sensitivity (Rossi, Johnson, & Campbell, 2015). Protein 
from soy reduce serum creatinine and C-reactive protein (Jing & Wei-Jie, 2016; Xu et al., 
2015; Zhang, Liu, Su, & Tian, 2014), higher intake of fruit and vegetables reduce BP, 
metabolic acidosis and weight gain (Goraya, Simoni, Jo, & Wesson, 2013), low sodium diets 
reduce BP (McMahon et al., 2015), higher red and processed meat intake is associated with 
worse renal function (Lew et al., 2016) and higher fibre intake is associated with lower 
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inflammation and all-cause mortality (Krishnamurthy et al., 2012). However, before a plant-
based dietary pattern can feature in future evidence-based practice guidelines, large scale 
trials are needed to test their long-term effectiveness and safety.  
Chapter 4 was a systematic review of observational cohort studies which aimed to evaluate 
the association between dietary patterns and all-cause mortality or ESKD among adults with 
CKD, giving further evidence to the theories discussed in Chapter 3. The primary finding was 
that from all the scientific literature available from large cohort studies, a healthy plant-based 
dietary pattern was consistently associated with a 35% reduced risk of mortality in CKD. 
While there was no standardised dietary pattern per se, there were consistent characteristics of 
dietary patterns promoting higher intake of healthy nutrients and/or food groups, that when 
consumed as part of an overall pattern, appeared to reduce the risk of all-cause mortality.  
Chapter 4 concluded that clinicians could consider using a healthy dietary pattern as their 
intervention of choice with low risk CKD patients. However, the question remained about 
how people with CKD can best be supported in achieving a healthy dietary pattern. This 
healthy dietary pattern could be considered keeping with the dietary advice given in healthy 
eating guidelines to the general population (Chan, Kelly, & Tapsell, 2017; National Health 
and Medical Research Council, 2013), and may give rationale to public health strategies for 
both primary and secondary CKD prevention. Unfortunately, no cohort studies were identified 
within the search date of this review which limited the generalisation of the findings to the 
Australian context.  
However, the candidate as a member of a larger research team recently completed a cohort 
study in stage 3-4 CKD participants in Australia (Appendix F) (Wai, Kelly, Johnson, & 
Campbell, 2016b). In this small (n=145) Australian cohort, a similar dietary pattern, 
predominantly higher in fruit and vegetables was associated with a 35% reduced risk of a 
composite outcome, mortality, ESKD and/or doubling of serum creatinine. This finding is in-
line with the primary meta-analysis of international participant datasets, supporting the 
robustness of the finding and its generalisability to the Australian CKD population.  
9.1.2 Delivery methods for complex dietary interventions 
Chapter 5 was a systematic review which aimed to determine if alternate delivery methods (of 
dietary education), specifically telehealth methods, were effective at facilitating dietary 
change toward a ‘healthy dietary pattern’ in chronic disease. The primary finding was that 
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telehealth methods are effective at improving diet quality and adherence scores, fruit and 
vegetable intake, and reducing dietary sodium intake. Furthermore, telehealth-delivered 
dietary interventions also led to reduced BP, lipid profiles and waist circumference outcomes.  
The mechanism by which telehealth appears to improve outcomes may be through regular and 
repeated contact with participants. In a sub-group analysis, fruit and vegetable servings per 
day was greater in interventions providing weekly contact (1.32 serves/day [CI: 0.38, 2.26]), 
compared to interventions of monthly contacts or less (0.27 serves/day [CI: 0.02, 0.52]) 
(Kelly, Reidlinger, Hoffmann, & Campbell, 2016). Telephone and mobile phone interventions 
lend themselves to deliver regular contacts for dietary education. As over 68% of the 
interventions in Chapter 5 utilised either telephones or mobile phones, these are likely the 
telehealth modalities that people with chronic diseases feel most comfortable with due to 
having greater confidence in their use and because they are inexpensive, simple to use and 
facilitate regular and repeated contacts (Salisbury et al., 2015). The findings from Chapter 5 
can be used to inform future policy and telehealth intervention development in chronic disease 
models of care.  
This systematic review identified no dietary telehealth trials conducted in CKD populations. 
Before a telehealth trial could be designed for this population, adequate patient engagement 
was needed to complement the evidence synthesis of Chapters 4 and 5, to specifically ensure: 
a) telehealth is an acceptable addition to usual care in CKD; and b) it would assist people with 
CKD overcome their everyday dietary challenges and fit within a patient-centred model.  
9.2 Formative Research to inform intervention development 
Chapter 6 was a focus group study which aimed to explore the perspectives of people with 
stage 3-4 CKD about their dietary challenges and the potential to use telehealth. The primary 
finding of this study was that people with CKD experience a myriad of difficulties which 
challenge their adherence to dietary recommendations and telehealth was considered an 
acceptable option to assist with dietary self-management. Specifically, participants felt dietary 
advice was stagnant and they were confused with an ambiguous food supply that they found 
challenging to navigate. Furthermore, people wanted a preventative and supportive approach 
to diet in CKD and that the success of any telehealth intervention relied on it being as a 
complement to their usual care and patient-centred. The findings of Chapter 6 are in support 
of previous studies. A systematic review of qualitative studies highlights the complexity that 
people with CKD view dietary recommendations (Palmer et al., 2014). Participants in this 
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study reported better self-management when taking responsibility for their treatment, however 
wanted regular contacts with health professionals to feel supported and empowered to make 
further dietary changes (Palmer et al., 2014). Despite this, people with CKD do not commonly 
receive co-ordinated and multidisciplinary care (Bear & Stockie, 2014; Lo et al., 2016). 
Participants in the focus group study reported in Chapter 6 felt that renal services were 
inflexible and out-dated, which ultimately led to a patronising patient experience, not aligned 
to patient-centred care.  
Although participants in the focus group study wanted a preventative and co-ordinated 
approach to their disease progression, it is acknowledged that this may not be feasible in the 
current healthcare system. Specifically, tertiary hospitals in Queensland have insufficient 
resources to effectively assess and review pre-dialysis patients (Campbell & Murray, 2013) 
and international studies have shown that dietitians commonly do not have the time to carry 
out standard nutrition care for people with CKD (Hand, Steiber, & Burrowes, 2013). 
The results from Chapter 6 show that telehealth was viewed as an acceptable low-cost option 
to compliment participants’ current care, particularly in supporting positive dietary changes. 
While telehealth itself was not a ‘theme’ which emerged in the inductive analysis, each of the 
five themes had important sub-themes related to telehealth, which participants viewed to 
facilitate (or hinder) achieving their dietary recommendations. For example, ‘seeking kidney 
diet information’, ‘making reminders’ and ‘tracking progress against targets’ were all 
subthemes within the overarching theme of ‘Fostering Ownership’. Simple-to-use telehealth 
modalities can facilitate these patient values for enacting dietary change. Furthermore, under 
the central theme ‘Supporting and Sustaining Change’, three of the five subthemes ('receiving 
regular feedback’, ‘incremental and comprehendible modification’, and ‘flexibility in 
monitoring schedule’) were identified to be possibly achieved by using telehealth methods 
(Tuot & Boulware, 2017). 
Chapter 6 concluded that people with CKD desire a preventative approach to CKD 
progression however, are stymied by restriction-focused dietary advice and a lack of dietetic 
service provision in the earlier stages of their disease. Telehealth methods such as the 
telephone and text messaging were viewed as acceptable over other telehealth options and 
could assist with dietary self-management. These views and experiences were used to inform 
the development of a new telehealth program, specifically for the dietary self-management of 




9.3.1 Feasibility and acceptability of the intervention  
Chapter 7 reports on the process evaluation of the pilot telehealth program, ENTICE-CKD. 
The aim of Chapter 7 was to assess the feasibility and acceptability of telehealth-delivered 
dietary coaching to support the improvement of dietary quality in stage 3-4 CKD over a six-
month period. The primary finding was that the ENTICE-CKD program was a feasible 
intervention which was delivered according to protocol and enabled participant adherence. 
The ENTICE-CKD study successfully recruited 80 participants, of which 95% remained in 
the study over its 6 month duration. The tailored telephone calls and text messages were 
acceptable to participants in this pilot, particularly for encouraging and motivating healthy 
dietary changes. In contrast, the acceptability varied for those in the non-tailored education-
only text message (control) group, who received a 3 month text message intervention only, 
with no tailoring to participant’s goals or prompts to encourage self-monitoring of those 
goals.  
The feasibility and acceptability of the ENTICE-CKD program demonstrated that dietary 
coaching through phone-based and text message platforms may provide an alternate strategy 
for providing the frequent and structured contact that is needed to support the complex dietary 
changes in CKD. However, it is important to note that the results of the ENTICE-CKD 
process evaluation specifically relate to the 35% of people who agreed to participate in the 
study and the wider feasibility and acceptability in people who are less motivated to 
participate is unknown. It is a recognised limitation in conducting dietary trials in populations 
where non-adherence is well-characterised, that people who participate in dietary intervention 
studies are commonly motivated to make dietary change (Crichton et al., 2012; MacNeill, 
Foley, Quirk, & McCambridge, 2016). In CKD populations specifically, adherence to 
common dietary approaches is as low as 20% for low sodium diets (McMahon, Campbell, 
Mudge, & Bauer, 2012) and as low as 15% for low protein diets (Woodrow, 2018). This 
illustrates the importance for future research to determine the feasibility of the ENTICE-CKD 
program in wider clinical practice and look to potential ways to engage with people who are 
less motivated to change their diet and lifestyle.  
Extensive process evaluation is important for replication and future intervention development. 
Unfortunately, the long-term maintenance and effectiveness of the ENTICE-CKD program is 
unclear from the process evaluation reported in Chapter 7. Maintenance of behaviour change 
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would require longer-term follow up with participants than was feasible within this PhD 
candidature. Some evidence of maintenance can be observed in the sustained levels of self-
monitoring evident from the second call through to the final coaching call in the ENTICE-
CKD study. However, future research is needed to evaluate more systematic data regarding 
the programs maintenance to enable reliable conclusions. To ensure the long-term 
maintenance at the individual and organisational level, there is opportunity to extend the 
intervention to incorporate the use of social networks and a multi-disciplinary team to build 
self-efficacy in other aspects of participants’ lifestyle. This was also an important 
consideration raised in participant interviews (post-intervention), as a key component to 
future self-efficacy which was not addressed by the ENTICE-CKD program.  
9.3.2 Effectiveness of the intervention 
Chapter 8 aimed to determine the safety and potential effectiveness of the ENTICE-CKD 
telehealth-delivered intervention for improving diet quality and clinical parameters in stage 3-
4 CKD. The primary finding was that participants in the intensive coaching arm of the study 
significantly improved important components of dietary quality specific to CKD including an 
increase in the proportion of calories from core (non-discretionary) foods, total vegetable 
serves per day and total fibre intake.  
Secondary outcomes, including body weight and waist circumference were significantly 
improved in the intensive coaching arm compared to the control, whereas BP did not 
significantly decrease at any time point. Some, but not all dietary changes were sustained 
following 3 months of extended contact through text message reminders. The control group 
showed modest changes in aspects of dietary quality at 6 months, once they started to receive 
non-tailored education-only text messages. However, there were no observed changes in any 
clinical parameters in the control group throughout the 6 month study duration. 
No adverse events related to the intervention or safety concerns were reported throughout the 
trial. The Australia Dietary Guidelines may therefore represent a ‘healthy’ dietary pattern 
which can safely emphasise fresh fruit, vegetables and wholegrain consumption and improve 
overall diet quality in CKD. Caution has long been advised against encouraging higher 
intakes of fruit, vegetables and wholegrains in CKD, as such recommendations are inherently 
higher in potassium and phosphate and therefore may place people at risk of hyperkalaemia or 
hyperphosphatemia. The results of the ENTICE-CKD study are in support of previous 
commentary which has urged clinicians to consider liberalising the renal diet to improve diet 
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quality (Biruete, Jeong, Barnes, & Wilund, 2017), now showing this to be a clinically safe 
intervention.  
The overall diet quality measure used in the trial was the Australian Recommended Food 
Score (ARFS), which is validated against the Recommended Food Score (Collins et al., 2015) 
and did not significantly change in either group. The choice was made to utilise an Australian 
FFQ which was validated in the Australian adult population (non-CKD) because this method 
fitted the pragmatic design of the study and as it generated instant reports which the dietitian 
coaches could utilise in their coaching. However, the ARFS as a diet quality indicator is 
neither validated to measure to assess diet quality in CKD, nor does it associate with 
meaningful renal outcomes (Smyth et al., 2016). This does not explain why the ENTICE-
CKD trial did not observe a change in ARFS, despite other changes in dietary intake. 
However, it does question the relevance of this tool for future CKD studies. A future study 
should consider using an FFQ system which easily enables the calculation of diet quality 
indices such as the Alternative Health Eating Index, the DASH diet score or Mediterranean 
Diet Score. Specifically, the Australian FFQ utilised in this pilot did not calculate food group 
servings of meat/alternatives, dairy or breads/cereals, as whole serves per day. It may be 
possible for future research to calculate a diet quality index for the ENTICE-CKD study based 
on published scoring systems for the Alternate Healthy Eating Index (Sotos-Prieto et al., 
2017), the Mediterranean Diet Score (Trichopoulou, Costacou, Bamia, & Trichopoulos, 
2003), and the DASH diet score (Fung et al., 2008), however it was beyond the scope of this 
PhD candidature.  
9.4 Qualitative follow-up 
The qualitative follow-up of participants that participated in the ENTICE-CKD program is 
important for informing future effectiveness trials, and its wider implementation into clinical 
practice. People who undertook the first phase of the telehealth intervention were interviewed, 
and results analysed using content analysis (for acceptability and feasibility [Chapter 7]) and 
thematic analysis (of experiences with the telehealth coaching program [Appendix B]). These 
interviews highlighted the acceptability and feasibility of the intervention, whereby 
participants preferred the frequent contact of the telephone calls and text messages to 
reinforce dietary changes. Participants also expressed that the regular contacts fostered a 
supportive relationship between participant and coach, which was viewed to allow for greater 
social accountability and progressive dietary change.  
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Overall, the results of the qualitative follow-up showed support for the acceptability of the 
ENTICE-CKD program, however this only relates to the people who participated in this pilot. 
Further qualitative research is needed to understand the significant proportion of people with 
CKD who did not wish to participate in the ENTICE-CKD program. This could be used to 
adapt recruitment and retention strategies and assist the wider translation into clinical practice.  
9.5 Is a telehealth-delivered coaching program translatable into practice?  
Successful dissemination and implementation of telephone coaching programs have been 
achieved in the general (non-CKD) setting in Australia. Dissemination of the ‘Optimal Health 
Program’ in the South-East region of Queensland provides evidence that this type of service 
can be successfully implemented in the chronic disease community of Queensland. The 
Optimal Health Program was evaluated predominantly using the RE-AIM framework 
(Glasgow, Vogt, & Boles, 1999) and observed significant reductions in weight and waist 
circumference over the 12-month evaluation period (Goode, Reeves, Owen, & Eakin, 2013). 
Similarly the implementation of the ‘Get Healthy’ free telephone coaching program in New 
South Wales (and now available in Queensland) (NSW Government, 2018; Queensland 
Government, 2018) showed a 35% uptake in New South Wales and highlights key barriers to 
implementation relating mostly to not offering adequate flexibility in the program (Khanal et 
al., 2016). This program was evaluated using the process of implementation and impact 
evaluation framework outlined by Bauman & Nutbeam (Bauman & Nutbeam, 2013). 
Understanding what elements of implementation interventions are effective is central to 
successfully translating the ENTICE-CKD program into practice. Essential features of a 
successful implementation intervention have been identified in a review of primary care CKD 
interventions (Tsang, Blakeman, Hegarty, Humphreys, & Harvey, 2016). Primary care 
interventions should address CKD in the context of cardiovascular health or diabetes, as this 
facilitates a more holistic understanding of CKD and is thought to better engage people to 
participate in an intervention. Implementation interventions should also build on existing 
programs or practices which enable them to be more efficiently integrated into primary care. 
This work emphasises the importance of an implementation program being patient-centred. 
Specifically, this includes giving participants ownership in interventions, individualising and 
tailoring interventions to suit individual needs and fostering collaborations between 
participants, doctors and allied health professionals (Tsang et al., 2016). 
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To facilitate translation of the ENTICE-CKD program into practice, there are implementation 
frameworks which would be appropriate to follow (Nilsen, 2015) (discussed later in Section 
9.8 - Future directions: Recommendation 5). The implementation of the ENTICE-CKD 
program would likely be achieved by following the Knowledge-to-Action Framework 
(Graham et al., 2006). This thesis has completed the Knowledge-Creation phase (Graham et 
al., 2006) specifically through the completion of scoping reviews (Chapter 2 and 3), 
systematic reviews (Chapters 4 and 5) and stakeholder engagement (Chapter 6 and Appendix 
C). It is prudent to note that although the ENTICE-CKD program has demonstrated 
feasibility, acceptability, safety, and potential effectiveness for exploratory clinical 
parameters, the long-term effectiveness, maintenance and feasibility of the wider 
implementation of the ENTICE-CKD program is an unanswered question for this thesis. 
Implementation of the Action-phase of the  Knowledge-to-Action Framework (Graham et al., 
2006) will require future research to determine the effectiveness, maintenance (both at the 
individual and organisational level) and uptake into clinical practice. These implications have 
been used to formulate specific recommendations (discussed further in Section 9.8 - Future 
directions and recommendations). 
9.6 Implications for implementing a chronic disease telehealth program in 
Australia 
As part of step 1 in the Knowledge-to-Action Framework, it is important to identify problems 
and adapt the knowledge creation to a local context (Graham et al., 2006). The most important 
context to consider is the healthcare setting that the ENTICE-CKD program best fits.  
The Australian health care system relies on a mixture of services funded by government (both 
State and Commonwealth) and non-government (private health insurance) agencies. An 
important limitation to the delivery of telehealth services and uptake into usual dietetic care is 
a lack of meaningful reimbursement under Medicare (i.e. the Australian public health system) 
and private health insurers. This is an issue facing health care systems internationally (Kruse 
et al., 2018; Raven & Bywood, 2013; Schwamm et al., 2016). 
9.6.1 Medicare  
In Australia, Medicare provides rebates for one-on-one consultation with a qualified dietitian, 
which must only be conducted face-to-face. This means online, and other telehealth 
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modalities are either utilised at the expense of the clinician, or the costs are passed onto the 
patient, both of whom are unable to claim an eligible rebate.  
The Medicare Benefits Schedule (MBS) currently recognises videoconferencing as the sole 
telehealth modality eligible for rebate. Medicare rebates are available for these services 
between medical specialists and patients, where an audio-visual link is maintained for the 
duration of the consultation (Department of Health, 2018). In the 2017-2018 Australian 
Federal budget, some allied health professional services were added to the MBS under the 
Better Access Initiative (Department of Health, 2018). These ‘Better Access’ telehealth 
services can be delivered by clinical psychologists, registered psychologists, occupational 
therapists and social workers (Department of Health, 2018). However, dietary and exercise 
physiology interventions delivered by dietitians or exercise physiologists are not part of this 
initiative and therefore people with chronic diseases requiring lifestyle interventions are not 
able to access telehealth services from these allied health professionals easily.  
9.6.2 Private health insurance  
Private health insurance (additional health cover to that provided under Medicare) is optional, 
to reimburse all or part of the cost of hospital and additional health services. The Australian 
Bureau of Statistics estimates that 55% of Australians had private health insurance for ‘extras’ 
cover (which provides rebates for non-hospital services including for dietitian services in 
some circumstances), and 47% had hospital cover in 2016 (Australian Prudential Regulation 
Authority (APRA), 2017). In 2007, changes to the Private Health Insurance Act included 
extended benefits to Broader Health Cover (BHC) which the majority of private health funds 
offer in today’s market. BHC enables private health insurers to offer their members with a 
chronic disease access to claimable programs (some of which can be telehealth) which are 
designed to prevent health complications related to that disease (Biggs, 2013).  
Some private health insurers offer some form of telehealth services as part of BHC in 
Australia. For example, Medibank Private Health has an initiative for their members, 
including a team of allied health professionals which include exercise physiologists, dietitians 
and nurses (Medibank Health Solutions, 2018). The initiative is telephone-based coaching to 
control risk factors known to lead to hospital admissions and other associated health benefit 
claims (Medibank Health Solutions, 2018). Another health insurance product, provided 
through AHM insurance offer a similar ‘Total Health Program’ to their members (Medibank 
Health Solutions, 2018). The Hospitals Contribution Fund of Australia (HCF) offer ‘Healthy 
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Weight for Life’, however only for those with appropriate level of cover and it specifically 
targets weight loss, where there is no other risk factors (Health Comes First (HCF), 2018). 
HCF also offer all their members access to ‘My Health Guardian’, an online system with tools 
to help with diet, health and fitness (Health Comes First (HCM), N.D). With private health 
insurers more inclined to offer telehealth services in chronic disease than government funded 
health services, the ENTICE-CKD program may have wider uptake if it is offered through 
private agencies. 
In a 2013 video consultation policy review, the evidence-base for the effectiveness of all 
allied health professionals using video conferencing was summarised (Raven & Bywood, 
2013). The evidence for dietetic services specifically was favourable, however primarily 
based on low-quality evidence, conducted in small sample size studies and reported mostly in 
feasibility studies which were not designed to establish long-term effectiveness (Raven & 
Bywood, 2013). The evidence base was similar in quality and findings for all allied health 
disciplines. With the added evidence from the telehealth-delivered dietary interventions 
systematic review (Chapter 5), future research should look to determine whether these 
services are cost-effective and have feasibility for wider uptake into clinical practice. This 
future work fits into the ‘assess barriers/facilitators to knowledge use’ in the Action-phase of 
the Knowledge-to-Action framework (Graham et al., 2006) (discussed further in Section 9.8 - 
Future directions and recommendations). 
In summary, despite recent changes in the Australian healthcare system, there are many 
limitations to the implementation of the ENTICE-CKD program into clinical practice. 
However, with future research this thesis summarises and reports evidence which can be used 
to inform policy change and a future implementation study. Future research and any future 
implementation study should be conducted in-line with the Knowledge-to-Action Framework 
(Graham et al., 2006). 
9.7 Strengths and limitations of this thesis 
This thesis reports on the first randomised controlled trial to examine the feasibility and 
acceptability of a telehealth program to improve dietary quality in people with CKD. There 
are several important strengths to note. First, this thesis demonstrates that a robust process 
was used to develop the telehealth program including two comprehensive systematic reviews, 
one which examined all trial literature on the dietary delivery method (telehealth) in all diet-
related chronic diseases and one examining the associations of the planned dietary approaches 
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(healthy dietary pattern) in CKD. Second, this thesis describes extensive CKD patient-
engagement co-creation approach used to develop and pilot the telehealth-delivered 
intervention. This includes a technology-use survey (Appendix C) and a qualitative study 
(Chapter 6) to inform the intervention development and address the concerns that people with 
CKD have about achieving their dietary recommendations. Patient feedback on the 
intervention materials was also sought, prior to finalising materials for the intervention study 
(example in Appendix D). Further patient-engagement activities were also conducted 
following the ENTICE-CKD intervention, through one-on-one interviews and surveying the 
utility and acceptability. The co-creation of the ENTICE-CKD program with patients may be 
a key reason for the successful recruitment and retention of participants in the trial (Chapter 
7). Finally, a pragmatic intervention design of telephone coaching and text messages in the 
ENTICE-CKD study was used to achieve the implementation of this intervention and enable a 
future large-scale effectiveness study.  
Despite these key strengths, there are important limitations to consider. Each of the projects 
contained in this thesis have limitations which have been summarised in their corresponding 
chapters. A summary of the limitations of each chapter is provided in Table 9-2. 
Table 9-2: Summary of the key limitations of each of the studies included in this thesis. 
Chapter Summary of key limitations 
3 
(Narrative Review) 
Did not use a systematic search. 
Inherent biases of narrative reviews which can relate to the 
researchers’ knowledge of the subject field, and selection of 
citations which supports the topic of the review. 
 
4 
(Systematic Review of 
Cohort Studies in 
CKD) 
Non- standardised ‘healthy dietary patterns’.  
Dietary assessment based on self-recalls via differing methods.  
The cohorts had participants with a range of different kidney 
functions.  
Limited generalisability to other global regions (other than United 
States and Sweden). 
Limited ESKD events, so no reliable conclusion on an association 
can be drawn. 
Unable to assess for evidence of publication bias.  




Chapter Summary of key limitations 
5 




Diet recommendations were only components of multifactorial 
lifestyle interventions in 22 of the 25 included studies. 
Limiting generalisability for other telehealth modalities other than 
the telephone. 
Poor intervention reporting in included studies.   











Generalisability of themes to other populations with CKD is 
unknown. 
Did not achieve a sample reflective of the current CKD 
demographic in Australia. 
7 
(Feasibility and 




The feasibility and acceptability results only relate to the enrolled 
participants.  
Limited generalisability to people with lower health literacy due to 
only 10% of participants with low health literacy recruited. 
Participant adherence to the intervention captured using non-
validated surveys.  
Non-tailored education-only (control) group participants were not 
interviewed post-intervention. 
8 




Underpowered to detect change in effectiveness outcomes. 
Reliable comparisons to usual care can only be drawn at 3 months, 
because control group commence an active intervention from 
month 3-6. 
Unable to determine whether a longer term non-tailored education-
only text message intervention would lead to similar results as 
observed in the tailored intervention over 6 months. 
Use of clinic blood pressure measurement and not the gold 
standard 24-hour ambulatory blood pressure monitoring. 
Potential volunteer bias: unable to determine the effects of the 
intervention on people with poor dietary quality and/or lower 
motivation to participants in dietary research trials.  
9.8 Future directions and recommendations  
The future recommendations arising from this body of work address the remaining gaps in the 
literature and key recommendations from individual chapters contained within this thesis. 
Each recommendation has been considered with what is needed to transition the ENTICE-
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CKD program to the Action-phase in the Knowledge-to-Action Framework (Graham et al., 
2006). These recommendations are discussed in detail below.  
Recommendation 1: Conduct a large randomised controlled trial to determine the 
effectiveness of the ENTICE-CKD program over a longer period. 
This thesis has shown the feasibility and acceptability of the ENITCE-CKD program. 
However, before the wider implementation could be considered, a large randomised 
controlled trial is needed to test the program’s overall effectiveness for controlling BP and 
preserving renal function.  
A future effectiveness trial should consider the following learnings from the pilot ENTICE-
CKD trial: 
1. Enhance the generalisability of the study sample by recruiting participants from primary 
care (including general practices) and public and private nephrology units. 
2. Extend to at least a 12-month intervention period (6 month active intervention with 6 
month extended contact), with an observational follow up for dietary behaviour at 24 
months to evaluate the maintenance of behaviour change. 
3. Modify the structure of coaching calls, which may include some tailoring based on 
participants’ progress. All participants who completed call 1 went on to complete at least 
4 calls in the ENTICE-CKD pilot. While reasons for missing the final two calls did vary, 
these calls were used for check-in and review of goals only. This could therefore be done 
at the participant’s discretion and to give participants more flexibility, which was a key 
learning from this thesis - that people with CKD want flexibility in their monitoring 
schedule. 
4. Trial the addition of education and support for general lifestyle change (including exercise 
and medication adherence, in addition to dietary education) as part of the intervention.  
5. Enhance the accuracy of outcome measures. This would include physical activity, 24-hour 
ambulatory BP and medication adherence. Furthermore, capture dietary intake data in 
such a way that a diet quality index such as the Alternative Health Eating Index, can be 
applied to determine changes in diet quality in this population. This index has evidence 
associating it with all-cause mortality and renal end-points outcomes in the general 
population (Smyth et al., 2016; Sotos-Prieto et al., 2017). 
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6. Future interventions to be powered for 24-hour ambulatory BP and/or an eGFR drop of 
30% from baseline (which is considered an important clinical end-point in CKD) (Levey 
et al., 2014). 
7. Due to the unexpected large volume of over 1,000 ‘unrecognised’ text messages sent by 
participants - adapt the program to provide an automated response. 
Recommendation 2: Investigate barriers to people with CKD participating in dietary trials 
and ways to encourage people who are not motivated to participate. 
The ENTICE-CKD study had a 35% recruitment rate, which is a similar recruitment rate to 
other dietary trials in the literature. However, the potential for implementation of this program 
will be dependent on the program’s ability to engage people who are not already motivated to 
change their diet. To investigate this topic, the following could be considered: 
1. Engage general practitioners, nephrologists and renal nurses and explore their 
expectations on dietary services provided to their patients. Specifically, there is a need to 
research general practitioners, nephrologists and renal nurse barriers to referral to dietary 
services and their expectations on outcomes. This could be done in a nation-wide cross-
sectional survey, which could be administered through national bodies such as the 
Australasian Kidney Trial Network, and/or the Australia & New Zealand Society of 
Nephrology. This recommendation is based on findings from the qualitative data in 
ENTICE-CKD, where many participants reported that their motivation to participate had 
come at the suggestion of their nephrologist. Approximately 69% of nephrologists report 
hesitation in prescribing (either ‘never’ or ‘rarely’) low protein dietary advice and less 
than half would consult a dietitian if they chose to intervene (Kalantar-Zadeh et al., 2016). 
Therefore, conducting this work could help understand a strategy for better engaging the 
target population for future trials. 
2. Collect and analyse qualitative data on reasons for non-participation in trials, consider 
inviting non-participants into a qualitative study to investigate reasons for non-
participation in dietary trials. This work could be influential for the wider dietetic 
community to understand how services can best match patient priorities, and better 
address health inequities through strategies that target people with lower motivation to 
change their diets. 
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Recommendation 3: Conduct cost-effectiveness investigations for the ENTICE-CKD 
program. 
One of the key barriers to the wider implementation of telehealth interventions is that 
evidence is lacking about its cost-effectiveness (Henderson et al., 2013). The evidence 
retrieved from the systematic review of telehealth interventions (Chapter 5) did not allow a 
cost-effectiveness summary analysis due to insufficient data. Conducting a cost-effectiveness 
analysis of a dietary program in chronic disease would assist policy makers in decision 
making about whether to fund such programs.  
To conduct this type of analysis, data needs to be collected to evaluate the relative resource 
use and costs associated with both the telehealth intervention and the control intervention. 
This could be done as follows:  
1. Consider keeping a record of start-up costs related to development and delivery of the 
intervention. Costs include programming of the software, technical and coach staffing, the 
telephone-delivered coaching (training, call duration, call attempts, phone call cost, text-
messages, and overheads), the automated text-message system and software licences.  
2. Capture downstream healthcare utilisation over the duration of the trial and follow-up 
using a patient-report calendar approach, including visits to any healthcare providers (e.g. 
general practitioner, specialist, and allied health) and visits to hospital or the emergency 
department (including linkage to diagnosis-reference groups). 
3. Capture health utility which is evaluated using the measure ‘Assessment of Quality of 
Life’ questionnaire (AQoL-4D) (Hawthorne, Richardson, & Osborne, 1999), a validated 
instrument which was used in ENTICE-CKD study. The AQoL-4D can be used to 
estimate the health benefit of the intervention, an important measure to evaluate cost-
effectiveness of this type of intervention.  
Recommendation 4: Conduct a large prospective cohort study to examine the association of 
multiple dietary patterns and single nutrients (such as sodium and protein) with progression to 
ESKD in a cohort with established CKD. 
More research is needed to understand the potential associations of dietary patterns and 
progression to ESKD. This thesis was unable to determine whether a healthy dietary pattern 
reduces the risk of ESKD (Chapter 4). End-stage kidney disease is a relatively rarer 
complication of CKD due to the competing risk of death (discussed in Chapter 2) and 
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demonstrated by the event rate reported in Chapter 4 (3,983 events for mortality, 1,027 events 
for ESKD). Therefore, progression to ESKD needs to be captured in large databases including 
robust dietary data in the CKD population and long-term (>10 years) follow up. While the use 
of registry-based trials may help to ameliorate this challenge (Perkovic et al., 2017), a large 
prospective cohort study is a pragmatic study design which could capture this data. 
Recommendation 5: Plan for the translation of the ENTICE-CKD program into practice 
using established implementation science frameworks as a guide. 
The ENTICE-CKD program is feasible, acceptable, safe and may be effective at improving 
dietary quality in people with CKD. However, longer-term studies are needed to determine its 
clinical effectiveness and long-term maintenance before wider implementation is 
recommended. To facilitate the translation of telehealth initiatives, such as ENTICE-CKD 
into practice, the utilisation of implementation frameworks is encouraged (Nilsen, 2015). For 
example, by using the Knowledge-to-Action cycle (Graham et al., 2006), this thesis provides 
has started to inform the Knowledge Creation stage through its extensive systematic and 
scoping reviews (knowledge synthesis) and stakeholder engagement (knowledge inquiry). 
Moving into the ‘Action cycle’ of this framework provides practical guidance in the planning 
and execution of its implementation. 
However, it is recognised that this thesis has simply shown a novel telehealth program to be 
feasible and acceptable, and the effectiveness results need to be evaluated in larger and 
longer-term studies. If the ENTICE-CKD program was to be implemented into practice, the 
following points should be considered: 
1. Utilising existing telehealth models of care in chronic disease, to facilitate the translation 
into practice. This could include modelling successfully implemented telehealth programs, 
such as the ‘Optimal Health Program’ (Goode et al., 2013) and ‘Get Healthy’ (Khanal et 
al., 2016). 
2. An implementation study should be based on the Action-phase in the Knowledge-to-
Action framework (discussed above) to capture important process data which can 
determine the program’s long-term feasibility in clinical practice. 
3. This program could be tested in clinical practice using a community-based cluster 
randomised implementation trial (Puffer, Torgerson, & Watson, 2005). This would mean 
randomisation would be conducted at the recruiting organisation level, rather than the 
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individual level. This would be less resource intensive and still enable important 
comparisons of referral rates and clinical effectiveness 
4. Under the current models of healthcare, private health insurance agencies may be more 
likely to adopt this program for wider chronic disease management (American Hospital 
Association, 2016). 
9.9 Conclusions 
The individual studies completed within this thesis were conducted with the overarching aim 
to develop and test the feasibility and acceptability of a patient-centred telehealth program for 
dietary self-management in people with CKD. Through two systematic reviews, this thesis 
has shown that healthy dietary patterns are associated with a reduced risk of death, are a 
possible dietary approach in CKD and that telehealth methods are effective in delivering 
dietary education in chronic disease. Using a qualitative design, this thesis utilised focus 
groups as a form of patient-engagement to collect patient-centred experiences with dietary 
recommendations and perceptions about using telehealth to support self-management. These 
three projects were collectively used to develop a patient-centred telehealth program (the 
ENTICE-CKD program) to improve diet quality in people with CKD. The ENTICE-CKD 
program was shown to be feasible and acceptable to people with CKD and was successfully 
delivered to protocol. The intensive coaching (intervention) group improved aspects of their 
diet quality and reduced their body weight and waist circumference. The non-tailored 
education-only text message (control) group participants observed some modest changes in 
components of diet quality but no significant changes in any clinical parameters. Collectively, 
the results of this thesis can be used to inform future public policy for the use of telehealth for 
dietary education in chronic disease management and a large-scale randomised controlled trial 
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Appendix G: Chapter 4 search terms 
Database searched Search terms 
Medline Kidney Diseases/ 
Diabetic Nephropathies/ 
exp Renal Replacement Therapy/ 
Renal Insufficiency/ 
exp Renal Insufficiency, Chronic/ 
dialysis.tw. 
(hemodialysis or haemodialysis).tw. 
(hemofiltration or haemofiltration).tw. 
(hemodiafiltration or haemodiafiltration).tw. 
(kidney disease or renal disease or kidney failure or renal failure).tw. 
(ESRF or ESKF or ESRD or ESKD).tw. 
(CKF or CKD or CRF or CRD).tw. 
(CAPD or CCPD or APD).tw. 
(predialysis or pre-dialysis).tw. 




Glomerular Filtration Rate/ 
proteinuria.tw. 
albuminuria.tw. 




exp Food Habits/ 
Fruit/ and Vegetables/ 
((diet or diets or dietary or nutrition*) adj2 (pattern* or quality or 
guideline*)).tw. 
((diet or diets or dietary) adj5 (Mediterranean or vegetarian or plant-
based or American Heart Association* or DASH or western or 
seafood)).tw. 
((diet or diets or dietary or high or increase* or rich) adj5 (fruit* or 
vegetable* or nut or nuts or fibre or fiber or olive oil or omega-3 fatty 
acids or unsaturated or polyunsaturated or monounsaturated or fish or 
seafood pulses)).tw. 
(food adj2 group*).tw. 
healthy eating index.tw. 
((diet or dietary or nutrition*) adj (survey* or record or records or 
score)).tw. 








Database searched Search terms 
risk.mp. 
exp Case-Control Studies/ 
((cohort or concurrent or longitudinal or follow-up or followup or 
prospective or retrospective or cross-sectional or case-control) adj2 
(analys* or design* or evaluation* or research or study or studies or 
survey*)).tw. 




Embase exp renal replacement therapy/ 
kidney disease/ 
chronic kidney disease/ 
kidney failure/ 
chronic kidney failure/ 
mild renal impairment/ 
stage 1 kidney disease/ 
moderate renal impairment/ 
severe renal impairment/ 
end stage renal disease/ 
renal replacement therapy-dependent renal disease/ 
kidney transplantation/ 
diabetic nephropathy/ 
(hemodialysis or haemodialysis).tw. 
(hemofiltration or haemofiltration).tw. 
(hemodiafiltration or haemodiafiltration).tw. 
(kidney disease* or renal disease* or kidney failure or renal 
failure).tw. 
(kidney transplant* or renal transplant* or kidney graft* or renal 
graft*).tw. 
(ESRF or ESKF or ESRD or ESKD).tw. 
(CKF or CKD or CRF or CRD).tw. 





glomerulus filtration rate/ 
proteinuria.tw. 
albuminuria.tw. 
(glomerular filtration rate or GFR or eGFR).tw. 
or/1-29                                           
exp diet/ 
diabetic diet/ 
low fat diet/ 
diet therapy/ 
dietary intake/ 
Fruit/ and Vegetable/ 
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Database searched Search terms 
((diet or diets or dietary or nutrition*) adj2 (pattern* or quality or 
guideline*)).tw. 
((diet or diets or dietary) adj5 (Mediterranean or vegetarian or plant-
based or American Heart Association* or DASH or western or 
seafood)).tw. 
((diet or diets or dietary or high or increase* or rich) adj5 (fruit* or 
vegetable* or nut or nuts or fibre or fiber or olive oil or omega-3 fatty 
acids or unsaturated or polyunsaturated or monounsaturated or fish or 
seafood or pulses)).tw. 
(food adj2 group*).tw. 
healthy eating index.tw. 
((diet or dietary or nutrition*) adj (survey* or record or records or 
score)).tw. 
food frequency questionnaire*.tw. 
diet.tw. 
or/31-44                                                   












((cohort or concurrent or longitudinal or follow-up or followup or 
prospective or retrospective or cross-sectional or case-control) adj2 
(analys* or design* or evaluation* or research or study or studies or 
survey*)).tw. 
(incidence adj1 (analys* or research or study or studies or 
survey*)).tw. 
or/47-59                                                        
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Appendix I: Chapter 6 focus group questions and vignettes 
Table I-1: Focus group questions  
1. Intro and ice-breaker 
- We want to hear your thoughts and experience with making diet changes in your life 
2. What has helped you in the past to change your diet?  
- Has a dietitian been the one telling you to make these changes? Or who do you go to 
for diet advice? 
- What makes it hard to make these changes? 
- Do you ever feel like think you need more help when it does get hard, from your 
dietitian or someone else? 
- What kind of help do you think you need?  
3. Have you been told to cut down your salt intake before?  
- How do you go following it? 
- What’s the longest you have been able to follow it? 
- What would help you to keep eating less salt in your diet? 
o Can you tell me what has made it easier to make this change to your diet? 
4. What other kidney diet changes do you find difficult to follow? 
- Do you feel you get enough information from your dietitian/other? Why, why not? 
- Many kidney patients have told us previously that they prefer regular appointments 
or follow up to help them keep up with changes to their diet – what do you think 
about that? 
5. We are looking at ways to give you regular coaching and diet reminders – rather 
than booking into see the dietitian for review appointments at the hospital or 
clinic, some research has shown that the telephone and some technology (like a 
mobile) can mean you get this regular reminding and coaching – do you think 
this would be a good thing for you?  
- Which way would you prefer? 
o Face-to-face at the hospital/clinic; 
o Over the telephone; 
o Text/SMS; 
o Combination 
6. If this was done face to face – waiting times could increase, and you might get less 
time with the dietitian – do you think the telephone or other types of technology 
would continue to help you make changes to your diet, without the wait times?  
- Are you confident in using the telephone? 
o Talk to family/friends? 
- Are you confident in using a mobile phone? 
o Apps? Text messaging? 
o Appointment reminders 
- What about visiting a website? 
o Have you ever used this as another source of information?  
o Can be used to put in your own diet information and then receive feedback 
o Online community with other kidney patients to support each other 
o What about email? 
7. Would receiving regular telephone call appointments to get this coaching for diet 
advice interest you? 
- Would that help you to make those difficult diet changes? (salt or other) 
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- Why can’t you use this technology? (contingent) - What would make it easier? 
- What would help you then to use more technology like this to follow low salt advice? 
(contingent) 
 
- If you did receive telephone calls, would SMS reminders about the calls be helpful? 
How often? 
- What about SMS reminders reinforcing the call content be helpful?  
- Do you think this could be a good way to get feedback on your diet? 
8. If you were the dietitian and coaching someone else to make kidney diet changes, 
what advice would you give them? 
o What is important to know for them? 
- How often would you contact them? 
- Would you do it face-to-face or …. 
- What if face-to-face meant you couldn’t see them as often as you like? 
- Is there anything else you would talk about?  
9. This may seem very futuristic – but do you think this type of dietary service is a 
better way forward? 
- Is tracking blood tests something that might be useful to you? 




    




   
 
Figure I-1: PowerPoint show vignettes for focus group  
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Appendix K: Chapter 7 Utility and acceptability questionnaire 
Table K-1. Utility and acceptability questionnaire completed at 6 months.  
Thinking about the text message component of the ENTICE intervention; please answer the 
following questions (part A). 
 
1. The text messages sent to me were useful in supporting me make a dietary change?  
o Strongly agree  
o Agree 
o Neither agree or disagree  
o Disagree 
o Strongly disagree  
2. The text messages sent to me were easy to understand? 
o Strongly agree  
o Agree 
o Neither agree or disagree  
o Disagree 
o Strongly disagree  
3. The text messages sent to me motivated me to change my diet 
o Strongly agree  
o Agree 
o Neither agree or disagree  
o Disagree 
o Strongly disagree 
4. The text messages sent to me made me eat healthier?  
o Strongly agree  
o Agree 
o Neither agree or disagree  
o Disagree 
o Strongly disagree 
5. The text messages sent to me made me exercise more? 
o Strongly agree  
o Agree 
o Neither agree or disagree  
o Disagree 
o Strongly disagree  
6. How many of the text messages sent to you did you read? 
o All  
o Approximately three quarters  
o Approximately one half  
o Approximately one quarter 
o None  
7. What did you do after receiving the text message? 
o Ignore it 
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o Read and saved  
o Read and deleted  
 
Thinking about the text message component of the ENTICE intervention; please answer the 
following questions (part B) 
 
8. Did you share your text messages with family friends or your health care providers? 
o No 
o Yes; (please specify) 
o Spouse 
o Other family member 
o Doctor 
o Nurse 
o Other Health Care Professional  
9. The text messages sent to me where worded in a suitable language 
o Yes  
o No 
10. The text messages sent to me were too regular  
o Yes  
o No 
11. The text message program (over 6 months) was long enough? 
o Yes  
o No 
12. The text messages sent to me were at an appropriate time of the day/night? 






Appendix L: Chapter 7 interview schedule for the semi-structured 
interviews 
Table L-1. Semi-structured Interview Schedule. 





I’m interested to hear about your story with a kidney condition. Would you be 
able to tell me about your story from when you first found out, how you felt 
and your journey up until now?  
- Can you tell me how you felt, or your initial reactions, when you were first 
diagnosed? 
- What was your experience with the healthcare system and dietitians before 
the ENTICE program? 
Can you talk me through how you got involved in the program? What 
happened? 
- How and why did you sign up? (Motivation? Knowledge? Priorities?) 
- Who influenced your decision to take part in the program? How? Why? 
- Did your doctor recommend the program? Did they have an influence on 
your decision to take part?  (Support/pressure? Influence of medical 
professionals?)  
What happened after you signed up for the program? 







Before ENTICE, did you have any needs, challenges, concerns about diet? 
Could you briefly tell me about that? 
To what degree does the ENTICE program meet your needs or address what 
you want? How? Why? 
What do you like most/least about being involved in the program - why? 
What were some of the things that made the program easy/difficult to take part 
in? 









Let’s move on to your experiences with the phone calls. 
- What did you expect from the calls and did they meet your expectations? 
- What are your thoughts on never having seen [coach name] and building 
a relationship with them? 
- How do you think using the telephone is different to seeing someone in 
person? Feel any different being in a familiar environment compared to a 
clinic? 
- Can you share some things that made the phone calls easier/harder than 
seeing [coach name] in person? 
- Were you able to make the calls at a suitable time - how? 
- What do you think about the frequency of the calls? – why? 
- How did you feel about the length of the calls? Did you feel you were 
rushed during the calls? 
- Do you have anything more to add about the phone calls? 
Let’s talk about the text messages now, what did you think about getting the 
text messages from [coach name]? 




- Do you think the text messages were necessary - why?  
- What do you think about how frequently you got the text messages? 
Why? 
- Do you have anything more to add about the text messages? 
You got a workbook at the start of the program. 
- What are your thoughts on the information in the workbook? – why? 
- Can you give me an example of something from the workbook that had 
an impact on you? (Why? Motivation? Knowledge?) 
- Did you have any difficulties understanding the information in the 
workbook? 
- Did you show the workbook to anyone? Who? Why? What did they 
think? 




Can you think of an example recommendation that [JK/MC] gave you about 
your diet or your lifestyle? 
- What are some things that helped you/made it hard for you to follow 





What are your thoughts on setting health goals?  
- How do you feel about goal setting? 
- Can you tell me about your experience with goal setting before the 
program? 
- Did you set goals in the program? When? Are you able to tell me about 
one of your goals? 
- Do you think ENTICE helped you to achieve your goals - why? 
One of the aims of ENTICE is to improve self-monitoring –do you know what 
self-monitoring means? (Stuff you’ll do without people reminding you, like 
writing down or taking note of what you eat or how active you’ve been) 
- Do you find you do that? Why? 
- What impact do you think the program has had on your self-monitoring? 
(The way you go about it? How often?) 




You have made some changes to your lifestyle in order to meet your goals 
[example] 
- Will these changes be something that you’ll continue to do? – how? why? 
- Can you tell me about your motivation to make changes before the 
program? 
- How and why did your motivation change during the program?  
- How do you feel about keeping motivated after the program? 
Do you feel like your daily activities have changed since before the program? 
How? (Eating behaviour? Purchasing of foods? How physically active you 
are?)   
7. 
Experiences 
- Did you feel that the recommendations from [coach name] were specific 
to you and nobody else?  
- Can you give an example of when you felt this way? 
- Were the recommendations clear? How? Why? 
- Do you understand why the advice was given to you? 
- Do you think the program and the telephone sessions were suited to your 
culture? 
- Did you share your experiences with the program with anybody else? 
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Family, friends, other health professionals? How? Why? Did you find it 
helpful? 
Imagine you became director of the hospital and you had the power to improve 
the services for people with kidney disease. What would be the top 2 changes 
you would make to improve the care and support for people with kidney 
disease? 
8. Closing We would like you to help us evaluate the program to help improve it and the 
difference it makes to patients. Is there anything that you think would be 
important to mention that we haven’t covered?  
 
